@article{Tibshirani2011,
    title = {{Regression shrinkage and selection via the lasso: A retrospective}},
    year = {2011},
    journal = {Journal of the Royal Statistical Society. Series B: Statistical Methodology},
    author = {Tibshirani, Robert},
    number = {3},
    pages = {273--282},
    volume = {73},
    pmid = {16272381},
    arxivId = {1369–7412/11/73273},
    keywords = {Penalization, Regularization, l{\\\}                        1-penalty}
}

@book{Nocedal1999,
    title = {{Numerical Optimization}},
    year = {1999},
    booktitle = {Analysis},
    author = {Nocedal, J and Wright, S J},
    editor = {Glynn, Peter and Robinson, Stephen M},
    chapter = {5},
    number = {2},
    pages = {164--75},
    series = {Springer Series in Operations Research},
    volume = {43},
    publisher = {Springer},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/21643320},
    isbn = {0387987932},
    doi = {10.1002/lsm.21040},
    issn = {10969101},
    pmid = {21384397}
}

@article{Shewchuk1994,
    title = {{An Introduction to the Conjugate Gradient Method Without the Agonizing Pain}},
    year = {1994},
    journal = {Science},
    author = {Shewchuk, Jonathan Richard},
    number = {CS-94-125},
    pages = {64},
    volume = {49},
    publisher = {Citeseer},
    url = {http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.110.418&amp;rep=rep1&amp;type=pdf\nhttp://www.cs.cmu.edu/~quake-papers/painless-conjugate-gradient.pdf},
    institution = {Carnegie Mellon University},
    keywords = {1, 2, 5, agonizing pain, conjugate gradient method, convergence analysis, eigen do, eigenvalues, i try, jacobi iterations, preconditioning, thinking with eigenvectors}
}

@misc{RDevelopmentCoreTeam2011,
    title = {{R: A Language and Environment for Statistical Computing}},
    year = {2011},
    booktitle = {R Foundation for Statistical Computing},
    author = {R Development Core Team, R},
    editor = {Team, R Development Core},
    number = {2.11.1},
    pages = {409},
    series = {R Foundation for Statistical Computing},
    volume = {1},
    publisher = {R Foundation for Statistical Computing},
    url = {http://www.r-project.org},
    institution = {R Foundation for Statistical Computing},
    isbn = {3900051070},
    doi = {10.1007/978-3-540-74686-7},
    issn = {16000706}
}

@article{Thall2004,
    title = {{Dose-Finding Based on Efficacy-Toxicity Trade-Offs}},
    year = {2004},
    journal = {Biometrics},
    author = {Thall, PF and Cook, JD},
    number = {3},
    pages = {684--693},
    volume = {60},
    keywords = {adaptive design, bayesian design, biologic agents, dose-finding, phase i clinical trial, phase ii}
}

@article{Wages2014,
    title = {{Seamless Phase I/II Adaptive Design For Oncology Trials of Molecularly Targeted Agents.}},
    year = {2014},
    journal = {Journal of biopharmaceutical statistics},
    author = {Wages, Nolan a and Tait, Christopher},
    pages = {1--30},
    url = {http://dx.doi.org/10.1080/10543406.2014.920873},
    doi = {10.1080/10543406.2014.920873},
    issn = {1520-5711},
    pmid = {24904956},
    keywords = {continual reassessment method, dose finding, larly targeted agent, molecu-, optimal biological dose}
}

@article{Andtbacka2015,
    title = {{Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma}},
    year = {2015},
    journal = {Journal of Clinical Oncology},
    author = {Andtbacka, R. H. I. and Kaufman, H. L. and Collichio, F. and Amatruda, T. and Senzer, N. and Chesney, J. and Delman, K. a. and Spitler, L. E. and Puzanov, I. and Agarwala, S. S. and Milhem, M. and Cranmer, L. and Curti, B. and Lewis, K. and Ross, M. and Guthrie, T. and Linette, G. P. and Daniels, G. a. and Harrington, K. and Middleton, M. R. and Miller, W. H. and Zager, J. S. and Ye, Y. and Yao, B. and Li, A. and Doleman, S. and VanderWalde, A. and Gansert, J. and Coffin, R.},
    url = {http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.58.3377},
    doi = {10.1200/JCO.2014.58.3377},
    issn = {0732-183X}
}

@article{Wason2011a,
    title = {{Reducing sample sizes in two-stage phase II cancer trials by using continuous tumour shrinkage end-points}},
    year = {2011},
    journal = {European Journal of Cancer},
    author = {Wason, James M S and Mander, Adrian P. and Eisen, Tim G.},
    number = {7},
    pages = {983--989},
    volume = {47},
    publisher = {Elsevier Ltd},
    url = {http://dx.doi.org/10.1016/j.ejca.2010.12.007},
    doi = {10.1016/j.ejca.2010.12.007},
    issn = {09598049},
    pmid = {21239164},
    keywords = {Phase II cancer clinical trials, RECIST, Sample sizes, Trial design}
}

@article{Wason2013,
    title = {{Using continuous data on tumour measurements to improve inference in phase II cancer studies}},
    year = {2013},
    journal = {Statistics in Medicine},
    author = {Wason, James M S and Seaman, Shaun R.},
    number = {26},
    pages = {4639--4650},
    volume = {32},
    doi = {10.1002/sim.5867},
    issn = {02776715},
    pmid = {23776143},
    keywords = {Continuous tumour shrinkage endpoints, Informative dropout, Longitudinal model, Phase II cancer trial}
}

@article{Wason2011,
    title = {{The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expected}},
    year = {2011},
    journal = {Statistical Methods in Medical Research},
    author = {Wason, J. M. and Mander, a. P.},
    isbn = {0962280211432},
    doi = {10.1177/0962280211432192},
    issn = {0962-2802},
    pmid = {22179821}
}

@article{Abel2012,
    title = {{Sample sizes for time-to-event endpoints: Should you insure against chance variations in accrual?}},
    year = {2012},
    journal = {Contemporary Clinical Trials},
    author = {Abel, Ulrich R. and Jensen, Katrin and Karapanagiotou-Schenkel, Irini},
    number = {2},
    pages = {456--458},
    volume = {33},
    publisher = {Elsevier Inc.},
    url = {http://dx.doi.org/10.1016/j.cct.2011.10.009},
    doi = {10.1016/j.cct.2011.10.009},
    issn = {15517144},
    pmid = {22094431},
    keywords = {Accrual, Controlled clinical trials, Sample size, Survival}
}

@article{Thall2005,
    title = {{Monitoring event times in early phase clinical trials: some practical issues.}},
    year = {2005},
    journal = {Clinical trials (London, England)},
    author = {Thall, Peter F and Wooten, Leiko H and Tannir, Nizar M},
    number = {6},
    pages = {467--478},
    volume = {2},
    doi = {10.1191/1740774505cn121oa},
    issn = {17407745},
    pmid = {16422307}
}

@article{Thall2003,
    title = {{Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes}},
    year = {2003},
    journal = {Statistics in Medicine},
    author = {Thall, Peter F. and Wathen, J. Kyle and Bekele, B. Nebiyou and Champlin, Richard E. and Baker, Laurence H. and Benjamin, Robert S.},
    number = {5},
    pages = {763--780},
    volume = {22},
    isbn = {0277-6715; 0277-6715},
    doi = {10.1002/sim.1399},
    issn = {02776715},
    pmid = {12587104},
    keywords = {Activity trial, Bone marrow transplantation, Heterogeneity, Phase II clinical trial, Sarcoma}
}

@article{LeTourneau2009,
    title = {{Dose escalation methods in phase i cancer clinical trials}},
    year = {2009},
    journal = {Journal of the National Cancer Institute},
    author = {Le Tourneau, Christophe and Lee, J. Jack and Siu, Lillian L.},
    number = {10},
    pages = {708--720},
    volume = {101},
    doi = {10.1093/jnci/djp079},
    issn = {00278874},
    pmid = {19436029}
}

@article{Thall2014,
    title = {{Effective sample size for computing prior hyperparameters in Bayesian phase I-II dose-finding}},
    year = {2014},
    journal = {Clinical Trials},
    author = {Thall, PF and Herrick, RC and Nguyen, HQ and Venier, JJ and Norris, JC},
    number = {6},
    pages = {657--666},
    volume = {11},
    url = {http://ctj.sagepub.com/cgi/doi/10.1177/1740774514547397},
    isbn = {1740774514547},
    doi = {10.1177/1740774514547397},
    issn = {1740-7745},
    keywords = {adaptive design, bayesian design, clinical trial, dose-finding, ii trial, phase i}
}

@techreport{Cook2006,
    title = {{Efficacy-Toxicity trade-offs based on L-p norms: Technical Report UTMDABTR-003-06}},
    year = {2006},
    author = {Cook, John D},
    pages = {1--9}
}

@article{Bryant1995,
    title = {{Incorporating toxicity considerations into the design of two-stage phase II clinical trials.}},
    year = {1995},
    journal = {Biometrics},
    author = {Bryant, J and Day, R},
    number = {4},
    pages = {1372--1383},
    volume = {51},
    doi = {10.2307/2533268},
    issn = {0006-341X},
    pmid = {8589229},
    keywords = {early stopping, ii trials, toxicity considerations in phase, two-stage clinical trials}
}

@article{Yap2011,
    title = {{Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia}},
    year = {2011},
    journal = {Trials},
    author = {Yap, Christina and Billingham, Lucinda and Pettitt, Andrew},
    number = {Suppl 1},
    pages = {A91},
    volume = {12},
    publisher = {BMC Medical Research Methodology},
    url = {BMC Medical Research Methodology},
    doi = {10.1186/1745-6215-12-S1-A91},
    issn = {1745-6215},
    pmid = {23819695},
    keywords = {Moderate Sample Sizes, Oncology, Play-the-Winner, Randomised Phase II, Screening Design, Selection Design, moderate sample, oncology, play-the-winner, randomised phase ii, screening design, selection design}
}

@article{Larkin2015,
    title = {{Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma}},
    year = {2015},
    journal = {New England Journal of Medicine},
    author = {Larkin, J and Chiaron-Sileni, V and Gonzalez, R and Grob, JJ and Cowey, CL and Lao, CD and Schadendorf, D and Dummer, R and Smylie, M and Rutkowski, P and Ferrucci, P F and Hill, A and Wagstaff, J and Carlino, M S and Haanen, J B and Maio, M and Rodas, I Marquez and Hodi, F S and Wolchok, J D},
    doi = {10.1056/NEJMoa1504030}
}

@article{Thall1999,
    title = {{Treatment comparisons based on two-dimensional safety and efficacy alternatives in oncology trials.}},
    year = {1999},
    journal = {Biometrics},
    author = {Thall, P F and Cheng, S C},
    number = {3},
    pages = {746--753},
    volume = {55},
    issn = {0006341X},
    pmid = {11315002},
    keywords = {bivariate data, cancer chemotherapy, clinical trials, hypothesis testing, safety monitoring}
}

@article{Bakhshi2011,
    title = {{Modelling and predicting patient recruitment in multi-centre clinical trials}},
    year = {2011},
    author = {Bakhshi, Andisheh},
    url = {http://theses.gla.ac.uk/3301/},
    keywords = {QA Mathematics}
}

@article{Anisimov2007,
    title = {{Modelling, prediction and adaptive adjustment of recruitment in multicentre trials}},
    year = {2007},
    journal = {Statistics in medicine},
    author = {Anisimov, Vladimir V. and Fedorov, Valerii V.},
    pages = {4958--4975},
    volume = {26},
    isbn = {2007090091480},
    doi = {10.1002/sim},
    pmid = {19455509},
    keywords = {estimation, multicentre trial, poisson-gamma model, prediction, random recruitment}
}

@article{Anisimov2011b,
    title = {{Effects of unstratified and centre-stratified randomization in multi-centre clinical trials}},
    year = {2011},
    journal = {Pharmaceutical Statistics},
    author = {Anisimov, Vladimir V.},
    number = {1},
    pages = {50--59},
    volume = {10},
    isbn = {1539-1612 (Electronic){\textbackslash}r1539-1604 (Linking)},
    doi = {10.1002/pst.412},
    issn = {15391604},
    pmid = {20112277},
    keywords = {Poisson-gamma recruitment model, centre-stratified randomization, imbalance, multicentre trials, sample size, unstratified randomization}
}

@article{Anisimov2011a,
    title = {{Statistical Modeling of Clinical Trials (Recruitment and Randomization)}},
    year = {2011},
    journal = {Communications in Statistics-Theory and Methods},
    author = {Anisimov, Vladimir V},
    number = {19-20},
    pages = {3684--3699},
    volume = {40},
    url = {<Go to ISI>://WOS:000294892100023},
    isbn = {0361-0926},
    doi = {10.1080/03610926.2011.581189},
    issn = {0361-0926}
}

@article{Zhang2012,
    title = {{Modeling and prediction of subject accrual and event times in clinical trials : a systematic review}},
    year = {2012},
    journal = {Clinical Trials},
    author = {Zhang, X. and Long, Q.},
    doi = {10.1177/1740774512447996},
    issn = {1740-7745},
    pmid = {22674642}
}

@article{Ying2013,
    title = {{Prediction of event times in the REMATCH Trial.}},
    year = {2013},
    journal = {Clinical trials (London, England)},
    author = {Ying, Gui-Shuang and Heitjan, Daniel F},
    number = {2},
    pages = {197--206},
    volume = {10},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/23321264},
    doi = {10.1177/1740774512470314},
    issn = {1740-7753},
    pmid = {23321264}
}

@article{Anisimov2011,
    title = {{Predictive event modelling in multicenter clinical trials with waiting time to response}},
    year = {2011},
    journal = {Pharmaceutical Statistics},
    author = {Anisimov, Vladimir V.},
    number = {6},
    pages = {517--522},
    volume = {10},
    doi = {10.1002/pst.525},
    issn = {15391604},
    pmid = {22140055},
    keywords = {Event modeling, Markov model, Poisson-gamma recruitment model, estimation, multicenter clinical trial, prediction}
}

@article{Thall2006,
    title = {{Adaptive dose selection using efficacy-toxicity trade-offs: illustrations and practical considerations.}},
    year = {2006},
    journal = {Journal of biopharmaceutical statistics},
    author = {Thall, PF and Cook, JD and Estey, EH},
    number = {5},
    pages = {623--638},
    volume = {16},
    doi = {10.1080/10543400600860394},
    issn = {1054-3406},
    pmid = {17037262}
}

@article{Braun2002,
    title = {{The bivariate continual reassessment method: Extending the CRM to phase I trials of two competing outcomes}},
    year = {2002},
    journal = {Controlled Clinical Trials},
    author = {Braun, Thomas M.},
    number = {3},
    pages = {240--256},
    volume = {23},
    isbn = {0197-2456 (Print){\textbackslash}r0197-2456 (Linking)},
    doi = {10.1016/S0197-2456(01)00205-7},
    issn = {01972456},
    pmid = {12057877},
    keywords = {Bayesian inference, Bone marrow transplant, Clinical trial, Correlated binary data}
}

@article{Yin2006,
    title = {{Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios}},
    year = {2006},
    journal = {Biometrics},
    author = {Yin, Guosheng and Li, Yisheng and Ji, Yuan},
    number = {3},
    pages = {777--787},
    volume = {62},
    isbn = {0006-341X},
    doi = {10.1111/j.1541-0420.2006.00534.x},
    issn = {0006341X},
    pmid = {16984320},
    keywords = {Bayesian adaptive design, Bivariate binary model, Equivalence contour, Gibbs sampling, Trade-offs}
}

@article{Eisenhauer2009,
    title = {{New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)}},
    year = {2009},
    journal = {European Journal of Cancer},
    author = {Eisenhauer, E. a. and Therasse, P. and Bogaerts, J. and Schwartz, L. H. and Sargent, D. and Ford, R. and Dancey, J. and Arbuck, S. and Gwyther, S. and Mooney, M. and Rubinstein, L. and Shankar, L. and Dodd, L. and Kaplan, R. and Lacombe, D. and Verweij, J.},
    number = {2},
    pages = {228--247},
    volume = {45},
    publisher = {Elsevier Ltd},
    url = {http://dx.doi.org/10.1016/j.ejca.2008.10.026},
    isbn = {1879-0852 (Electronic)},
    doi = {10.1016/j.ejca.2008.10.026},
    issn = {09598049},
    pmid = {19097774},
    keywords = {Guidelines, Response criteria, Solid tumours}
}

@article{OQuigley1990,
    title = {{Continual reassessment method: a practical design for phase 1 clinical trials in cancer.}},
    year = {1990},
    journal = {Biometrics},
    author = {O'Quigley, J and Pepe, M and Fisher, L},
    number = {1},
    pages = {33--48},
    volume = {46},
    isbn = {0006-341X},
    doi = {10.2307/2531628},
    issn = {0006-341X},
    pmid = {2350571}
}

@article{Lai2001,
    title = {{Brownian motion and long-term clinical trial recruitment}},
    year = {2001},
    journal = {Journal of Statistical Planning and Inference},
    author = {Lai, D J and Moye, L a and Davis, B R and Brown, L E and Sacks, F M},
    number = {1-2},
    pages = {239--246},
    volume = {93},
    url = {<Go to ISI>://WOS:000166861200015},
    isbn = {0378-3758},
    doi = {10.1016/s0378-3758(00)00203-2},
    keywords = {brownian motion, clinical trial recruitment, decision making, prediction}
}

@article{Gajewsji2008,
    title = {{Predicting accrual in clinical trials with Bayesian posterior predictive distributions}},
    year = {2008},
    journal = {Statistics in medicine},
    author = {Gajewski, Byron J. and Simon, Stephen D. and Carlson, Susan E.},
    pages = {2328--2340},
    volume = {27},
    isbn = {2007090091480},
    doi = {10.1002/sim},
    pmid = {19455509},
    keywords = {bayesian, exponential, inverse gamma, prior elicitation, sample size}
}

@article{Altman2006,
    title = {{Statistics Notes 52: The cost of dichotomising continuous variables}},
    year = {2006},
    journal = {British Medical Journal},
    author = {Altman, Douglas G and Royston, Patrick},
    number = {7549},
    pages = {1080},
    volume = {332},
    url = {http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1458573&tool=pmcentrez&rendertype=abstract\nhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1458573&amp;tool=pmcentrez&amp;rendertype=abstract},
    isbn = {1468-5833 (Electronic){\textbackslash}r0959-535X (Linking)},
    doi = {10.1136/bmj.332.7549.1080},
    issn = {1468-5833},
    pmid = {16675816},
    keywords = {Data Interpretation, Regression Analysis, Statistical}
}

@article{Garrett-Mayer2006,
    title = {{The continual reassessment method for dose-finding studies: a tutorial.}},
    year = {2006},
    journal = {Clinical trials (London, England)},
    author = {Garrett-Mayer, Elizabeth},
    number = {1},
    pages = {57--71},
    volume = {3},
    doi = {10.1191/1740774506cn134oa},
    issn = {17407745},
    pmid = {16539090}
}

@article{Iasonos2008,
    title = {{A comprehensive comparison of the continual reassessment method to the standard 3 + 3 dose escalation scheme in Phase I dose-finding studies.}},
    year = {2008},
    journal = {Clinical trials (London, England)},
    author = {Iasonos, Alexia and Wilton, Andrew S and Riedel, Elyn R and Seshan, Venkatraman E and Spriggs, David R},
    number = {5},
    pages = {465--477},
    volume = {5},
    isbn = {1740774508096},
    doi = {10.1177/1740774508096474},
    issn = {1740-7745},
    pmid = {18827039}
}

@article{OQuigley2001,
    title = {{Dose-finding designs for HIV studies.}},
    year = {2001},
    journal = {Biometrics},
    author = {O'Quigley, J and Hughes, M D and Fenton, T},
    number = {4},
    pages = {1018--1029},
    volume = {57},
    doi = {10.1111/j.0006-341X.2001.01018.x},
    issn = {0006341X},
    pmid = {11764240},
    keywords = {clinical trials, continual reassessment method, dose escalation, dose-finding studies, efficacy studies, hiv, phase i trial, phase ii trial, toxicity}
}

@article{Ji2010,
    title = {{A modified toxicity probability interval method for dose-finding trials.}},
    year = {2010},
    journal = {Clinical trials (London, England)},
    author = {Ji, Yuan and Liu, Ping and Li, Yisheng and Bekele, B Nebiyou},
    number = {6},
    pages = {653--663},
    volume = {7},
    isbn = {1740774507},
    doi = {10.1177/1740774510382799},
    issn = {1740-7745},
    pmid = {20935021}
}

@article{Babb1998,
    title = {{Cancer phase I clinical trials: Efficient dose escalation with overdose control}},
    year = {1998},
    journal = {Statistics in Medicine},
    author = {Babb, James and Rogatko, André and Zacks, Shelemyahu},
    number = {10},
    pages = {1103--1120},
    volume = {17},
    doi = {10.1002/(SICI)1097-0258(19980530)17:10<1103::AID-SIM793>3.0.CO;2-9},
    issn = {02776715},
    pmid = {9618772}
}

@article{AhnOptimal,
    title = {{Optimal Biological Dose for Molecularly-Targeted Therapies}},
    journal = {Wiley StatsRef: Statistics Reference Online},
    author = {Ahn, Chul and Kang, Seung-Ho and Xie, Yang}
}

@book{Cheung2011,
    title = {{Dose Finding by the Continual Reassessment Method}},
    year = {2011},
    author = {Cheung, Ying Kuen},
    publisher = {Chapman {\&} Hall / CRC Press},
    address = {New York}
}

@article{Cortes2013,
    title = {{A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.}},
    year = {2013},
    journal = {The New England journal of medicine},
    author = {Cortes, J E and Kim, D-W and Pinilla-Ibarz, J and le Coutre, P and Paquette, R and Chuah, C and Nicolini, F E and Apperley, J F and Khoury, H J and Talpaz, M and DiPersio, J and DeAngelo, D J and Abruzzese, E and Rea, D and Baccarani, M and M{\"{u}}ller, M C and Gambacorti-Passerini, C and Wong, S and Lustgarten, S and Rivera, V M and Clackson, T and Turner, C D and Haluska, F G and Guilhot, F and Deininger, M W and Hochhaus, A and Hughes, T and Goldman, J M and Shah, N P and Kantarjian, H},
    number = {19},
    pages = {1783--96},
    volume = {369},
    url = {http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3886799&tool=pmcentrez&rendertype=abstract},
    isbn = {1533-4406 (Electronic){\textbackslash}r0028-4793 (Linking)},
    doi = {10.1056/NEJMoa1306494},
    issn = {1533-4406},
    pmid = {24180494},
    keywords = {80 and over, Adolescent, Adult, Aged, BCR-ABL Positive, BCR-ABL Positive: drug therapy, Chronic, Female, Humans, Imidazoles, Imidazoles: adverse effects, Imidazoles: therapeutic use, Leukemia, Male, Middle Aged, Myelogenous, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma: dr, Protein Kinase Inhibitors, Protein Kinase Inhibitors: adverse effects, Protein Kinase Inhibitors: therapeutic use, Pyridazines, Pyridazines: adverse effects, Pyridazines: therapeutic use, Thrombocytopenia, Thrombocytopenia: chemically induced, Thrombosis, Thrombosis: chemically induced, Young Adult}
}

@article{Cortes2012,
    title = {{Ponatinib in refractory Philadelphia chromosome-positive leukemias.}},
    year = {2012},
    journal = {The New England journal of medicine},
    author = {Cortes, Jorge E and Kantarjian, Hagop and Shah, Neil P and Bixby, Dale and Mauro, Michael J and Flinn, Ian and O'Hare, Thomas and Hu, Simin and Narasimhan, Narayana I and Rivera, Victor M and Clackson, Tim and Turner, Christopher D and Haluska, Frank G and Druker, Brian J and Deininger, Michael W N and Talpaz, Moshe},
    number = {22},
    pages = {2075--88},
    volume = {367},
    url = {http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3777383&tool=pmcentrez&rendertype=abstract},
    isbn = {1533-4406 (Electronic){\textbackslash}r0028-4793 (Linking)},
    doi = {10.1056/NEJMoa1205127},
    issn = {1533-4406},
    pmid = {23190221},
    keywords = {80 and over, Adult, Aged, Amylases, Amylases: blood, Antineoplastic Agents, Antineoplastic Agents: administration {\&} dosage, Antineoplastic Agents: adverse effects, Antineoplastic Agents: chemistry, BCR-ABL Positive, BCR-ABL Positive:, Chronic, Dose-Response Relationship, Drug, Drug Resistance, Female, Follow-Up Studies, Fusion Proteins, Humans, Imidazoles, Imidazoles: administration {\&} dosage, Imidazoles: adverse effects, Imidazoles: chemistry, Leukemia, Lipase, Lipase: blood, Male, Middle Aged, Mutation, Myelogenous, Neoplasm, Pancreatitis, Pancreatitis: chemically induced, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma: dr, Protein-Tyrosine Kinases, Protein-Tyrosine Kinases: antagonists {\&} inhibitors, Protein-Tyrosine Kinases: genetics, Pyridazines, Pyridazines: administration {\&} dosage, Pyridazines: adverse effects, Pyridazines: chemistry, Structure-Activity Relationship, bcr-abl, bcr-abl: antagonists {\&} inhibitors, bcr-abl: genetics}
}

@article{Wadhwa2012,
    title = {{Factors affecting duration of survival after onset of blastic transformation of chronic myeloid leukemia Factors affecting duration of survival after onset of blastic transformation of chronic myeloid leukemia}},
    year = {2012},
    author = {Wadhwa, Jyoti and Szydlo, Richard M and Apperley, Jane F and Chase, Andrew and Bua, Marco and Marin, David and Kanfer, Edward and Goldman, John M and Olavarria, Eduardo},
    number = {7},
    pages = {2304--2309},
    volume = {99},
    doi = {10.1182/blood.V99.7.2304}
}

@article{Schnipper2015,
    title = {{American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options}},
    year = {2015},
    journal = {Journal of Clinical Oncology},
    author = {Schnipper, L. E. and Davidson, N. E. and Wollins, D. S. and Tyne, C. and Blayney, D. W. and Blum, D. and Dicker, a. P. and Ganz, P. a. and Hoverman, J. R. and Langdon, R. and Lyman, G. H. and Meropol, N. J. and Mulvey, T. and Newcomer, L. and Peppercorn, J. and Polite, B. and Raghavan, D. and Rossi, G. and Saltz, L. and Schrag, D. and Smith, T. J. and Yu, P. P. and Hudis, C. a. and Schilsky, R. L.},
    url = {http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.61.6706},
    doi = {10.1200/JCO.2015.61.6706},
    issn = {0732-183X}
}

@article{Souers2013,
    title = {{ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.}},
    year = {2013},
    journal = {Nature medicine},
    author = {Souers, Andrew J and Leverson, Joel D and Boghaert, Erwin R and Ackler, Scott L and Catron, Nathaniel D and Chen, Jun and Dayton, Brian D and Ding, Hong and Enschede, Sari H and Fairbrother, Wayne J and Huang, David C S and Hymowitz, Sarah G and Jin, Sha and Khaw, Seong Lin and Kovar, Peter J and Lam, Lloyd T and Lee, Jackie and Maecker, Heather L and Marsh, Kennan C and Mason, Kylie D and Mitten, Michael J and Nimmer, Paul M and Oleksijew, Anatol and Park, Chang H and Park, Cheol-Min and Phillips, Darren C and Roberts, Andrew W and Sampath, Deepak and Seymour, John F and Smith, Morey L and Sullivan, Gerard M and Tahir, Stephen K and Tse, Chris and Wendt, Michael D and Xiao, Yu and Xue, John C and Zhang, Haichao and Humerickhouse, Rod a and Rosenberg, Saul H and Elmore, Steven W},
    number = {2},
    pages = {202--8},
    volume = {19},
    publisher = {Nature Publishing Group},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/23291630},
    isbn = {1546-170X (Electronic){\textbackslash}r1078-8956 (Linking)},
    doi = {10.1038/nm.3048},
    issn = {1546-170X},
    pmid = {23291630},
    keywords = {Aniline Compounds, Aniline Compounds: pharmacology, Animals, Antineoplastic Agents, Antineoplastic Agents: pharmacology, Antineoplastic Agents: therapeutic use, Apoptosis, Apoptosis: drug effects, Bicyclo Compounds, Blood Platelets, Blood Platelets: drug effects, Cell Survival, Cell Survival: drug effects, Dogs, Female, HeLa Cells, Hematologic Neoplasms, Hematologic Neoplasms: drug therapy, Heterocyclic, Heterocyclic: pharmacology, Humans, Mice, Proto-Oncogene Proteins c-bcl-2, Proto-Oncogene Proteins c-bcl-2: antagonists {\&} inh, Proto-Oncogene Proteins c-bcl-2: chemistry, SCID, Sulfonamides, Sulfonamides: pharmacology, Tumor Burden, Xenograft Model Antitumor Assays, bcl-X Protein, bcl-X Protein: antagonists {\&} inhibitors}
}

@article{Brown2001,
    title = {{Interval Estimation for a Binomial Proportion}},
    year = {2001},
    journal = {Statistical Science},
    author = {Brown, Lawrence D. and Cai, T. Tony and DasGupta, Anirban},
    number = {2},
    pages = {101--133},
    volume = {16},
    isbn = {0883-4237},
    doi = {10.1214/ss/1009213286},
    issn = {0883-4237},
    pmid = {17566141},
    keywords = {and phrases, bayes, binomial distribution, confidence, coverage probability, edgeworth expansion, expected length, intervals, jeffreys prior, normal approximation, posterior}
}

@unpublished{Wason,
    title = {{Supplementary material for “ Using continuous data on tumour measurements to improve inference in phase II cancer studies ”}},
    author = {Wason, James and Seaman, Shaun R.},
    pages = {1--9}
}

@article{Deng2014,
    title = {{Bayesian modeling and prediction of accrual in multi-regional clinical trials}},
    year = {2014},
    journal = {Statistical Methods in Medical Research},
    author = {Deng, Y. and Zhang, X. and Long, Q.},
    url = {http://smm.sagepub.com/cgi/doi/10.1177/0962280214557581},
    doi = {10.1177/0962280214557581},
    issn = {0962-2802},
    keywords = {bayesian modeling, clinical trials, multi-regional trials, nonhomogeneous poisson process, patient accrual}
}

@article{Cheung2000,
    title = {{Sequential designs for phase I clinical trials with late-onset toxicities.}},
    year = {2000},
    journal = {Biometrics},
    author = {Cheung, Y K and Chappell, R},
    number = {4},
    pages = {1177--1182},
    volume = {56},
    issn = {0006-341X},
    pmid = {11129476},
    keywords = {continual reassessment method, dose limiting, late-onset toxicities, likelihood-based design, phase i trial, time-to-event}
}

@article{Ghebretinsae2012,
    title = {{Joint modeling of hierarchically clustered and overdispersed non-gaussian continuous outcomes for comet assay data}},
    year = {2012},
    journal = {Pharmaceutical Statistics},
    author = {Ghebretinsae, Aklilu Habteab and Faes, Christel and Molenberghs, Geert and Geys, Helena and Van Der Leede, Bas Jan},
    number = {6},
    pages = {449--455},
    volume = {11},
    doi = {10.1002/pst.1533},
    issn = {15391604},
    pmid = {22997130},
    keywords = {comet assay, gamma random effect, hierarchical model, joint model, normal random effect}
}

@article{Cook1994,
    title = {{Guidelines for monitoring efficacy and toxicity responses in clinical trials.}},
    year = {1994},
    journal = {Biometrics},
    author = {Cook, R J and Farewell, V T},
    number = {4},
    pages = {1146--1152},
    volume = {50},
    doi = {10.2307/2533451},
    issn = {0006-341X},
    pmid = {7786995}
}

@article{Bouckaert2001,
    title = {{Sure outcomes of random events: A model for clinical trials}},
    year = {2001},
    journal = {Statistics in Medicine},
    author = {Bouckaert, A. and Mouchart, M.},
    number = {4},
    pages = {521--543},
    volume = {20},
    doi = {10.1002/sim.659},
    issn = {02776715},
    pmid = {11223899}
}

@article{Jin2007,
    title = {{Alternative designs of phase II trials considering response and toxicity}},
    year = {2007},
    journal = {Contemporary Clinical Trials},
    author = {Jin, Hua},
    number = {4},
    pages = {525--531},
    volume = {28},
    doi = {10.1016/j.cct.2007.03.003},
    issn = {15517144},
    pmid = {17428744},
    keywords = {Phase II clinical trial, Robust, Two-stage design, Type I error}
}

@article{Conaway1996,
    title = {{Designs for phase II trials allowing for a trade-off between response and toxicity.}},
    year = {1996},
    journal = {Biometrics},
    author = {Conaway, M R and Petroni, G R},
    number = {4},
    pages = {1375--1386},
    volume = {52},
    doi = {10.2307/2532851},
    issn = {0006-341X},
    pmid = {8962459}
}

@article{Conaway1995,
    title = {{Bivariate sequential designs for phase II trials.}},
    year = {1995},
    journal = {Biometrics},
    author = {Conaway, M R and Petroni, G R},
    number = {2},
    pages = {656--664},
    volume = {51},
    doi = {10.2307/2532952},
    issn = {0006341X},
    pmid = {7662852}
}

@article{Jennison1993,
    title = {{Group sequential tests for bivariate response: interim analyses of clinical trials with both efficacy and safety endpoints.}},
    year = {1993},
    journal = {Biometrics},
    author = {Jennison, C and Turnbull, B W},
    number = {3},
    pages = {741--752},
    volume = {49},
    issn = {0006-341X},
    pmid = {8241370},
    keywords = {bivariate}
}

@article{Mandrekar2010,
    title = {{Model-based phase I designs incorporating toxicity and efficacy for single and dual agent drug combinations: Methods and challenges}},
    year = {2010},
    journal = {Statistics in Medicine},
    author = {Mandrekar, Sumithra J. and Qin, Rui and Sargent, Daniel J.},
    number = {10},
    pages = {1077--1083},
    volume = {29},
    isbn = {1097-0258 (Electronic){\textbackslash}n0277-6715 (Linking)},
    doi = {10.1002/sim.3706},
    issn = {02776715},
    pmid = {20419760},
    keywords = {Continual reassessment method, Dose-finding, Efficacy, Model-based designs, Toxicity, Trinary outcome}
}

@article{Brutti2011,
    title = {{An extension of the single threshold design for monitoring efficacy and safety in phase II clinical trials}},
    year = {2011},
    journal = {Statistics in Medicine},
    author = {Brutti, P. and Gubbiotti, S. and Sambucini, V.},
    number = {14},
    pages = {1648--1664},
    volume = {30},
    isbn = {1097-0258},
    doi = {10.1002/sim.4229},
    issn = {02776715},
    pmid = {21520453},
    keywords = {Bayesian design, Binary outcomes, Multiple endpoints, Phase II clinical trials, Two-stage design}
}

@article{Zhang2006,
    title = {{An adaptive dose-finding design incorporating both toxicity and efficacy}},
    year = {2006},
    journal = {Statistics in Medicine},
    author = {Zhang, Wei and Sargent, Daniel J. and Mandrekar, Sumithra},
    number = {14},
    pages = {2365--2383},
    volume = {25},
    doi = {10.1002/sim.2325},
    issn = {02776715},
    pmid = {16220478},
    keywords = {Bayesian method, Continual reassessment method, Continuation-ratio model, Phase I trail, Proportional odds model, Trinomial}
}

@article{Ivanova2003,
    title = {{A New Dose-Finding Design for Bivariate Outcomes}},
    year = {2003},
    journal = {Biometrics},
    author = {Ivanova, Anastasia},
    number = {4},
    pages = {1001--1007},
    volume = {59},
    doi = {10.1111/j.0006-341X.2003.00115.x},
    issn = {0006341X},
    pmid = {14969479},
    keywords = {Dose-finding studies, Optimal dose, Phase I trial, Random walk, Up-and-down design}
}

@article{Wang2010,
    title = {{Adaptive Bayesian design for phase I dose-finding trials using a joint model of response and toxicity.}},
    year = {2010},
    journal = {Journal of biopharmaceutical statistics},
    author = {Wang, Meihua and Day, Roger},
    number = {1},
    pages = {125--144},
    volume = {20},
    isbn = {1520-5711 (Electronic){\textbackslash}r1054-3406 (Linking)},
    doi = {10.1080/10543400903280613},
    issn = {1054-3406},
    pmid = {20077253}
}

@article{Ivanova2009,
    title = {{An adaptive design for identifying the dose with the best efficacy/tolerability profile with application to a crossover dose-finding study}},
    year = {2009},
    journal = {Statistics in medicine},
    author = {Ivanova, Anastasia (University of North Carolina) and Liu, Ken and Snyder, Ellen and Snavely, Duane},
    number = {15},
    pages = {1999--2011},
    volume = {28},
    isbn = {2007090091480},
    doi = {10.1002/sim},
    pmid = {19455509},
    keywords = {dose finding, proof-of-concept trial, utility function}
}

@article{Salter2013,
    title = {{Evaluating Approaches in Dose Finding for Two Groups Using the Time-to-Event Continual Reassessment Method}},
    year = {2013},
    author = {Salter, Amber and Al, Et}
}

@article{Murtaugh1990,
    title = {{Bivariate Binary Models of Efficacy and Toxicity in Dose-Ranging Trials}},
    year = {1990},
    journal = {Communications in Statistics-Theory and Methods},
    author = {Murtaugh, Paul A. and Fisher, L},
    number = {6},
    pages = {2003--2020},
    volume = {19}
}

@article{OQuigley1999,
    title = {{Two-sample continual reassessment method.}},
    year = {1999},
    journal = {Journal of biopharmaceutical statistics},
    author = {O'Quigley, J and Shen, L Z and Gamst, A},
    number = {1},
    pages = {17--44},
    volume = {9},
    doi = {10.1081/BIP-100100998},
    issn = {1054-3406},
    pmid = {10091908}
}

@article{Salter2015a,
    title = {{B i o s t a t i s t i c s D e p a r t m e n t T e c h n i c a l R e p o r t B S T 2 0 1 5 - 0 0 1 T w o - G r o u p T i m e - T o - E v e n t C o n t i n u a l R e a s s e s s m e n t M e t h o d U s i n g L i k e l i h o o d E s t i m a t i o n A m b e r}},
    author = {Salter, Amber and O'Quigley, J and Cutter, G and Aban, I}
}

@article{Thatcher2005,
    title = {{Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: Results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)}},
    year = {2005},
    journal = {Lancet},
    author = {Thatcher, Nick and Chang, Alex and Parikh, Purvish and Pereira, José Rodrigues and Ciuleanu, Tudor and Von Pawel, Joachim and Thongprasert, Sumitra and Tan, Eng Huat and Pemberton, Kristine and Archer, Venice and Carroll, Kevin},
    number = {9496},
    pages = {1527--1537},
    volume = {366},
    isbn = {1474-547X (Electronic){\textbackslash}n0140-6736 (Linking)},
    doi = {10.1016/S0140-6736(05)67625-8},
    issn = {01406736},
    pmid = {16257339}
}

@article{Lachin1986,
    title = {{Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-up, Noncompliance, and Stratification.pdf}},
    year = {1986},
    journal = {Biometrics},
    author = {Lachin, John M and Foulkes, Mary A},
    number = {3},
    pages = {507--519},
    volume = {42}
}

@book{Spiegelhalter2004,
    title = {{Bayesian Approaches to Clinical Trials and Helath-Care Evaluation}},
    year = {2004},
    author = {Spiegelhalter, David J. and Abrams, Keith R. and Myles, Jonathan P.},
    isbn = {0471499757}
}

@article{Dimairo2015,
    title = {{Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials}},
    year = {2015},
    journal = {Trials},
    author = {Dimairo, Munyaradzi and Boote, Jonathan and Julious, Steven a. and Nicholl, Jonathan P. and Todd, Susan},
    number = {1},
    pages = {430},
    volume = {16},
    publisher = {Trials},
    url = {http://www.trialsjournal.com/content/16/1/430},
    doi = {10.1186/s13063-015-0958-9},
    issn = {1745-6215},
    keywords = {Adaptive designs,Flexible designs,Qualitative inte, ac, adaptive designs, clinical trials, confirmatory trials, correspondence, dimairo, early stopping, flexible designs, funded trials, interim analyses, m, phase 3, publicly, qualitative interviews, sheffield, uk}
}

@article{Topalian2012,
    title = {{Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer}},
    year = {2012},
    journal = {The New England journal of medicineNew},
    author = {Suzanne L. Topalian, M.D. and F. Stephen Hodi, M.D. and Julie R. Brahmer, M.D. and Scott N. Gettinger, M.D. and David C. Smith, M.D. and David F. McDermott, M.D. and John D. Powderly, M.D. and Richard D. Carvajal, M.D. and Jeffrey A. Sosman, M.D. and Michael B. Atkins, M.D. and Philip D. Leming, M.D. and David R. Spigel, M.D. and Scott J. Antonia, M.D., Ph.D., Leora Horn, M.D. and Charles G. Drake, M.D., Ph.D., Drew M. Pardoll, M.D., Ph.D., Lieping Chen, M.D., Ph.D., William H. Sharfman, M.D., Robert A. Anders, M.D., Ph.D., Janis M. Taube, M.D. and Tracee L. McMiller, M.S. and Haiying Xu, B.A. and Alan J. Korman, Ph.D. and Maria Jure-Kunkel, Ph.D. and Shruti Agrawal, Ph.D. and Daniel McDonald, M.B.A. and Georgia D. Kollia, Ph.D. and Ashok Gupta, M.D., Ph.D. and Jon M. Wigginton, M.D. and Mario Sznol, M.D.},
    pages = {2443--2454}
}

@article{Garrido2009,
    title = {{Surrogate outcomes in health technology assessment: An international comparison}},
    year = {2009},
    journal = {International Journal of Technology Assessment in Health Care},
    author = {Garrido, Marcial Velasco and Mangiapane, Sandra},
    number = {03},
    pages = {315},
    volume = {25},
    url = {http://www.journals.cambridge.org/abstract_S0266462309990213},
    doi = {10.1017/S0266462309990213},
    issn = {0266-4623},
    keywords = {Surrogate outcomes, Biological Markers, Intermedia, biological markers, intermediate outcomes, outcome, surrogate outcomes}
}

@article{Ciani2013,
    title = {{Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study}},
    year = {2013},
    journal = {Bmj},
    author = {Ciani, O. and Buyse, M. and Garside, R. and Pavey, T. and Stein, K. and Sterne, J. a. C. and Taylor, R. S.},
    number = {jan29 1},
    pages = {f457-f457},
    volume = {346},
    url = {http://www.bmj.com/cgi/doi/10.1136/bmj.f457},
    doi = {10.1136/bmj.f457},
    issn = {1756-1833}
}

@article{Taylor2009,
    title = {{The use of surrogate outcomes in model-based cost-effectiveness analyses: a survey of UK Health Technology Assessment reports}},
    year = {2009},
    journal = {Health Technology Assessment},
    author = {Taylor, R and Elston, J},
    number = {8},
    volume = {13},
    url = {http://www.journalslibrary.nihr.ac.uk/hta/volume-13/issue-8},
    doi = {10.3310/hta13080},
    issn = {1366-5278},
    keywords = {COST-EFFECTIVENESS-MODEL, FINAL-OUTCOME, HEALTH-TECHNOLOGY-ASSESSMENT, SURROGATE-OUTCOME}
}

@article{Paoletti2015,
    title = {{Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials}},
    year = {2015},
    journal = {Annals of Oncology},
    author = {Paoletti, X. and Ezzalfani, M. and Le Tourneau, C.},
    number = {9},
    pages = {1808--1812},
    volume = {26},
    url = {http://annonc.oxfordjournals.org/lookup/doi/10.1093/annonc/mdv266},
    doi = {10.1093/annonc/mdv266},
    issn = {0923-7534},
    keywords = {continual reassessment method, dose finding, efficiency, targeted agents}
}

@article{Lewis2006,
    title = {{Adjuvant local irradiation for Merkel cell carcinoma.}},
    year = {2006},
    journal = {Archives of dermatology},
    author = {Lewis, Kevan G and Weinstock, Martin a and Weaver, Amy L and Otley, Clark C},
    number = {6},
    pages = {693--700},
    volume = {142},
    doi = {10.1016/S0093-3619(08)70612-9},
    issn = {00933619},
    pmid = {16785371}
}

@article{Allen2005,
    title = {{Merkel Cell Carcinoma: Prognosis and Treatment of Patients From a Single Institution}},
    year = {2005},
    journal = {Journal of Clinical Oncology},
    author = {Allen, P. J.},
    number = {10},
    pages = {2300--2309},
    volume = {23},
    url = {http://www.jco.org/cgi/doi/10.1200/JCO.2005.02.329},
    doi = {10.1200/JCO.2005.02.329},
    issn = {0732-183X}
}

@article{Pape2011,
    title = {{Radiotherapy alone for Merkel cell carcinoma: A comparative and retrospective study of 25 patients}},
    year = {2011},
    journal = {Journal of the American Academy of Dermatology},
    author = {Pape, Emeline and Rezvoy, Nicolas and Penel, Nicolas and Salleron, Julia and Martinot, Veronique and Guerreschi, Pierre and Dziwniel, Veronique and Darras, Sophie and Mirabel, Xavier and Mortier, Laurent},
    number = {5},
    pages = {983--990},
    volume = {65},
    publisher = {Elsevier Inc},
    url = {http://dx.doi.org/10.1016/j.jaad.2010.07.043},
    isbn = {1097-6787; 0190-9622},
    doi = {10.1016/j.jaad.2010.07.043},
    issn = {01909622},
    pmid = {21641081},
    keywords = {Merkel cell carcinoma, inoperable patient, neuroendocrine tumor, prognosis, radiation therapy, skin tumor}
}

@article{Harrington2014,
    title = {{Outcomes of Merkel Cell Carcinoma Treated with Radiotherapy without Radical Surgical Excision}},
    year = {2014},
    journal = {Annals of Surgical Oncology},
    author = {Harrington, Chris and Kwan, Winkle},
    number = {11},
    pages = {3401--3405},
    volume = {21},
    url = {http://link.springer.com/10.1245/s10434-014-3757-8},
    doi = {10.1245/s10434-014-3757-8},
    issn = {1068-9265}
}

@article{Senchenkov2007,
    title = {{Predictors of Survival and Recurrence in the Surgical Treatment of Merkel Cell Carcinoma of the Extremities}},
    year = {2007},
    journal = {Journal of surgical oncology},
    author = {Senchenkov, Alex and Barnes, Sunni and Moran, Steven},
    number = {3},
    pages = {148--155},
    volume = {95},
    isbn = {8229702403},
    doi = {10.1002/jso},
    pmid = {17323329}
}

@article{Middleton2015,
    title = {{The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer}},
    year = {2015},
    journal = {Annals of Oncology},
    author = {Middleton, G. and Crack, L. R. and Popat, S. and Swanton, C. and Hollingsworth, S. J. and Buller, R. and Walker, I. and Carr, T. H. and Wherton, D. and Billingham, L. J.},
    pages = {mdv394},
    url = {http://annonc.oxfordjournals.org/lookup/doi/10.1093/annonc/mdv394},
    doi = {10.1093/annonc/mdv394},
    issn = {0923-7534},
    keywords = {adaptive trial design, national lung matrix trial, non-small-cell lung cancer, strati fi ed medicine, umbrella trial}
}

@article{Buyse2011,
    title = {{Integrating biomarkers in clinical trials}},
    year = {2011},
    journal = {Expert Review of Molecular Diagnostics2},
    author = {Buyse, Marc and Michiels, Stefan and Sargent, Daniel J and Grothey, Axel and Matheson, Alastair and de Gramont, Aimery},
    number = {2},
    pages = {171--182},
    volume = {11},
    doi = {10.1586/ERM.10.120},
    issn = {1473-7159}
}

@article{Hayes2015,
    title = {{Lessons for tumor biomarker trials: vicious cycles, scientific method {\&} developing guidelines.}},
    year = {2015},
    journal = {Expert review of molecular diagnostics},
    author = {Hayes, Daniel and Raison, Claire},
    number = {2},
    pages = {165--169},
    volume = {15},
    doi = {10.1586/14737159.2015.991893},
    issn = {1744-8352 (Electronic)},
    pmid = {25548983}
}

@article{Buyse2013,
    title = {{Omics-based clinical trial designs}},
    year = {2013},
    journal = {Current Opinion in Oncology},
    author = {Buyse, Marc and Michiels, Stefan},
    pages = {1},
    url = {http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001622-900000000-99632},
    doi = {10.1097/CCO.0b013e32835ff2fe},
    issn = {1040-8746},
    keywords = {clinical trials, genomics, predictive biomarker, prognostic biomarker, signature}
}

@article{Antoniou2015a,
    title = {{Evaluating Statistical Characteristics of Biomarker-Guided Trial Designs Personalized Medicine}},
    year = {2015},
    author = {Antoniou, Miranta}
}

@article{Bosch2015,
    title = {{Ibrutinib in CLL: 2 sides of the same coin}},
    year = {2015},
    journal = {Blood},
    author = {Bosch, F. and Abrisqueta, P.},
    number = {19},
    pages = {2173--2174},
    volume = {126},
    url = {http://www.bloodjournal.org/cgi/doi/10.1182/blood-2015-09-670653},
    doi = {10.1182/blood-2015-09-670653},
    issn = {0006-4971},
    pmid = {26542251}
}

@article{Antoniou2015,
    title = {{Evaluating Statistical Characteristics of Biomarker-Guided Trial Designs Personalized Medicine}},
    year = {2015},
    author = {Antoniou, Miranta}
}

@article{Zukin2013,
    title = {{Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2}},
    year = {2013},
    journal = {Journal of Clinical Oncology},
    author = {Zukin, Mauro and Barrios, Carlos H. and Pereira, Jose Rodrigues and Ribeiro, Ronaldo De Albuquerque and Beato, Carlos Augusto De Mendonça and Do Nascimento, Yeni Neron and Murad, Andre and Franke, Fabio a. and Precivale, Maristela and Araujo, Luiz Henrique De Lima and Baldotto, Clarissa Serodio Da Rocha and Vieira, Fernando Meton and Small, Isabele a. and Ferreira, Carlos G. and Lilenbaum, Rogerio C.},
    number = {23},
    pages = {2849--2853},
    volume = {31},
    doi = {10.1200/JCO.2012.48.1911},
    issn = {0732183X},
    pmid = {23775961}
}

@article{Ludbrook2013,
    title = {{Should we use one-sided or two-sided P values in tests of significance?}},
    year = {2013},
    journal = {Clinical and Experimental Pharmacology and Physiology},
    author = {Ludbrook, John},
    number = {6},
    pages = {357--361},
    volume = {40},
    url = {http://doi.wiley.com/10.1111/1440-1681.12086},
    doi = {10.1111/1440-1681.12086},
    issn = {03051870},
    keywords = {11, and new zealand, con fi dence interval, fisher, from a google scholar, google scholar, journal of surgery over, lehmann, neyman, p values were used, pearson, search of the australian, the decade 2002, type iii error}
}

@article{Monahan1997,
    title = {{Spherical-Radial Integration Rules for Bayesian Computation}},
    year = {1997},
    journal = {Journal of the American Statistical Association},
    author = {Monahan, John and Genz, Alan},
    number = {438},
    pages = {664--674},
    volume = {92},
    url = {http://www.jstor.org/stable/2965714},
    keywords = {importance, monte carlo, randomized numerical}
}

@article{Kearns,
    title = {{DIAGNOSTICS , DRUGS , DEVICES AND BIOMARKERS COLLABORATIVE}},
    author = {Kearns, Pam}
}

@article{McCulloch2009,
    title = {{No surgical innovation without evaluation: the IDEAL recommendations}},
    year = {2009},
    journal = {The Lancet},
    author = {McCulloch, Peter and Altman, Douglas G. and Campbell, W. Bruce and Flum, David R. and Glasziou, Paul and Marshall, John C. and Nicholl, Jon},
    number = {9695},
    pages = {1105--1112},
    volume = {374},
    publisher = {Elsevier Ltd},
    url = {http://dx.doi.org/10.1016/S0140-6736(09)61116-8},
    isbn = {1474-547X (Electronic){\textbackslash}r0140-6736 (Linking)},
    doi = {10.1016/S0140-6736(09)61116-8},
    issn = {01406736},
    pmid = {19782876},
    keywords = {3, evaluation, no surgical innovation without, surgical innovation and evaluation, the ideal}
}

@article{Handmer2012,
    title = {{Sticking to the facts: a systematic review of fibrin glue for pilonidal disease}},
    year = {2012},
    journal = {ANZ Journal of Surgery},
    author = {Handmer, M},
    number = {4},
    pages = {221--224},
    volume = {82},
    url = {http://sfxhosted.exlibrisgroup.com/calgary?sid=OVID:Ovid+MEDLINE(R)&id=pmid:22510177&id=doi:10.1111/j.1445-2197.2011.05752.x&issn=1445-1433&isbn=&volume=82&issue=4&spage=221&pages=221-4&date=2012&title=ANZ+Journal+of+Surgery&atitle=Sticking+to+the+f},
    isbn = {1445-2197 (Electronic){\textbackslash}r1445-1433 (Linking)},
    doi = {http://dx.doi.org/10.1111/j.1445-2197.2011.05752.x},
    issn = {1445-2197; 1445-1433},
    pmid = {22510177},
    keywords = {Fibrin Tissue Adhesive/tu [Therapeutic Use], Humans, Index Medicus, Pilonidal Sinus/su [Surgery], Tissue Adhesives/tu [Therapeutic Use], Wound Healing}
}

@article{Smith2015,
    title = {{Early experience of the use of fibrin sealant in the management of children with pilonidal sinus disease.}},
    year = {2015},
    journal = {Journal of pediatric surgery},
    author = {Smith, Caroline Mary and Jones, Abigail and Dass, Dipankar and Murthi, Govind and Lindley, Richard},
    number = {2},
    pages = {320--2},
    volume = {50},
    publisher = {Elsevier Inc.},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/25638628},
    doi = {10.1016/j.jpedsurg.2014.11.022},
    issn = {1531-5037},
    pmid = {25638628},
    keywords = {Fibrin glue, Fibrin sealant, Pilonidal disease, Pilonidal sinus}
}

@article{Lilenbaum2005,
    title = {{Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: The Cancer and Leukemia Group B (study 9730)}},
    year = {2005},
    journal = {Journal of Clinical Oncology},
    author = {Lilenbaum, Rogerio C. and Herndon, James E. and List, Marcy a. and Desch, Chris and Watson, Dorothy M. and Miller, Antonius a. and Graziano, Stephen L. and Perry, Michael C. and Saville, Wayne and Chahinian, Philippe and Weeks, Jane C. and Holland, Jimmie C. and Green, Mark R.},
    number = {1},
    pages = {190--196},
    volume = {23},
    doi = {10.1200/JCO.2005.07.172},
    issn = {0732183X},
    pmid = {15625373}
}

@article{Zukin2013b,
    title = {{Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2}},
    year = {2013},
    journal = {Journal of Clinical Oncology},
    author = {Zukin, Mauro and Barrios, Carlos H. and Pereira, Jose Rodrigues and Ribeiro, Ronaldo De Albuquerque and Beato, Carlos Augusto De Mendonça and Do Nascimento, Yeni Neron and Murad, Andre and Franke, Fabio a. and Precivale, Maristela and Araujo, Luiz Henrique De Lima and Baldotto, Clarissa Serodio Da Rocha and Vieira, Fernando Meton and Small, Isabele a. and Ferreira, Carlos G. and Lilenbaum, Rogerio C.},
    number = {23},
    pages = {2849--2853},
    volume = {31},
    doi = {10.1200/JCO.2012.48.1911},
    issn = {0732183X},
    pmid = {23775961}
}

@article{Lilenbaum2008,
    title = {{Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2.}},
    year = {2008},
    journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
    author = {Lilenbaum, Rogerio and Axelrod, Rita and Thomas, Sachdev and Dowlati, Afshin and Seigel, Leonard and Albert, Donald and Witt, Karsten and Botkin, David},
    number = {6},
    pages = {863--869},
    volume = {26},
    isbn = {0732-183X},
    doi = {10.1200/JCO.2007.13.2720},
    issn = {1527-7755},
    pmid = {18281658}
}

@article{Garon2015a,
    title = {{Supplement - Pembrolizumab for the treatment of non-small-cell lung cancer.}},
    year = {2015},
    journal = {The New England journal of medicine},
    author = {Garon, Edward B and Rizvi, Naiyer a and Hui, Rina and Leighl, Natasha and Balmanoukian, Ani S and Eder, Joseph Paul and Patnaik, Amita and Aggarwal, Charu and Gubens, Matthew and Horn, Leora and Carcereny, Enric and Ahn, Myung-ju and Felip, Enriqueta and Lee, Jong-seok and Hellmann, Matthew D and Hamid, Omid and Goldman, Jonathan W and Soria, Jean-charles and Dolled-Filhart, Marisa and Rutledge, Ruth Z and Zhang, Jin and Lunceford, Jared K and Rangwala, Reshma and Lubiniecki, Gregory M and Roach, Charlotte and Emancipator, Kenneth and Gandhi, Leena and {KEYNOTE-001 Investigators}},
    number = {21},
    pages = {2018--28},
    volume = {372},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/25891174},
    isbn = {1533-4406 (Electronic) 0028-4793 (Linking)},
    doi = {10.1056/NEJMoa1501824},
    issn = {1533-4406},
    pmid = {25891174}
}

@article{Garon2015,
    title = {{Pembrolizumab for the treatment of non-small-cell lung cancer.}},
    year = {2015},
    journal = {The New England journal of medicine},
    author = {Garon, Edward B and Rizvi, Naiyer a and Hui, Rina and Leighl, Natasha and Balmanoukian, Ani S and Eder, Joseph Paul and Patnaik, Amita and Aggarwal, Charu and Gubens, Matthew and Horn, Leora and Carcereny, Enric and Ahn, Myung-ju and Felip, Enriqueta and Lee, Jong-seok and Hellmann, Matthew D and Hamid, Omid and Goldman, Jonathan W and Soria, Jean-charles and Dolled-Filhart, Marisa and Rutledge, Ruth Z and Zhang, Jin and Lunceford, Jared K and Rangwala, Reshma and Lubiniecki, Gregory M and Roach, Charlotte and Emancipator, Kenneth and Gandhi, Leena and {KEYNOTE-001 Investigators}},
    number = {21},
    pages = {2018--28},
    volume = {372},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/25891174},
    isbn = {1533-4406 (Electronic) 0028-4793 (Linking)},
    doi = {10.1056/NEJMoa1501824},
    issn = {1533-4406},
    pmid = {25891174}
}

@article{Borghaei2015,
    title = {{Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.}},
    year = {2015},
    journal = {The New England journal of medicine},
    author = {Borghaei, H. and Paz-Ares, L. and Horn, L. and Spigel, D.R. and Steins, M. and Ready, N.E. and Chow, L.Q. and Vokes, E.E. and Felip, E. and Holgado, E. and Barlesi, F. and Kohlh{\"{a}}ufl, M. and Arrieta, O. and Burgio, M.A. and Fayette, J. and Lena, H. and Poddubskaya, E. and Gerber, D.E. and Gettinger, S.N. and Rudin, C.M. and Rizvi, N. and Crin{\`{o}}, L. and G.R. Blumenschein, Jr. and Antonia, S.J. and Dorange, C. and Harbison, C.T. and Finckenstein, F. Graf and Brahmer, J.R.},
    pages = {1--13},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/26028407},
    isbn = {0028-4793},
    doi = {10.1056/NEJMoa1504627},
    issn = {1533-4406},
    pmid = {26028407}
}

@article{White2009,
    title = {{Accounting for regression-to-the-mean in tests for recent changes in institutional performance: Analysis and power}},
    year = {2009},
    journal = {Statistics in medicine},
    author = {Jones, Hayley E. and Spiegelhalter, David J.},
    number = {15},
    pages = {1982--1998},
    volume = {28},
    isbn = {2007090091480},
    doi = {10.1002/sim},
    issn = {02776715},
    pmid = {19455509},
    keywords = {missing covariates, missing data, multiple imputation, proportional hazards model}
}

@article{Spiegelhalter2003,
    title = {{Risk-adjusted sequential probability ratio tests: Applications to Bristol, Shipman and adult cardiac surgery}},
    year = {2003},
    journal = {International Journal for Quality in Health Care},
    author = {Spiegelhalter, David and Grigg, Olivia and Kinsman, Robin and Treasure, Tom},
    number = {1},
    pages = {7--13},
    volume = {15},
    isbn = {1353-4505 (Print){\textbackslash}n1353-4505 (Linking)},
    doi = {10.1093/intqhc/15.1.7},
    issn = {13534505},
    pmid = {12630796},
    keywords = {Adverse clinical outcomes, General practitioners, Monitoring, Mortality, Paediatric and adult cardiac surgery, Risk-adjustment, Sequential probability ratio tests}
}

@article{Spiegelhalter2005,
    title = {{Funnel plots for comparing institutional performance}},
    year = {2005},
    journal = {Statistics in Medicine},
    author = {Spiegelhalter, David J.},
    number = {8},
    pages = {1185--1202},
    volume = {24},
    isbn = {0277-6715 (Print)},
    doi = {10.1002/sim.1970},
    issn = {02776715},
    pmid = {15568194},
    keywords = {Control charts, Institutional profiling, Outliers, Over-dispersion, Ranking}
}

@article{Roberts2015a,
    title = {{Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia}},
    year = {2015},
    journal = {New England Journal of Medicine},
    author = {Roberts, Andrew W. and Davids, Matthew S. and Pagel, John M. and Kahl, Brad S. and Puvvada, Soham D. and Gerecitano, John F. and Kipps, Thomas J. and Anderson, Mary Ann and Brown, Jennifer R. and Gressick, Lori and Wong, Shekman and Dunbar, Martin and Zhu, Ming and Desai, Monali B. and Cerri, Elisa and Enschede, Sari Heitner and Humerickhouse, Rod a. and Wierda, William G. and Seymour, John F.},
    pages = {151206090218007},
    url = {http://www.nejm.org/doi/abs/10.1056/NEJMoa1513257},
    doi = {10.1056/NEJMoa1513257},
    issn = {0028-4793},
    pmid = {26639348}
}

@article{Gelman2013,
    title = {{Understanding predictive information criteria for Bayesian models}},
    year = {2013},
    journal = {Statistics and Computing},
    author = {Gelman, Andrew and Hwang, Jessica and Vehtari, Aki},
    pages = {1--20},
    isbn = {0960-3174},
    doi = {10.1007/s11222-013-9416-2},
    issn = {09603174},
    arxivId = {arXiv:1307.5928v1},
    keywords = {AIC, Bayes, Cross-validation, DIC, Prediction, WAIC}
}

@book{For2012,
    title = {{Evolution of Translational Omics}},
    year = {2012},
    author = {For, N O T and Release, Public},
    isbn = {2612009000},
    doi = {10.17226/13297}
}

@article{Lachin2011,
    title = {{Power and sample size evaluation for the Cochran-Mantel-Haenszel mean score (Wilcoxon rank sum) test and the Cochran-Armitage test for trend}},
    year = {2011},
    journal = {Statistics in Medicine},
    author = {Lachin, John M.},
    doi = {10.1002/sim.4330},
    issn = {02776715},
    pmid = {22006667},
    keywords = {Cochran-Armitage test for trend, Cochran-Mantel-Haenszel mean score test, Kruskal-Wallis test, Power, Sample size, Wilcoxon rank sum test}
}

@article{Details2000,
    title = {{Tests for Two Proportions in a Repeated Measures Design}},
    year = {2000},
    journal = {Power},
    author = {Details, Technical},
    number = {1},
    pages = {1--13}
}

@article{Schiller2002,
    title = {{Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.}},
    year = {2002},
    journal = {The New England journal of medicine},
    author = {Schiller, Joan H and Harrington, David and Belani, Chandra P and Langer, Corey and Sandler, Alan and Krook, James and Zhu, Junming and Johnson, David H},
    number = {2},
    pages = {92--8},
    volume = {346},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/11784875},
    isbn = {1533-4406 LA - eng},
    doi = {10.1056/NEJMoa011954},
    issn = {1533-4406},
    pmid = {11784875},
    keywords = {80 and over, Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Combined Chemotherapy Protocols: ad, Antineoplastic Combined Chemotherapy Protocols: th, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung: drug therapy, Carcinoma, Non-Small-Cell Lung: mortality, Cisplatin, Cisplatin: administration {\&} dosage, Deoxycytidine, Deoxycytidine: administration {\&} dosage, Deoxycytidine: analogs {\&} derivatives, Disease-Free Survival, Female, Humans, Lung Neoplasms, Lung Neoplasms: drug therapy, Lung Neoplasms: mortality, Male, Middle Aged, Non-Small-Cell Lung, Non-Small-Cell Lung: drug therapy, Non-Small-Cell Lung: mortality, Paclitaxel, Paclitaxel: administration {\&} dosage, Paclitaxel: analogs {\&} derivatives, Survival Analysis, Taxoids}
}

@article{Borghaei2015a,
    title = {{Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.}},
    year = {2015},
    journal = {The New England journal of medicine},
    author = {Borghaei, Hossein and Paz-Ares, Luis and Horn, Leora and Spigel, David R and Steins, Martin and Ready, Neal E and Chow, Laura Q and Vokes, Everett E and Felip, Enriqueta and Holgado, Esther and Barlesi, Fabrice and Kohlh{\"{a}}ufl, Martin and Arrieta, Oscar and Burgio, Marco Angelo and Fayette, Jérôme and Lena, Hervé and Poddubskaya, Elena and Gerber, David E and Gettinger, Scott N and Rudin, Charles M and Rizvi, Naiyer and Crin{\`{o}}, Lucio and Blumenschein, George R and Antonia, Scott J and Dorange, Cécile and Harbison, Christopher T and Graf Finckenstein, Friedrich and Brahmer, Julie R},
    number = {17},
    pages = {1627--39},
    volume = {373},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/26412456},
    isbn = {1533-4406 (Electronic){\textbackslash}r0028-4793 (Linking)},
    doi = {10.1056/NEJMoa1507643},
    issn = {1533-4406},
    pmid = {26412456},
    keywords = {Aged, Antibodies, Antigens, Antineoplastic Agents, Antineoplastic Agents: adverse effects, Antineoplastic Agents: therapeutic use, CD274, CD274: antagonists {\&} inhibitors, CD274: immunology, CD274: metabolism, Carcinoma, Female, Humans, Lung Neoplasms, Lung Neoplasms: drug therapy, Lung Neoplasms: mortality, Male, Middle Aged, Monoclonal, Monoclonal: adverse effects, Monoclonal: therapeutic use, Non-Small-Cell Lung, Non-Small-Cell Lung: drug therapy, Non-Small-Cell Lung: mortality, Survival Analysis, Taxoids, Taxoids: adverse effects, Taxoids: therapeutic use}
}

@misc{EffTox,
    title = {{EffTox}},
    year = {2015},
    author = {Herrick, R and Norris, C and Cook, JD and Venier, J},
    publisher = {MD Anderson Cancer Center},
    url = {https://biostatistics.mdanderson.org/softwaredownload/SingleSoftware.aspx?Software_Id=2}
}

@misc{binarySimCLF,
    title = {{binarySimCLF}},
    author = {By, Kunthel and Qaqish, Bahjat F.},
    publisher = {CRAN},
    url = {https://cran.r-project.org/src/contrib/Archive/binarySimCLF/}
}

@article{Qaqish2003,
    title = {{A family of multivariate binary distributions for simulating correlated binary variables with specified marginal means and correlations}},
    year = {2003},
    journal = {Biometrika},
    author = {Qaqish, Bahjat F.},
    number = {2},
    pages = {455--463},
    volume = {90},
    doi = {10.1093/biomet/90.2.455},
    issn = {00063444},
    keywords = {Autoregressive correlation structure, Clustered data, Correlated Bernoulli variates, Exchangeable correlation structure, Simulation}
}

@misc{clintrials,
    title = {{clintrials}},
    year = {2016},
    author = {Brock, Kristian},
    publisher = {GitHub},
    url = {https://github.com/brockk/clintrials}
}

@article{OQuigley1996,
    title = {{Continual reassessment method: a likelihood approach}},
    year = {1996},
    journal = {Biometrics},
    author = {O'Quigley, J and Shen, L Z},
    number = {2},
    pages = {673--684},
    volume = {52},
    isbn = {0006-341X (Print){\textbackslash}r0006-341X (Linking)},
    doi = {10.2307/2532905},
    issn = {0006-{\{}341X{\}}},
    pmid = {8672707},
    keywords = {Bayes Theorem, Biometry, Clinical Trials, Clinical Trials as Topic, Data Interpretation, Drug Toxicity, Humans, Likelihood Functions, Pharmaceutical Preparations, Phase I as Topic, Phase {\{}II{\}} as Topic, Statistical}
}

@article{Anthonissen2013,
    title = {{Measurement of elasticity and transepidermal water loss rate of burn scars with the Dermalab??}},
    year = {2013},
    journal = {Burns},
    author = {Anthonissen, Mieke and Daly, Daniel and Fieuws, Steffen and Massag??, Patrick and Van Brussel, Michel and Vranckx, Jan and Van Den Kerckhove, Eric},
    isbn = {0305-4179},
    doi = {10.1016/j.burns.2012.07.026},
    issn = {03054179},
    pmid = {23000371},
    keywords = {Burn scar, DermaLab??, Elasticity, Transepidermal water loss}
}

@article{Billingham2016,
    title = {{Series Rare cancers XX Research methods to change clinical practice for patients with rare cancers}},
    year = {2016},
    journal = {Lancet Oncology},
    author = {Billingham, Lucinda and Malottki, Kinga and Steven, Neil},
    number = {2},
    pages = {e70-e80},
    volume = {17},
    publisher = {Elsevier Ltd},
    url = {www.thelancet.com/oncology},
    doi = {10.1016/S1470-2045(15)00396-4},
    issn = {1470-2045}
}

@article{Malottki2016,
    title = {{Problems of variable biomarker evaluation in stratified medicine research—A case study of ERCC1 in non-small-cell lung cancer}},
    year = {2016},
    journal = {Lung Cancer},
    author = {Malottki, Kinga and Popat, Sanjay and Deeks, Jonathan J. and Riley, Richard D. and Nicholson, Andrew G. and Billingham, Lucinda},
    pages = {1--7},
    volume = {92},
    publisher = {Elsevier Ireland Ltd},
    url = {http://linkinghub.elsevier.com/retrieve/pii/S0169500215301136},
    doi = {10.1016/j.lungcan.2015.11.017},
    issn = {01695002}
}

@article{Polley2011,
    title = {{Practical modifications to the time-to-event continual reassessment method for phase I cancer trials with fast patient accrual and late-onset toxicities}},
    year = {2011},
    journal = {Statistics in Medicine},
    author = {Polley, Mei Yin C},
    number = {17},
    pages = {2130--2143},
    volume = {30},
    isbn = {1097-0258},
    doi = {10.1002/sim.4255},
    issn = {02776715},
    pmid = {21590790},
    keywords = {Adaptive design, Bayesian inference, Dose finding, Late-onset toxicity, Phase I clinical trials, Time-to-Event Continual Reassessment Method}
}

@article{Wages2013,
    title = {{Using the time-to-event continual reassessment method in the presence of partial orders}},
    year = {2013},
    author = {Wages, Nolan and Conaway, Mark and O'Quigley, John},
    number = {2},
    pages = {181--204},
    volume = {72},
    isbn = {3143627344},
    doi = {10.1038/nature13314.A},
    issn = {1878-5832},
    pmid = {21959306},
    arxivId = {NIHMS150003},
    keywords = {continual reassessment method, dose finding, drug combination, partial order, phase 1 trials, time-}
}

@article{McGranahan2016,
    title = {{Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade}},
    year = {2016},
    journal = {Science},
    author = {McGranahan, Nicholas and Furness, Andrew J.S. and Rosenthal, Rachel and Ramskov, Sofie and Lyngaa, Rikke and Saini, Sunil Kumar and Jamal-Hanjani, Mariam and Wilson, Gareth a. and Birkbak, Nicolai J. and Hiley, Crispin T. and Watkins, Tom B.K. and Shafi, Seema and Murugaesu, Nirupa and Mitter, Richard and Akarca, Ayse U. and Linares, Joseph and Marafioti, Teresa and Henry, Jake Y. and Allen, Eliezer M. Van and Miao, Diana and Schilling, Bastian and Schadendorf, Dirk and Garraway, Levi a. and Makarov, Vladimir and Rizvi, Naiyer a. and Snyder, Alexandra and Hellmann, Matthew D. and Merghoub, Taha and Wolchok, Jedd D. and Shukla, Sachet a. and Wu, Catherine J. and Peggs, Karl S. and Chan, Timothy a. and Hadrup, Sine R. and Quezada, Sergio a. and Swanton, Charles},
    number = {March},
    pages = {1--11},
    volume = {Accepted f},
    doi = {10.1126/science.aaf1490},
    issn = {1095-9203}
}

@article{Jung2008,
    title = {{Randomized phase II trials with a prospective control Sin-Ho}},
    year = {2008},
    journal = {Statistics in medicine},
    author = {Jung, Sin-Ho},
    pages = {568--583},
    volume = {27},
    isbn = {2007090091480},
    doi = {10.1002/sim},
    issn = {02776715},
    pmid = {19455509}
}

@article{Brock2015,
    title = {{Modelling clinical trial recruitment using poisson processes}},
    year = {2015},
    journal = {Trials},
    author = {Brock, Kristian and Yap, Christina and Middleton, Gary and Billingham, Lucinda},
    number = {Suppl 2},
    pages = {P85},
    volume = {16},
    publisher = {BioMed Central Ltd},
    url = {http://www.trialsjournal.com/content/16/S2/P85},
    doi = {10.1186/1745-6215-16-S2-P85},
    issn = {1745-6215}
}

@article{Antoniou2016,
    title = {{Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review}},
    year = {2016},
    journal = {Plos One},
    author = {Antoniou, Miranta and Jorgensen, Andrea L and Kolamunnage-Dona, Ruwanthi},
    number = {2},
    pages = {e0149803},
    volume = {11},
    url = {http://dx.plos.org/10.1371/journal.pone.0149803},
    doi = {10.1371/journal.pone.0149803},
    issn = {1932-6203}
}

@article{Wages2015,
    title = {{Seamless Phase I/II Adaptive Design for Oncology Trials of Molecularly Targeted Agents.}},
    year = {2015},
    journal = {Journal of biopharmaceutical statistics},
    author = {Wages, Nolan A. and Tait, Christopher},
    number = {5},
    pages = {903--20},
    volume = {25},
    url = {http://www.tandfonline.com/doi/abs/10.1080/10543406.2014.920873#.Vdjqwnh3910},
    doi = {10.1080/10543406.2014.920873},
    issn = {1520-5711},
    pmid = {24904956},
    keywords = {Continual reassessment method, Dose finding, Molecularly targeted agent, Optimal biological dose}
}

@article{Billingham2004,
    title = {{Modelling the Time to Recurrent Infections in a Randomised Double-Blind , Placebo- Controlled Trial of Antibacterial Prophylaxis Following Myelosuppressive Chemotherapy in Patients with Solid Tumours or Lymphoma Time to First Infection by Treatment Arm}},
    year = {2004},
    author = {Billingham, Lucinda and Steven, Neil and Gaunt, Claire and Cullen, Michael}
}

@article{GeeKee2013,
    title = {{Comparison of three different dressings for partial thickness burns in children: study protocol for a randomised controlled trial.}},
    year = {2013},
    journal = {Trials},
    author = {Gee Kee, Emma and Kimble, Roy M and Cuttle, Leila and Stockton, Kellie},
    pages = {403},
    volume = {14},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/24274190},
    isbn = {1261300010574},
    doi = {10.1186/1745-6215-14-403},
    issn = {1745-6215},
    pmid = {24274190},
    keywords = {burn injuries, child, distress, healing, pain, partial thickness, randomised clinical trial, silver dressings}
}

@article{Ergina2009,
    title = {{Challenges in evaluating surgical innovation}},
    year = {2009},
    journal = {The Lancet},
    author = {Ergina, Patrick L. and Cook, Jonathan a. and Blazeby, Jane M. and Boutron, Isabelle and Clavien, Pierre Alain and Reeves, Barnaby C. and Seiler, Christoph M.},
    number = {9695},
    pages = {1097--1104},
    volume = {374},
    publisher = {Elsevier Ltd},
    url = {http://dx.doi.org/10.1016/S0140-6736(09)61086-2},
    isbn = {1474-547X (Electronic){\textbackslash}r0140-6736 (Linking)},
    doi = {10.1016/S0140-6736(09)61086-2},
    issn = {01406736},
    pmid = {19782875}
}

@article{Barkun2009,
    title = {{Evaluation and stages of surgical innovations}},
    year = {2009},
    journal = {The Lancet},
    author = {Barkun, Jeffrey S. and Aronson, Jeffrey K. and Feldman, Liane S. and Maddern, Guy J. and Strasberg, Steven M.},
    number = {9695},
    pages = {1089--1096},
    volume = {374},
    isbn = {1474-547X},
    doi = {10.1016/S0140-6736(09)61083-7},
    issn = {01406736},
    pmid = {19782874}
}

@article{Birkmeyer2004,
    title = {{Measuring the quality of surgical care: Structure, process, or outcomes?}},
    year = {2004},
    journal = {Journal of the American College of Surgeons},
    author = {Birkmeyer, John D. and Dimick, Justin B. and Birkmeyer, Nancy J O},
    number = {4},
    pages = {626--632},
    volume = {198},
    isbn = {1072-7515},
    doi = {10.1016/j.jamcollsurg.2003.11.017},
    issn = {10727515},
    pmid = {15051016}
}

@article{Barker2004,
    title = {{Is surgical science dead?}},
    year = {2004},
    journal = {Journal of the American College of Surgeons},
    author = {Barker, Clyde F. and Kaiser, Larry R.},
    number = {1},
    pages = {1--19},
    volume = {198},
    doi = {10.1016/j.jamcollsurg.2003.08.021},
    issn = {10727515},
    pmid = {14698306}
}

@article{Meakins2009,
    title = {{Surgical research: act 3, answers}},
    year = {2009},
    journal = {The Lancet},
    author = {Meakins, Jonathan L.},
    number = {9695},
    pages = {1039--1040},
    volume = {374},
    publisher = {Elsevier Ltd},
    url = {http://dx.doi.org/10.1016/S0140-6736(09)61681-0},
    doi = {10.1016/S0140-6736(09)61681-0},
    issn = {01406736},
    pmid = {19782853}
}

@article{Boers2005,
    title = {{OMERACT: An international initiative to improve outcome measurement in rheumatology}},
    year = {2005},
    journal = {Clinical and Experimental Rheumatology},
    author = {Boers, Maarten and Brooks, Peter and Simon, Lee S. and Strand, Vibeke and Tugwell, Peter},
    number = {5 SUPPL. 39},
    pages = {1--6},
    volume = {23},
    isbn = {1745-6215 (Electronic) 1745-6215 (Linking)},
    doi = {10.1186/1745-6215-8-38},
    issn = {0392856X},
    pmid = {18039364},
    keywords = {Clinical trial, Longitudinal observational study, Outcome measures, Rheumatology}
}

@article{Morita2014,
    title = {{Biomarker-based Bayesian randomized phase II clinical trial design to identify a sensitive patient subpopulation}},
    year = {2014},
    journal = {Statistics in medicine},
    author = {Morita, Satoshi and Yamamoto, Hideharu and Sugitani, Yasuo},
    number = {23},
    pages = {4008--4016},
    volume = {33},
    doi = {10.1002/sim.6209},
    issn = {10970258},
    pmid = {24820639},
    keywords = {Bayesian statistics, biomarker, molecular-targeted agent, randomized phase II trial, time-to-event data}
}

@article{Calvert2014,
    title = {{Reporting of Patient-Reported Outcomes in Randomized Trials}},
    year = {2014},
    author = {Calvert, Melanie and Blazeby, Jane and Altman, Douglas G and Revicki, Dennis a and Moher, David and Brundage, Michael D}
}

@article{Thall1998,
    title = {{Some extensions and applications of a Bayesian strategy for monitoring multiple outcomes in clinical trials}},
    year = {1998},
    journal = {Statistics in Medicine},
    author = {Thall, Peter F. and Sung, Hsi Guang},
    number = {14},
    pages = {1563--1580},
    volume = {17},
    isbn = {0277-6715 (Print){\textbackslash}r0277-6715 (Linking)},
    doi = {10.1002/(SICI)1097-0258(19980730)17:14<1563::AID-SIM873>3.0.CO;2-L},
    issn = {02776715},
    pmid = {9699230}
}

@article{Thall1996a,
    title = {{New statistical strategy for monitoring safety and efficacy in single- arm clinical trials}},
    year = {1996},
    journal = {J.Clin.Oncol.},
    author = {Thall, P F and Simon, R M and Estey, E H},
    number = {0732-183X SB - M SB - X},
    pages = {296--303},
    volume = {14},
    issn = {0732-183X},
    pmid = {8558211},
    keywords = {Anthracyclines, Antineoplastic Agents, Antineoplastic Agents,Combined, Bayes Theorem, Clinical Trials, Clinical Trials,Phase II, Comparative Study, Cyclosporine, Cytarabine, Human, Idarubicin, Leukemia, Leukemia,Myelocytic,Acute, Mathematical Computing, Monitoring,Physiologic, Patients, Probability, Remission Induction, Research Design, Safety, United States, administration {\&} dosage, adverse effects, drug therapy, methods, therapeutic use, toxicity}
}

@article{Wathen2008,
    title = {{Accounting for patient heterogeneity in phase II clinical trials J.}},
    year = {2008},
    journal = {Statistics in medicine},
    author = {Wathen, J. Kyle and Thall, Peter F. and Cook, John D. and Estey, Elihu H},
    pages = {2802--2815},
    volume = {27},
    isbn = {2007090091480},
    doi = {10.1002/sim},
    issn = {02776715},
    pmid = {19455509}
}

@article{Wardlaw2015,
    title = {{Noninferiority Trials: Is a New Treatment Almost as Effective as Another}},
    year = {2015},
    journal = {Jama},
    author = {Kaji, Amy and Lewis, Roger},
    number = {23},
    pages = {2327--8},
    volume = {313},
    isbn = {9789241597746},
    doi = {10.1001/jama},
    issn = {01406736},
    pmid = {7637476},
    keywords = {Appendectomy, Clinical Trials: methods, Clinical Trials: noninferiority}
}

@article{Thall1995,
    title = {{Single-Arm Clinical Trials With Multiple Outcomes}},
    year = {1995},
    journal = {Statistics in Medicine},
    author = {Thall, Peter F and Simon, Richard M and Estey, Elihu H},
    number = {October 1993},
    pages = {357--379},
    volume = {14}
}

@article{Ergina2013,
    title = {{IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages.}},
    year = {2013},
    journal = {BMJ (Clinical research ed.)},
    author = {Ergina, Patrick L and Barkun, Jeffrey S and McCulloch, Peter and Cook, Jonathan a and Altman, Douglas G},
    number = {jun18{\_}3},
    pages = {f3011},
    volume = {346},
    url = {http://www.bmj.com/content/346/bmj.f3011},
    isbn = {1756-1833},
    doi = {10.1136/bmj.f3011},
    issn = {1756-1833},
    pmid = {23778426},
    keywords = {Evaluation Studies as Topic, Humans, Inventions, Observation, Observation: methods, Operative, Operative: standards, Surgical Procedures}
}

@article{Smith2003,
    title = {{Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials.}},
    year = {2003},
    journal = {BMJ (Clinical research ed.)},
    author = {Smith, Gordon C S. and Pell, Jill P},
    number = {7429},
    pages = {1459--61},
    volume = {327},
    url = {http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=300808&tool=pmcentrez&rendertype=abstract},
    isbn = {1468-5833 (Electronic)},
    doi = {10.1136/bmj.327.7429.1459},
    issn = {1468-5833},
    pmid = {14684649},
    arxivId = {z0024},
    keywords = {Accidents, Aviation, Aviation: prevention {\&} control, Death, Humans, Odds Ratio, Protective Devices, Publication Bias, Randomized Controlled Trials as Topic, Sudden, Sudden: prevention {\&} control, Wit and Humor as Topic, Wounds and Injuries, Wounds and Injuries: prevention {\&} control}
}

@article{Loke2015,
    title = {{Acquired isodisomy on chromosome 13 at diagnosis results in impaired overall survival in Patients with FLT3-ITD mutant acute myeloid leukaemia}},
    year = {2015},
    journal = {Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K},
    author = {Loke, J C T and Akiki, S and Borrow, J and Ewing, J and Bokhari, S W and Chandra, D and Arrazi, J and Hazlewood, P and Arthur, K and Walsh, J and Wandroo, F a and Watts, a and Borg, a and Brock, K and Craddock, C and Griffiths, M and Raghavan, M and Arrazi, J and Hazlewood, P and Arthur, K and Walsh, J and Membwange, Y and Watts, a and Borg, a and Brock, K and Ferguson, P and Craddock, C and Griffiths, M and Raghavan, M},
    number = {June},
    pages = {1--7},
    volume = {25},
    url = {http://dx.doi.org/10.1038/leu.2015.148},
    doi = {10.1038/leu.2015.148},
    issn = {0887-6924}
}

@article{Blazeby2015,
    title = {{Core information set for oesophageal cancer surgery}},
    year = {2015},
    journal = {British Journal of Surgery},
    author = {Blazeby, J. M. and Macefield, R. and Blencowe, N. S. and Jacobs, M. and McNair, a. G K and Sprangers, M. and Brookes, S. T.},
    number = {8},
    pages = {936--943},
    volume = {102},
    doi = {10.1002/bjs.9840},
    issn = {13652168},
    pmid = {25980524}
}

@article{Cochran1968,
    title = {{The Effectiveness of Adjustment by Subclassification in Removing Bias in Observational Studies}},
    year = {1968},
    journal = {Biometrics},
    author = {Cochran, W.G.},
    number = {2},
    pages = {295--313},
    volume = {24}
}

@article{Xu2016,
    title = {{Bayesian two-stage dose finding for cytostatic agents via model adaptation}},
    year = {2016},
    journal = {Journal of the Royal Statistical Society (Series C)},
    author = {Xu, Jiajing and Yin, Guosheng and Ohlssen, David and Bretz, Frank},
    pages = {465--482},
    doi = {10.1111/rssc.12129},
    issn = {14679876},
    keywords = {bayesian adaptive design, cytostatic agent, deviance information criterion, dose, efficacy, finding, model selection, probit model, toxicity}
}

@article{Brock2015a,
    title = {{186: Forecasting patient recruitment for time-to-event analysis in National Lung Matrix Trial}},
    year = {2015},
    journal = {Lung Cancer},
    author = {Brock, K. and Billingham, L. and Crack, L. and Popat, S. and Middleton, G.},
    number = {2010},
    pages = {S69},
    volume = {87},
    publisher = {Elsevier Masson SAS},
    url = {http://linkinghub.elsevier.com/retrieve/pii/S0169500215501803},
    doi = {10.1016/S0169-5002(15)50180-3},
    issn = {01695002}
}

@article{Cook2004,
    title = {{Statistical evaluation of learning curve effects in surgical trials.}},
    year = {2004},
    journal = {Clinical trials (London, England)},
    author = {Cook, Jonathan a and Ramsay, Craig R and Fayers, Peter},
    number = {5},
    pages = {421--427},
    volume = {1},
    isbn = {1740-7745 (Print)},
    doi = {10.1191/1740774504cn042oa},
    issn = {1740-7745},
    pmid = {16279280}
}

@article{Adamina2006,
    title = {{Propensity scores and the surgeon}},
    year = {2006},
    journal = {British Journal of Surgery},
    author = {Adamina, M. and Guller, U. and Weber, W. P. and Oertli, D.},
    number = {4},
    pages = {389--394},
    volume = {93},
    doi = {10.1002/bjs.5265},
    issn = {00071323},
    pmid = {16400708}
}

@article{Heinze2011,
    title = {{An overview of the objectives of and the approaches to propensity score analyses}},
    year = {2011},
    journal = {European Heart Journal},
    author = {Heinze, Georg and J{\"{u}}ni, Peter},
    number = {14},
    pages = {1704--1708},
    volume = {32},
    isbn = {1522-9645 (Electronic){\textbackslash}n0195-668X (Linking)},
    doi = {10.1093/eurheartj/ehr031},
    issn = {0195668X},
    pmid = {21362706},
    keywords = {Bias, Causality, Confounding by indication, Non-randomized studies, Observational studies}
}

@article{Mrc1998,
    title = {{Good Clinical Practice in Clinical Trials}},
    year = {1998},
    journal = {MRC Clinical Trials Series},
    author = {{Mrc}},
    pages = {47}
}

@article{Calvert2015,
    title = {{Composite Outcomes in Randomized Trials Greater Precision But With Greater Uncertainty ? COMPOSITE OUTCOMES}},
    year = {2003},
    journal = {Jama},
    author = {Freemantle, Nick and Calvert, Melanie and Wood, John and Eastaugh, Joanne and Griffin, Carl},
    number = {19},
    pages = {2554--2559},
    volume = {289},
    doi = {10.1001/jama.289.19.2554}
}

@article{Jacobe2007,
    title = {{Understanding clinical trial outcomes : design , analysis ,}},
    year = {2007},
    journal = {Dermatology Therapy},
    author = {Jacobe, Heidi and Leitenberger, Justin and Bergstresser, Paul},
    pages = {77--85},
    volume = {20},
    keywords = {clinical trial design, outcome measure, statistical analysis}
}

@article{Freemantle2010,
    title = {{Treatment of heavy menstrual bleeding.}},
    year = {2010},
    journal = {BMJ (Clinical research ed.)},
    author = {Freemantle, Nick and Calvert, Melanie},
    number = {August},
    pages = {354},
    volume = {341},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/20716600},
    isbn = {1468-5833 (Electronic){\textbackslash}n0959-535X (Linking)},
    doi = {10.1136/bmj.c3771},
    issn = {1756-1833},
    pmid = {20716600}
}

@article{Macefield2014,
    title = {{Selecting and measuring optimal outcomes for randomised controlled trials in surgery}},
    year = {2014},
    journal = {Langenbeck's Archives of Surgery},
    author = {Macefield, Rhiannon C. and Boulind, Caroline E. and Blazeby, Jane M.},
    number = {3},
    pages = {263--272},
    volume = {399},
    doi = {10.1007/s00423-013-1136-8},
    issn = {14352451},
    pmid = {24233344},
    keywords = {Blinding, Outcomes, Randomised controlled trial, Surgery, Trial design}
}

@article{Cordoba2010,
    title = {{Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review.}},
    year = {2010},
    journal = {BMJ (Clinical research ed.)},
    author = {Cordoba, Gloria and Schwartz, Lisa and Woloshin, Steven and Bae, Harold and G{\o}tzsche, Peter C},
    pages = {c3920},
    volume = {341},
    url = {http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2923692&tool=pmcentrez&rendertype=abstract},
    isbn = {1756-1833 (Electronic){\textbackslash}n0959-535X (Linking)},
    doi = {10.1136/bmj.c3920},
    issn = {1756-1833},
    pmid = {20719825},
    keywords = {Data Interpretation, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic: standards, Research Design, Research Design: standards, Statistical, Treatment Outcome}
}

@article{Potter2015,
    title = {{Development of a core outcome set for research and audit studies in reconstructive breast surgery}},
    year = {2015},
    journal = {British Journal of Surgery},
    author = {Potter, S. and Holcombe, C. and Ward, J. a. and Blazeby, J. M.},
    number = {11},
    pages = {1360--1371},
    volume = {102},
    isbn = {0007-1323},
    doi = {10.1002/bjs.9883},
    issn = {13652168},
    pmid = {26179938}
}

@article{Tomlinson2010,
    title = {{Composite End Points in Randomized Trials}},
    year = {2010},
    journal = {Jama},
    author = {Tomlinson, George and Detsky, Allan S.},
    number = {3},
    pages = {267},
    volume = {303},
    url = {http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2009.2017},
    doi = {10.1001/jama.2009.2017},
    issn = {0098-7484}
}

@article{Sinclair2010,
    title = {{Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study.}},
    year = {2010},
    journal = {BMJ (Clinical research ed.)},
    author = {Sinclair, Alexandra J and Burdon, Michael a and Nightingale, Peter G and Ball, Alexandra K and Good, Peter and Matthews, Timothy D and Jacks, Andrew and Lawden, Mark and Clarke, Carl E and Stewart, Paul M and Walker, Elizabeth a and Tomlinson, Jeremy W and Rauz, Saaeha},
    number = {jul07{\_}2},
    pages = {c2701},
    volume = {341},
    url = {http://www.bmj.com/content/341/bmj.c2701},
    isbn = {1756-1833 (Electronic){\textbackslash}r0959-535X (Linking)},
    doi = {10.1136/bmj.c2701},
    issn = {1756-1833},
    pmid = {20610512},
    keywords = {Adult, Diet, Female, Headache Disorders, Headache Disorders: diet therapy, Humans, Intracranial Pressure, Intracranial Pressure: physiology, Papilledema, Papilledema: diet therapy, Prospective Studies, Pseudotumor Cerebri, Pseudotumor Cerebri: diet therapy, Reducing, Reducing: methods, Treatment Outcome, Weight Loss}
}

@article{Clarke2007,
    title = {{Standardising outcomes for clinical trials and systematic reviews.}},
    year = {2007},
    journal = {Trials},
    author = {Clarke, Mike},
    pages = {39},
    volume = {8},
    url = {http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2169261&tool=pmcentrez&rendertype=abstract},
    isbn = {1745-6215},
    doi = {10.1186/1745-6215-8-39},
    issn = {1745-6215},
    pmid = {18039365}
}

@article{Wall2014,
    title = {{Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.}},
    year = {2014},
    journal = {Jama},
    author = {Wall, Michael and McDermott, Michael P and Kieburtz, Karl D and Corbett, James J and Feldon, Steven E and Friedman, Deborah I and Katz, David M and Keltner, John L and Schron, Eleanor B and Kupersmith, Mark J},
    number = {16},
    pages = {1641--51},
    volume = {311},
    url = {http://jama.jamanetwork.com/article.aspx?articleid=1861803},
    doi = {10.1001/jama.2014.3312},
    issn = {1538-3598},
    pmid = {24756514},
    keywords = {Acetazolamide, Acetazolamide: therapeutic use, Adult, Carbonic Anhydrase Inhibitors, Carbonic Anhydrase Inhibitors: therapeutic use, Combined Modality Therapy, Diet, Female, Humans, Male, Pseudotumor Cerebri, Pseudotumor Cerebri: complications, Pseudotumor Cerebri: diet therapy, Pseudotumor Cerebri: drug therapy, Quality of Life, Sodium-Restricted, Treatment Outcome, Vision Disorders, Vision Disorders: drug therapy, Vision Disorders: etiology, Weight Loss}
}

@article{Meacock2016,
    title = {{Higher mortality rates amongst emergency patients admitted to hospital at weekends reflect a lower probability of admission}},
    year = {2016},
    journal = {Journal of Health Services Research {\&} Policy},
    author = {Meacock, Rachel and Anselmi, Laura and Kristensen, Soren Rud and Doran, Tim. and Sutton, Matt},
    doi = {10.1177/1355819616649630}
}

@book{Senn2002,
    title = {{Cross-over Trials in Clinical Research}},
    year = {2002},
    author = {Senn, Stephen},
    edition = {2nd},
    publisher = {Wiley},
    isbn = {0471496537}
}

@article{Weber2014,
    title = {{American Society of Clinical Oncology Policy Statement Update: The Critical Role of Phase I Trials in Cancer Research and Treatment}},
    year = {2014},
    journal = {Journal of Clinical Oncology},
    author = {Weber, Jeffrey and Al, Et},
    number = {3},
    pages = {278--285},
    volume = {33},
    doi = {10.1200/JCO.2008.16.3691},
    issn = {0732183X},
    pmid = {25512456}
}

@article{VanVliet2016,
    title = {{Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial}},
    year = {2016},
    journal = {The Lancet},
    author = {van Vliet, Elvira O G and Nijman, Tobias a J and Schuit, Ewoud and Heida, Karst Y and Opmeer, Brent C and Kok, Marjolein and Gyselaers, Wilfried and Porath, Martina M and Woiski, Mallory and Bax, Caroline J and Bloemenkamp, Kitty W M and Scheepers, Hubertina C J and Jacquemyn, Yves and Beek, Erik Van and Duvekot, Johannes J and Franssen, Maureen T M and Papatsonis, Dimitri N and Kok, Joke H and van der Post, Joris a M and Franx, Arie and Mol, Ben W and Oudijk, Martijn a},
    number = {10033},
    pages = {2117--2124},
    volume = {387},
    publisher = {Elsevier Ltd},
    url = {http://www.thelancet.com/article/S0140673616005481/fulltext},
    isbn = {1474-547X (Electronic)0140-6736 (Linking)},
    doi = {10.1016/S0140-6736(16)00548-1},
    issn = {01406736},
    pmid = {26944026}
}

@article{Norman2016,
    title = {{Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial}},
    year = {2016},
    journal = {The Lancet},
    author = {Norman, Jane Elizabeth and Marlow, Neil and Messow, Claudia-Martina and Shennan, Andrew and Bennett, Phillip R and Thornton, Steven and Robson, Stephen C and McConnachie, Alex and Petrou, Stavros and Sebire, Neil J and Lavender, Tina and Whyte, Sonia and Norrie, John},
    number = {10033},
    pages = {2106--2116},
    volume = {387},
    publisher = {Norman et al. Open Access article distributed under the terms of CC BY},
    url = {http://linkinghub.elsevier.com/retrieve/pii/S0140673616003500},
    isbn = {0140-6736},
    doi = {10.1016/S0140-6736(16)00350-0},
    issn = {01406736},
    pmid = {26921136}
}

@article{Maughan2014,
    title = {{A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?}},
    year = {2014},
    journal = {British journal of cancer},
    author = {Maughan, T S and Meade, a M and Adams, R a and Richman, S D and Butler, R and Fisher, D and Wilson, R H and Jasani, B and Taylor, G R and Williams, G T and Sampson, J R and Seymour, M T and Nichols, L L and Kenny, S L and Nelson, A and Sampson, C M and Hodgkinson, E and Bridgewater, J a and Furniss, D L and Roy, R and Pope, M J and Pope, J K and Parmar, M and Quirke, P and Kaplan, R},
    number = {9},
    pages = {2178--86},
    volume = {110},
    publisher = {Nature Publishing Group},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/24743706\nhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4007241},
    isbn = {0007-0920},
    doi = {10.1038/bjc.2014.182},
    issn = {1532-1827},
    pmid = {24743706},
    keywords = {a feasibility study testing, a model for, biomarkers, cancer, colorectal cancer, four hypotheses, in advanced colorectal, mrc focus3, multi-arm trials, personalised medicine, with phase ii outcomes}
}

@article{Kaplan2013,
    title = {{Evaluating many treatments and biomarkers in oncology: A new design}},
    year = {2013},
    journal = {Journal of Clinical Oncology},
    author = {Kaplan, Richard and Maughan, Timothy and Crook, Angela and Fisher, David and Wilson, Richard and Brown, Louise and Parmar, Mahesh},
    number = {36},
    pages = {4562--4568},
    volume = {31},
    isbn = {1527-7755 (Electronic){\textbackslash}r0732-183X (Linking)},
    doi = {10.1200/JCO.2013.50.7905},
    issn = {15277755},
    pmid = {24248692}
}

@article{Freidlin2010,
    title = {{Biomarker-adaptive clinical trial designs.}},
    year = {2010},
    journal = {Pharmacogenomics},
    author = {Freidlin, Boris and Korn, Edward L},
    number = {12},
    pages = {1679--82},
    volume = {11},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/21142910},
    doi = {10.2217/pgs.10.153},
    issn = {1744-8042},
    pmid = {21142910},
    keywords = {Biomarkers, Humans, Pharmacological, Pharmacological: analysis, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic: methods, Research Design}
}

@article{Bang2010,
    title = {{Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial}},
    year = {2010},
    journal = {The Lancet},
    author = {Bang, Yung Jue and Van Cutsem, Eric and Feyereislova, Andrea and Chung, Hyun C. and Shen, Lin and Sawaki, Akira and Lordick, Florian and Ohtsu, Atsushi and Omuro, Yasushi and Satoh, Taroh and Aprile, Giuseppe and Kulikov, Evgeny and Hill, Julie and Lehle, Michaela and R??schoff, Josef and Kang, Yoon Koo},
    number = {9742},
    pages = {687--697},
    volume = {376},
    publisher = {Elsevier Ltd},
    url = {http://dx.doi.org/10.1016/S0140-6736(10)61121-X},
    isbn = {01406736 (ISSN)},
    doi = {10.1016/S0140-6736(10)61121-X},
    issn = {01406736},
    pmid = {20728210}
}

@article{Simon,
    title = {{Using Predictive Biomarkers in the Design of Pivotal Trials}},
    journal = {Technical Report},
    author = {Simon, Richard},
    url = {http://linus.nci.nih.gov/techreport/PredictiveBiomarkerPivotalClinicalTrials.pdf},
    keywords = {biometric research branch, classification, clinical trial design, d, gene expression, predictive biomarker, richard simon, sc, supervised, targeted clinical trial}
}

@article{Kim2011,
    title = {{The BATTLE trial: Personalizing Therapy for Lung Cancer}},
    year = {2011},
    journal = {Cancer Discovery},
    author = {Kim, Edward S. and Herbst, Roy S. and Wistuba, Ignacio I. and Jack Lee, J. and Blumenschein, George R. and Tsao, Anne and Stewart, David J. and Hicks, Marshall E. and Erasmus, Jeremy and Gupta, Sanjay and Alden, Christine M. and Liu, Suyu and Tang, Ximing and Khuri, Fadlo R. and Tran, Hai T. and Johnson, Bruce E. and Heymach, John V. and Mao, Li and Fossella, Frank and Kies, Merrill S. and Papadimitrakopoulou, Vassiliki and Davis, Suzanne E. and Lippman, Scott M. and Hong, Waun K.},
    number = {1},
    pages = {44--53},
    volume = {1},
    isbn = {2159-8290 (Electronic){\textbackslash}r2159-8274 (Linking)},
    doi = {10.1158/2159-8274.CD-10-0010},
    issn = {21598274},
    pmid = {22586319},
    arxivId = {1112.3563}
}

@article{Pang2016,
    title = {{Statistical aspect of translational and correlative studies in clinical trials.}},
    year = {2016},
    journal = {Chinese clinical oncology},
    author = {Pang, Herbert and Wang, Xiaofei},
    number = {1},
    pages = {11},
    volume = {5},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/26932435},
    doi = {10.3978/j.issn.2304-3865.2014.07.04},
    issn = {2304-3873},
    pmid = {26932435},
    keywords = {04, 07, 10, 18, 2014, 2304-3865, 3978, accepted for publication jun, big data, bioinformatics, biomarkers, doi, dx, http, issn, j, oncology, org, personalized medicine, submitted may 05, translational science, view this article at}
}

@article{Braun2014,
    title = {{The current design of oncology phase I clinical trials}},
    year = {2014},
    journal = {Chinese clinical oncology},
    author = {Braun, Thomas M},
    number = {1},
    volume = {3},
    doi = {10.3978/j.issn.2304-3865.2014.02.01},
    keywords = {e 1 of 11}
}

@article{Buyse2016,
    title = {{Phase III design: principles}},
    year = {2016},
    journal = {Chinese clinical oncology},
    author = {Buyse, Marc},
    number = {1},
    pages = {1--13},
    volume = {5},
    doi = {10.3978/j.issn.2304-3865.2014.08.05},
    keywords = {05, 08, 10, 2014, 2304-3865, 31, 3978, accepted for publication jul, doi, dx, http, hypothesis testing, issn, j, org, phase iii trials, randomization, sample size, stratification, submitted apr 09, view this article at}
}

@article{Rubinstein2014,
    title = {{Phase II design : history and evolution}},
    year = {2014},
    journal = {Chinese Clinical Oncology},
    author = {Rubinstein, Larry},
    number = {4},
    pages = {48},
    volume = {3},
    doi = {10.3978/j.issn.2304-3865.2014.02.02},
    issn = {23043873},
    keywords = {02, 07, 10, 2013, 2014, 2304-3865, 3978, accepted for publication jan, doi, iii trial, issn, j, phase ii, phase ii trial, randomized, randomized phase ii trial, randomized screening trial, selection design trial, submitted dec 10}
}

@article{Renfro2014,
    title = {{Adaptive randomized phase II design for biomarker threshold selection and independent evaluation.}},
    year = {2014},
    journal = {Chinese clinical oncology},
    author = {Renfro, Lindsay A and Coughlin, Christina M and Grothey, Axel M and Sargent, Daniel J},
    number = {1},
    pages = {3},
    volume = {3},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/25842081},
    doi = {10.3978/j.issn.2304-3865.2013.12.04},
    issn = {2304-3873},
    pmid = {25842081},
    keywords = {04, 10, 12, 2013, 2304-3865, 27, 3978, accepted for publication dec, adaptive design, doi, interim futility analysis, issn, j, phase ii, predictive biomarker, randomized clinical trial, submitted oct 09, threshold identification, trial}
}

@article{Simon2014,
    title = {{Biomarker based clinical trial design.}},
    year = {2014},
    journal = {Chinese clinical oncology},
    author = {Simon, Richard},
    number = {3},
    pages = {39},
    volume = {3},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/25841465},
    doi = {10.3978/j.issn.2304-3865.2014.02.03},
    issn = {2304-3873},
    pmid = {25841465},
    keywords = {02, 03, 10, 2014, 2304-3865, 27, 3978, accepted for publication feb, adaptive design, clinical trial design, companion diagnostic, doi, dx, enrichment trial, http, issn, j, org, predictive biomarker, submitted jan 07, view this article at}
}

@article{Chen2014,
    title = {{Biomarker adaptive designs in clinical trials}},
    year = {2014},
    journal = {Translational Cancer Research},
    author = {Chen, James J. and Lu, Tzu-Pin and Chen, Dung-Tsa and Wang, Sue-Jane},
    number = {3},
    pages = {279--292},
    volume = {3},
    url = {http://www.thetcr.org/article/view/2551/html},
    doi = {10.3978/j.issn.2218-676X.2014.05.04},
    issn = {2218-676X},
    keywords = {04, 05, 08, 10, 2014, 2218-676x, 3978, accepted for publication may, adaptive signature design, analysis, asd, classification, doi, issn, j, personalized medicine, predictive classifier, subgroup, subgroup identification, submitted mar 17}
}

@article{Freidlin2010b,
    title = {{Randomized clinical trials with biomarkers: Design issues}},
    year = {2010},
    journal = {Journal of the National Cancer Institute},
    author = {Freidlin, Boris and McShane, Lisa M. and Korn, Edward L.},
    number = {3},
    pages = {152--160},
    volume = {102},
    isbn = {1460-2105 (Electronic) 0027-8874 (Linking)},
    doi = {10.1093/jnci/djp477},
    issn = {00278874},
    pmid = {20075367}
}

@article{Bogaerts2015,
    title = {{Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative}},
    year = {2015},
    journal = {European Journal of Cancer},
    author = {Bogaerts, Jan and Sydes, Matthew R. and Keat, Nicola and McConnell, Andrea and Benson, Al and Ho, Alan and Roth, Arnaud and Fortpied, Catherine and Eng, Cathy and Peckitt, Clare and Coens, Corneel and Pettaway, Curtis and Arnold, Dirk and Hall, Emma and Marshall, Ernie and Sclafani, Francesco and Hatcher, Helen and Earl, Helena and Ray-Coquard, Isabelle and Paul, James and Blay, Jean Yves and Whelan, Jeremy and Panageas, Kathy and Wheatley, Keith and Harrington, Kevin and Licitra, Lisa and Billingham, Lucinda and Hensley, Martee and McCabe, Martin and Patel, Poulam M. and Carvajal, Richard and Wilson, Richard and Glynne-Jones, Rob and McWilliams, Rob and Leyvraz, Serge and Rao, Sheela and Nicholson, Steve and Filiaci, Virginia and Negrouk, Anastassia and Lacombe, Denis and Dupont, Elisabeth and Pauport{\'{e}}, Iris and Welch, John J. and Law, Kate and Trimble, Ted and Seymour, Matthew},
    number = {3},
    pages = {271--281},
    volume = {51},
    isbn = {1879-0852},
    doi = {10.1016/j.ejca.2014.10.027},
    issn = {18790852},
    pmid = {25542058},
    keywords = {Bayesian, Clinical trials, Frequentist, Methodology, Multi-arm, Randomised controlled trials, Rare cancers}
}

@article{Lindsey2001,
    title = {{Adapting sample size calculations to repeated measurements in clinical trials}},
    year = {2001},
    journal = {Journal of Applied Statistics},
    author = {Lindsey, P. J.},
    number = {1},
    pages = {81--89},
    volume = {28},
    url = {http://www.tandfonline.com/doi/abs/10.1080/02664760120011617#preview},
    doi = {10.1080/02664760120011617},
    issn = {0266-4763, 1360-0532}
}

@book{Diggle2000,
    title = {{Analysis of Longitudinal Data}},
    year = {2000},
    author = {Diggle, Peter J. and Liang, Kung-Yee and Zeger, Scott L.},
    publisher = {Oxford University Press},
    isbn = {0-19-852284-3}
}

@article{Lilford2001,
    title = {{Issues in methodological research: Perspectives from researchers and commissioners}},
    year = {2001},
    journal = {Health Technology Assessment},
    author = {Lilford, R. J. and Richardson, a. and Stevens, a. and Fitzpatrick, R. and Edwards, S. and Rock, F. and Hutton, J. L.},
    number = {8},
    volume = {5},
    isbn = {1366-5278},
    doi = {10.3310/hta5080},
    issn = {13665278},
    pmid = {11368832}
}

@article{Ioannidis2016,
    title = {{Why Most Clinical Research Is Not Useful}},
    year = {2016},
    journal = {Plos Medicine},
    author = {Ioannidis, John P A},
    number = {6},
    volume = {13},
    doi = {10.1371/journal.pmed.1002049}
}

@article{Sharma2016,
    title = {{Clinical development of new drug–radiotherapy combinations}},
    year = {2016},
    journal = {Nature Reviews Clinical Oncology},
    author = {Sharma, Ricky A. and Plummer, Ruth and Stock, Julie K. and Greenhalgh, Tessa A. and Ataman, Ozlem and Kelly, Stephen and Clay, Robert and Adams, Richard A. and Baird, Richard D. and Billingham, Lucinda and Brown, Sarah R. and Buckland, Sean and Bulbeck, Helen and Chalmers, Anthony J. and Clack, Glen and Cranston, Aaron N. and Damstrup, Lars and Ferraldeschi, Roberta and Forster, Martin D. and Golec, Julian and Hagan, Russell M. and Hall, Emma and Hanauske, Axel-R. and Harrington, Kevin J. and Haswell, Tom and Hawkins, Maria A. and Illidge, Tim and Jones, Hazel and Kennedy, Andrew S. and McDonald, Fiona and Melcher, Thorsten and O'Connor, James P. B. and Pollard, John R. and Saunders, Mark P. and Sebag-Montefiore, David and Smitt, Melanie and Staffurth, John and Stratford, Ian J. and Wedge, Stephen R. and Group, NCRI CTRad Academia-Pharma Joint Working},
    publisher = {Nature Publishing Group},
    url = {http://www.nature.com/doifinder/10.1038/nrclinonc.2016.79},
    doi = {10.1038/nrclinonc.2016.79},
    issn = {1759-4774},
    pmid = {27245279}
}

@unpublished{Agency2012,
    title = {{Guideline on the evaluation of anticancer medicinal products in man}},
    year = {2012},
    booktitle = {European Medicines Agency},
    author = {Agency, European Medicines},
    number = {December 2012},
    pages = {33},
    volume = {44},
    keywords = {0, 20 7418 8400 facsimile, 20 7418 8416, 44, 7 westferry circus, biomarker, canary wharf, cancer, london e14 4hb, malignancy, pharmacogenomics, targeted drugs, telephone, united kingdom}
}

@article{Glimelius2011,
    title = {{Window-of-opportunity trials to evaluate clinical activity of new molecular entities in oncology}},
    year = {2011},
    journal = {Annals of Oncology},
    author = {Glimelius, B. and Lahn, M.},
    number = {8},
    pages = {1717--1725},
    volume = {22},
    isbn = {1569-8041},
    doi = {10.1093/annonc/mdq622},
    issn = {09237534},
    pmid = {21239400},
    keywords = {New molecular entities, Safety monitoring, Systematic review, Window trial}
}

@article{Basch2014,
    title = {{Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).}},
    year = {2014},
    journal = {Journal of the National Cancer Institute},
    author = {Basch, Ethan and Reeve, Bryce B and Mitchell, Sandra A and Clauser, Steven B and Minasian, Lori M and Dueck, Amylou C and Mendoza, Tito R and Hay, Jennifer and Atkinson, Thomas M and Abernethy, Amy P and Bruner, Deborah W and Cleeland, Charles S and Sloan, Jeff A and Chilukuri, Ram and Baumgartner, Paul and Denicoff, Andrea and St Germain, Diane and O'Mara, Ann M and Chen, Alice and Kelaghan, Joseph and Bennett, Antonia V and Sit, Laura and Rogak, Lauren and Barz, Allison and Paul, Diane B and Schrag, Deborah},
    number = {9},
    volume = {106},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/25265940 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4200059},
    doi = {10.1093/jnci/dju244},
    issn = {1460-2105},
    pmid = {25265940}
}

@article{Li2014,
    title = {{Vision-Related Quality of Life in Patients with Infectious Keratitis}},
    year = {2014},
    journal = {Optometry and Vision Science},
    author = {Li, Yimin and Hong, Jiaxu and Wei, Anji and Wang, Xin and Chen, Yan and Cui, Xinhan and Sun, Xinghuai and Liu, Zuguo and Xu, Jianjiang},
    number = {3},
    pages = {278--283},
    volume = {91},
    keywords = {best corrected visual acuity, infectious keratitis, nei vfq-25, quality of life, vision-related quality of life}
}

@article{Fayers2015,
    title = {{Estimates of Minimally Important Differences}},
    year = {2015},
    author = {Fayers, Peter M and Hays, Ron D},
    number = {1},
    pages = {1--4},
    volume = {23},
    doi = {10.1007/s11136-013-0443-4.Don},
    keywords = {clinical significance, minimally important difference, patient-reported outcomes, quality of life, regression to the mean}
}

@article{Herbst2016,
    title = {{Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): A randomised controlled trial}},
    year = {2016},
    journal = {The Lancet},
    author = {Herbst, Roy S. and Baas, Paul and Kim, Dong Wan and Felip, Enriqueta and P{\'{e}}rez-Gracia, José L. and Han, Ji Youn and Molina, Julian and Kim, Joo Hang and Arvis, Catherine Dubos and Ahn, Myung Ju and Majem, Margarita and Fidler, Mary J. and De Castro, Gilberto and Garrido, Marcelo and Lubiniecki, Gregory M. and Shentu, Yue and Im, Ellie and Dolled-Filhart, Marisa and Garon, Edward B.},
    number = {10027},
    pages = {1540--1550},
    volume = {387},
    isbn = {0140-6736},
    doi = {10.1016/S0140-6736(15)01281-7},
    issn = {1474547X},
    pmid = {26712084}
}

@article{Ioannidis2005,
    title = {{Why most published research findings are false}},
    year = {2005},
    journal = {PLoS Medicine},
    author = {Ioannidis, John P A},
    number = {8},
    pages = {0696--0701},
    volume = {2},
    isbn = {3540239081},
    doi = {10.1371/journal.pmed.0020124},
    issn = {15491277},
    pmid = {16060722},
    arxivId = {gr-qc/0208024}
}

@article{Kantarjian2011,
    title = {{Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial}},
    year = {2011},
    journal = {The Lancet Oncology},
    author = {Kantarjian, Hagop M. and Hochhaus, Andreas and Saglio, Giuseppe and Souza, Carmino De and Flinn, Ian W. and Stenke, Leif and Goh, Yeow Tee and Rosti, Gianantonio and Nakamae, Hirohisa and Gallagher, Neil J. and Hoenekopp, Albert and Blakesley, Rick E. and Larson, Richard A. and Hughes, Timothy P.},
    number = {9},
    pages = {841--851},
    volume = {12},
    publisher = {Elsevier Ltd},
    url = {http://dx.doi.org/10.1016/S1470-2045(11)70201-7},
    isbn = {1474-5488 (Electronic){\textbackslash}n1470-2045 (Linking)},
    doi = {10.1016/S1470-2045(11)70201-7},
    issn = {14702045},
    pmid = {21856226}
}

@article{Chen2010,
    title = {{Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia}},
    year = {2010},
    journal = {New England Journal of Medicine},
    author = {Chen, Dalei and Ph, D and Ramirez, Luz Margarita and Investigators, Advance-},
    number = {24},
    pages = {2487--2498},
    volume = {362},
    doi = {10.1056/NEJMoa1514204},
    pmid = {19038878}
}

@article{Kantarjian2014,
    title = {{Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia : 2-year follow-up from a randomized phase 3 trial ( DASISION )}},
    year = {2014},
    author = {Kantarjian, Hagop M and Shah, Neil P and Cortes, Jorge E and Baccarani, Michele and Agarwal, Mohan B and Undurraga, María Soledad and Wang, Jianxiang and Julio, Juan and Ipin, Kassack and Kim, Dong-wook and Ogura, Michinori and Pavlovsky, Carolina},
    number = {5},
    pages = {1123--1129},
    volume = {119},
    doi = {10.1182/blood-2011-08-376087.The}
}

@article{Kim2014,
    title = {{Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors.}},
    year = {2014},
    journal = {Haematologica},
    author = {Kim, Sung-Hyun and Menon, Hari and Jootar, Saengsuree and Saikia, Tapan and Kwak, Jae-Yong and Sohn, Sang-Kyun and Park, Joon Seong and Jeong, Seong Hyun and Kim, Hyeoung Joon and Kim, Yeo-Kyeoung and Oh, Suk Joong and Kim, Hawk and Zang, Dae Young and Chung, Joo Seop and Shin, Ho Jin and Do, Young Rok and Kim, Jeong-A and Kim, Dae-Young and Choi, Chul Won and Park, Sahee and Park, Hye Lin and Lee, Gong Yeal and Cho, Dae Jin and Shin, Jae Soo and Kim, Dong-Wook},
    number = {7},
    pages = {1191--6},
    volume = {99},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/24705186},
    doi = {10.3324/haematol.2013.096776},
    issn = {1592-8721},
    pmid = {24705186}
}

@article{Hochhaus2012,
    title = {{Dasatinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic-phase (CML-CP):DASISION  3-year follow-up}},
    year = {2012},
    journal = {J Clin Oncol (2012 ASCO Annual Meeting Proceedings)},
    author = {Hochhaus, A and Shah, N P and Cortes, J E and Baccarani, M and Bradley-Garelik, M B and Dejardin, D and Kantarjian, H M},
    number = {15{\_}suppl-May 20},
    pages = {6504},
    volume = {30},
    keywords = {Age of Onset, Algorithms, Antineoplastic Agents/adverse effects/therapeutic, Cytogenetic Analysis, DNA Mutational Analysis, Follow-Up Studies, Fusion Proteins, bcr-abl/genetics, Humans, Leukemia, Myeloid, Chronic-Phase/diagnosis/*drug t, Middle Aged, Neoadjuvant Therapy, Piperazines/adverse effects/*therapeutic use, Pyrimidines/adverse effects/*therapeutic use, Thiazoles/adverse effects/*therapeutic use, Time Factors, Treatment Outcome}
}

@article{Hughes2014,
    title = {{Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib}},
    year = {2014},
    journal = {Blood},
    author = {Hughes, Timothy P. and Saglio, Giuseppe and Kantarjian, Hagop M. and Guilhot, Fran??ois and Niederwieser, Dietger and Rosti, Gianantonio and Nakaseko, Chiaki and De Souza, Carmino Antonio and Kalaycio, Matt E. and Meier, Stephan and Fan, Xiaolin and Menssen, Hans D. and Larson, Richard A. and Hochhaus, Andreas},
    number = {9},
    pages = {1353--1360},
    volume = {123},
    isbn = {0006-4971},
    doi = {10.1182/blood-2013-06-510396},
    issn = {15280020},
    pmid = {24335106}
}

@article{Baccarani2013,
    title = {{Review Article European LeukemiaNet recommendations for the management of chronic myeloid leukemia : 2013}},
    year = {2013},
    journal = {Blood},
    author = {Baccarani, Michele and Deininger, Michael W and Rosti, Gianantonio and Hochhaus, Andreas and Soverini, Simona and Apperley, Jane F and Cervantes, Francisco and Clark, Richard E and Cortes, Jorge E and Hjorth-Hansen, Henrik and Hughes, Timothy P and Kantarjian, Hagop M and Kim, Dong-Wook and Larson, Richard a and Lipton, Jeffrey H and Martinelli, Giovanni and Mayer, Jiri and Martin, C M and Steegmann, Juan-Luis and Goldman, John M and Guilhot, François and Hjorth-Hansen, Henrik and Hughes, Timothy P and Kantarjian, Hagop M and Kim, Dong-Wook and Larson, Richard a and Lipton, Jeffrey H and Mahon, François-Xavier and Martinelli, Giovanni and Mayer, Jiri and M{\"{u}}ller, Martin C and Niederwieser, Dietger and Pane, Fabrizio and Radich, Jerald P and Rousselot, Philippe and Saglio, Giuseppe and Sau{\ss}ele, Susanne and Schiffer, Charles and Silver, Richard and Simonsson, Bengt and Steegmann, Juan-Luis and Goldman, John M and Hehlmann, Rüdiger},
    number = {6},
    pages = {872--884},
    volume = {122},
    url = {http://www.bloodjournal.org/content/122/6/872.abstract},
    doi = {10.1182/blood-2013-05-501569.The},
    issn = {1528-0020},
    pmid = {23803709},
    keywords = {Antineoplastic Agents, Antineoplastic Agents: therapeutic use, BCR-ABL Positive, BCR-ABL Positive:, Benzamides, Benzamides: therapeutic use, Chronic, Europe, Fusion Proteins, Humans, Leukemia, Myelogenous, Piperazines, Piperazines: therapeutic use, Prognosis, Pyrimidines, Pyrimidines: therapeutic use, Randomized Controlled Trials as Topic, Stem Cell Transplantation, Thiazoles, Thiazoles: therapeutic use, Treatment Outcome, bcr-abl, bcr-abl: metabolism}
}

@article{Bowen2016,
    title = {{Accumulated workloads and the acute:chronic workload ratio relate to injury risk in elite youth football players}},
    year = {2016},
    journal = {British Journal of Sports Medicine},
    author = {Bowen, Laura and Gross, Aleksander Stefan and Gimpel, Mo and Li, François-Xavier},
    doi = {10.1136/bjsports-2015-095820},
    issn = {0306-3674}
}

@article{Chatterjee2016,
    title = {{Systematic evaluation of pembrolizumab dosing in patients with advanced non-small cell lung cancer.}},
    year = {2016},
    journal = {Annals of oncology : official journal of the European Society for Medical Oncology / ESMO},
    author = {Chatterjee, M and Turner, D C and Felip, E and Lena, H and Cappuzzo, F and Horn, L and Garon, E B and Hui, R and Arkenau, H-T and Gubens, M A and Hellmann, M D and Dong, D and Li, C and Mayawala, K and Freshwater, T and Ahamadi, M and Stone, J and Lubiniecki, G M and Zhang, J and Im, E and De Alwis, D P and Kondic, A G and Fl{\o}tten, Ø},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/27117531},
    doi = {10.1093/annonc/mdw174},
    issn = {1569-8041},
    pmid = {27117531},
    keywords = {exposure, immunotherapy, non-small-cell lung cancer, pd-l1, pembrolizumab, response, tumor size}
}

@article{Carpenter2016,
    title = {{Stan: A Probabilistic Programming Language}},
    year = {2016},
    journal = {Journal of Statistical Software},
    author = {Carpenter, Bob and Gelman, Andrew and Hoffman, Matt and Lee, Daniel and Goodrich, Ben and Betancourt, Michael and Brubaker, Marcus A. and Li, Peter and Riddell, Allen},
    number = {Ii},
    volume = {VV}
}

@article{Gillespie2014,
    title = {{Estimating minimally important differences for two vision-specific quality of life measures}},
    year = {2014},
    journal = {Investigative Ophthalmology and Visual Science},
    author = {Gillespie, Brenda W. and Musch, David C. and Niziol, Leslie M. and Janz, Nancy K.},
    number = {7},
    pages = {4206--4212},
    volume = {55},
    publisher = {Nature Publishing Group},
    url = {http://www.nature.com/doifinder/10.1038/nrclinonc.2016.79 http://www.ncbi.nlm.nih.gov/pubmed/25265940 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4200059},
    isbn = {0146-0404},
    doi = {10.1167/iovs.13-13683},
    issn = {15525783},
    pmid = {24906863},
    keywords = {CIGTS, Glaucoma, MID, NEI-VFQ, VAQ}
}

@article{KMok2016,
    title = {{Are we ready for immune checkpoint inhibitors for advanced non-small-cell lung cancer?}},
    year = {2016},
    journal = {The Lancet},
    author = {K Mok, Tony S and Loong, Herbert H},
    pages = {1488--90},
    volume = {387},
    url = {http://dx.doi.org/10.1016/S0140-6736(15)01308-2},
    isbn = {0140-6736},
    doi = {10.1016/S0140-6736(15)01308-2},
    issn = {01406736},
    pmid = {26712085}
}

@article{Eisenstein2008,
    title = {{Sensible approaches for reducing clinical trial costs}},
    year = {2008},
    journal = {Clinical Trials},
    author = {Eisenstein, E. L and Collins, R. and Cracknell, B. S and Podesta, O. and Reid, E. D and Sandercock, P. and Shakhov, Y. and Terrin, M. L and Sellers, M. a. and Califf, R. M and Granger, C. B and Diaz, R.},
    number = {1},
    pages = {75--84},
    volume = {5},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/18283084},
    isbn = {1740774507},
    doi = {10.1177/1740774507087551},
    issn = {1740-7745},
    pmid = {18283084},
    keywords = {Chronic Disease, Chronic Disease: drug therapy, Clinical Trials as Topic, Clinical Trials as Topic: economics, Clinical Trials as Topic: methods, Computer Simulation, Econometric, Humans, Information Systems, Information Systems: organization {\&} administration, Models, Multicenter Studies as Topic, Multicenter Studies as Topic: economics, Multicenter Studies as Topic: methods, Research Design}
}

@article{Ioannidis2014,
    title = {{How to Make More Published Research True}},
    year = {2014},
    journal = {PLoS Medicine},
    author = {Ioannidis, John P A},
    number = {10},
    volume = {11},
    isbn = {1549-1277},
    doi = {10.1371/journal.pmed.1001747},
    issn = {15491676},
    pmid = {25334033}
}

@article{Fasullo2016,
    title = {{Is the detection of accelerated sea level rise imminent?}},
    year = {2016},
    journal = {Scientific Reports},
    author = {Fasullo, J. T. and Nerem, R. S. and Hamlington, B. and Church, J. A. and Stocker, T. F. and Nerem, R. S. and Chambers, D. and Choe, C. and Mitchum, G. T. and Boening, C. and Willis, J. K. and Landerer, F. W. and Nerem, R. S. and Fasullo, J. and Fasullo, J. T. and Boening, C. and Landerer, F. W. and Nerem, R. S. and Hanna, Edward and Shepherd, Andrew and Haigh, I. D. and Moser, Susanne C. and Trenberth, K. E. and Fasullo, J. T. and Cazenave, Anny and Watson, Christopher S. and Mitchum, G. T. and Douglas, B. C. and Douglas, B. C. and Church, J. A. and White, N. J. and Church, J. A. and White, N. J. and Jevrejeva, S. and Moore, J. C. and Grinsted, A. and Woodworth, P. L. and Ray, R. and Douglas, B. and Hay, C. H. and Morrow, E. and Kopp, R. E. and Mitrovica, J. X. and Minnis, P. and McCormick, M. P. and Thomason, L. W. and Trepte., C. R. and Church, J. A. and White, N. J. and Arblaster, J. M. and Gleckler, P. J. and Gregory, J. M. and Lowe, J. A. and Tett., S. F. B. and Slangen, Aimée and Slangen, Aimée B. A. and Fasullo, J. T. and Lawrence, D. M. and Swenson., S. C. and Tapley, Byron D. and Trenberth, K. E. and Dai, A. and Abraham, J. P. and Nerem, R. S. and Chambers, D. P. and Leuliette, E. W. and Mitchum, G. T. and Giese, B. S. and Kay, J. E. and Lamarque, J. F. and Lamarque, J. F. and Lawrence, David M. and Church, John A.},
    number = {April},
    pages = {31245},
    volume = {6},
    publisher = {Nature Publishing Group},
    url = {http://www.nature.com/articles/srep31245},
    doi = {10.1038/srep31245},
    issn = {2045-2322}
}

@article{Middleton2015a,
    title = {{The National Lung Matrix Trial: Translating the biology of stratification in advanced non-small-cell lung cancer}},
    year = {2015},
    journal = {Annals of Oncology},
    author = {Middleton, G. and Crack, L. R. and Popat, S. and Swanton, C. and Hollingsworth, S. J. and Buller, R. and Walker, I. and Carr, T. H. and Wherton, D. and Billingham, L. J.},
    number = {12},
    pages = {2464--2469},
    volume = {26},
    isbn = {0923-7534},
    doi = {10.1093/annonc/mdv394},
    issn = {15698041},
    pmid = {26410619},
    keywords = {Adaptive trial design, National Lung Matrix Trial, Non-small-cell lung cancer, Stratified medicine, Umbrella Trial}
}

@article{Robert2014,
    title = {{Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trial}},
    year = {2014},
    journal = {The Lancet},
    author = {Robert, Caroline and Ribas, Antoni and Wolchok, Jedd D. and Hodi, F. Stephen and Hamid, Omid and Kefford, Richard and Weber, Jeffrey S. and Joshua, Anthony M. and Hwu, Wen Jen and Gangadhar, Tara C. and Patnaik, Amita and Dronca, Roxana and Zarour, Hassane and Joseph, Richard W. and Boasberg, Peter and Chmielowski, Bartosz and Mateus, Christine and Postow, Michael A. and Gergich, Kevin and Elassaiss-Schaap, Jeroen and Li, Xiaoyun Nicole and Iannone, Robert and Ebbinghaus, Scot W. and Kang, S. Peter and Daud, Adil},
    isbn = {1474-547X (Electronic) 0140-6736 (Linking)},
    doi = {10.1016/S0140-6736(14)60958-2},
    issn = {1474547X},
    pmid = {25034862}
}

@article{Robert2015,
    title = {{Pembrolizumab versus Ipilimumab in Advanced Melanoma.}},
    year = {2015},
    journal = {The New England journal of medicine},
    author = {Robert, Caroline and Schachter, Jacob and Long, Georgina V and Arance, Ana and Grob, Jean Jacques and Mortier, Laurent and Daud, Adil and Carlino, Matteo S and McNeil, Catriona and Lotem, Michal and Larkin, James and Lorigan, Paul and Neyns, Bart and Blank, Christian U and Hamid, Omid and Mateus, Christine and Shapira-Frommer, Ronnie and Kosh, Michele and Zhou, Honghong and Ibrahim, Nageatte and Ebbinghaus, Scot and Ribas, Antoni and {KEYNOTE-006 investigators}},
    number = {26},
    pages = {2521--32},
    volume = {372},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/25891173},
    isbn = {1533-4406 (Electronic){\textbackslash}r0028-4793 (Linking)},
    doi = {10.1056/NEJMoa1503093},
    issn = {1533-4406},
    pmid = {25891173}
}

@article{Dummer2015,
    title = {{A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma}},
    year = {2015},
    journal = {Journal of Translational Medicine},
    author = {Dummer, Reinhard and Daud, Adil and Puzanov, Igor and Hamid, Omid and Schadendorf, Dirk and Robert, Caroline and Schachter, Jacob and Pavlick, Anna and Gonzalez, Rene and Hodi, F Stephen and Cranmer, Lee D and Blank, Christian and Day, Steven J O and Ascierto, Paolo a and Salama, April K S and Li, Nicole Xiaoyun and Zhou, Wei and Lis, Joy},
    number = {Suppl 1},
    pages = {O5},
    volume = {13},
    publisher = {BioMed Central Ltd},
    url = {http://www.translational-medicine.com/content/13/S1/O5},
    isbn = {1479587613},
    doi = {10.1186/1479-5876-13-S1-O5},
    issn = {1479-5876},
    pmid = {25779181}
}

@article{Hamid2013,
    title = {{Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.}},
    year = {2013},
    journal = {The New England journal of medicine},
    author = {Hamid, Omid and Robert, Caroline and Daud, Adil and Hodi, F Stephen and Hwu, Wen-Jen and Kefford, Richard and Wolchok, Jedd D and Hersey, Peter and Joseph, Richard W and Weber, Jeffrey S and Dronca, Roxana and Gangadhar, Tara C and Patnaik, Amita and Zarour, Hassane and Joshua, Anthony M and Gergich, Kevin and Elassaiss-Schaap, Jeroen and Algazi, Alain and Mateus, Christine and Boasberg, Peter and Tumeh, Paul C and Chmielowski, Bartosz and Ebbinghaus, Scot W and Li, Xiaoyun Nicole and Kang, S Peter and Ribas, Antoni},
    number = {2},
    pages = {134--44},
    volume = {369},
    url = {http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4126516&tool=pmcentrez&rendertype=abstract},
    isbn = {1533-4406 (Electronic){\textbackslash}r0028-4793 (Linking)},
    doi = {10.1056/NEJMoa1305133},
    issn = {1533-4406},
    pmid = {23724846},
    keywords = {80 and over, Adult, Aged, Antibodies, Antineoplastic Agents, Antineoplastic Agents: administration {\&} dosage, Antineoplastic Agents: adverse effects, Antineoplastic Agents: pharmacokinetics, Brain Neoplasms, Brain Neoplasms: secondary, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Humans, Male, Melanoma, Melanoma: drug therapy, Melanoma: secondary, Middle Aged, Monoclonal, Monoclonal: administration {\&} dosage, Monoclonal: adverse effects, Monoclonal: pharmacokinetics, Programmed Cell Death 1 Receptor, Programmed Cell Death 1 Receptor: antagonists {\&} in, Skin Neoplasms, Skin Neoplasms: drug therapy, Skin Neoplasms: pathology}
}

@misc{Bhatia2014,
    title = {{Melanoma: Immune checkpoint blockade story gets better}},
    year = {2014},
    booktitle = {The Lancet},
    author = {Bhatia, Shailender and Thompson, John A.},
    isbn = {0140-6736},
    doi = {10.1016/S0140-6736(14)61140-5},
    issn = {1474547X},
    pmid = {25034863}
}

@article{Ribas2015,
    title = {{Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): A randomised, controlled, phase 2 trial}},
    year = {2015},
    journal = {The Lancet Oncology},
    author = {Ribas, Antoni and Puzanov, Igor and Dummer, Reinhard and Schadendorf, Dirk and Hamid, Omid and Robert, Caroline and Hodi, F. Stephen and Schachter, Jacob and Pavlick, Anna C. and Lewis, Karl D. and Cranmer, Lee D. and Blank, Christian U. and O'Day, Steven J. and Ascierto, Paolo A. and Salama, April K S and Margolin, Kim A. and Loquai, Carmen and Eigentler, Thomas K. and Gangadhar, Tara C. and Carlino, Matteo S. and Agarwala, Sanjiv S. and Moschos, Stergios J. and Sosman, Jeffrey A. and Goldinger, Simone M. and Shapira-Frommer, Ronnie and Gonzalez, Rene and Kirkwood, John M. and Wolchok, Jedd D. and Eggermont, Alexander and Li, Xiaoyun Nicole and Zhou, Wei and Zernhelt, Adriane M. and Lis, Joy and Ebbinghaus, Scot and Kang, S. Peter and Daud, Adil},
    number = {8},
    pages = {908--918},
    volume = {16},
    isbn = {1470-2045},
    doi = {10.1016/S1470-2045(15)00083-2},
    issn = {14745488},
    pmid = {26115796}
}

@article{Nanda2016,
    title = {{Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study.}},
    year = {2016},
    journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
    author = {Nanda, Rita and Chow, Laura Q M and Dees, E Claire and Berger, Raanan and Gupta, Shilpa and Geva, Ravit and Pusztai, Lajos and Pathiraja, Kumudu and Aktan, Gursel and Cheng, Jonathan D and Karantza, Vassiliki and Buisseret, Laurence},
    pages = {1--10},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/27138582},
    isbn = {1527-7755},
    doi = {10.1200/JCO.2015.64.8931},
    issn = {1527-7755},
    pmid = {27138582}
}

@article{Seiwert2016,
    title = {{Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial}},
    year = {2016},
    journal = {The Lancet Oncology},
    author = {Seiwert, Tanguy Y and Burtness, Barbara and Mehra, Ranee and Weiss, Jared and Berger, Raanan and Eder, Joseph Paul and Heath, Karl and McClanahan, Terrill and Lunceford, Jared and Gause, Christine and Cheng, Jonathan D and Chow, Laura Q},
    number = {7},
    pages = {956--965},
    volume = {17},
    publisher = {Elsevier Ltd},
    url = {http://linkinghub.elsevier.com/retrieve/pii/S1470204516300663},
    doi = {10.1016/S1470-2045(16)30066-3},
    issn = {14702045},
    pmid = {27247226}
}

@article{Muro2016,
    title = {{Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial}},
    year = {2016},
    journal = {The Lancet Oncology},
    author = {Muro, Kei and Chung, Hyun Cheol and Shankaran, Veena and Geva, Ravit and Catenacci, Daniel and Gupta, Shilpa and Eder, Joseph Paul and Golan, Talia and Le, Dung T and Burtness, Barbara and McRee, Autumn J and Lin, Chia-Chi and Pathiraja, Kumudu and Lunceford, Jared and Emancipator, Kenneth and Juco, Jonathan and Koshiji, Minori and Bang, Yung-Jue},
    pages = {717--726},
    volume = {17},
    publisher = {Elsevier Ltd},
    url = {http://linkinghub.elsevier.com/retrieve/pii/S1470204516001753},
    isbn = {1474-5488 (Electronic) 1470-2045 (Linking)},
    doi = {10.1016/S1470-2045(16)00175-3},
    issn = {14702045},
    pmid = {27157491}
}

@article{Dalgleish2016,
    title = {{Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer}},
    year = {2016},
    journal = {British journal of cancer},
    author = {Dalgleish, Angus G and Stebbing, Justin and Adamson, Douglas JA and Safia Arif, Seema and Bidoli, Paolo and Chang, David and Cheeseman, Sue and Diaz-Beveridge, Robert and Fernandez-Martos, Carlos and Glynne-Jones, Rob and Granetto, Cristina and Massuti, Bartomeu and McAdam, Karen and McDermott, Raymond and Mu{\~{n}} oz Mart{\'{i}}n, André J and Papamichael, Demetris and Pazo-Cid, Roberto and Vieitez, Jose M and Zaniboni, Alberto and Carroll, Kevin J and Wagle, Shama and Gaya, Andrew and Mudan, Satvinder S},
    pages = {1--8},
    doi = {10.1038/bjc.2016.271}
}

@article{Jf2012,
    title = {{Supplementary Appendix - Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial}},
    year = {2015},
    author = {{Herbst} and {Baas} and {Kim} and {...}},
    number = {15},
    volume = {6736}
}

@article{Patnaik2015,
    title = {{Phase I study of pembrolizumab (MK-3475; Anti-PD-1 monoclonal antibody) in patients with advanced solid tumors}},
    year = {2015},
    journal = {Clinical Cancer Research},
    author = {Patnaik, Amita and Kang, S. Peter and Rasco, Drew and Papadopoulos, Kyriakos P. and Elassaiss-Schaap, Jeroen and Beeram, Muralidhar and Drengler, Ronald and Chen, Cong and Smith, Lon and Espino, Guillermo and Gergich, Kevin and Delgado, Liliana and Daud, Adil and Lindia, Jill A. and Nicole Li, Xiaoyun and Pierce, Robert H. and Yearley, Jennifer H. and Wu, Dianna and Laterza, Omar and Lehnert, Manfred and Iannone, Robert and Tolcher, Anthony W.},
    number = {19},
    pages = {4286--4293},
    volume = {21},
    isbn = {1078-0432 (Print) 1078-0432},
    doi = {10.1158/1078-0432.CCR-14-2607},
    issn = {15573265},
    pmid = {25977344}
}

@article{Patnaik2015a,
    title = {{Supplementary - Phase I study of pembrolizumab (MK-3475; Anti-PD-1 monoclonal antibody) in patients with advanced solid tumors}},
    author = {Patnaik, Amita and Kang, S. Peter and Rasco, Drew and Papadopoulos, Kyriakos P. and Elassaiss-Schaap, Jeroen and Beeram, Muralidhar and Drengler, Ronald and Chen, Cong and Smith, Lon and Espino, Guillermo and Gergich, Kevin and Delgado, Liliana and Daud, Adil and Lindia, Jill A. and Nicole Li, Xiaoyun and Pierce, Robert H. and Yearley, Jennifer H. and Wu, Dianna and Laterza, Omar and Lehnert, Manfred and Iannone, Robert and Tolcher, Anthony W.}
}

@article{Hamid2013a,
    title = {{Supplementary - Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.}},
    year = {2013},
    journal = {The New England journal of medicine},
    author = {Hamid, Omid and Robert, Caroline and Daud, Adil and Hodi, F Stephen and Hwu, Wen-Jen and Kefford, Richard and Wolchok, Jedd D and Hersey, Peter and Joseph, Richard W and Weber, Jeffrey S and Dronca, Roxana and Gangadhar, Tara C and Patnaik, Amita and Zarour, Hassane and Joshua, Anthony M and Gergich, Kevin and Elassaiss-Schaap, Jeroen and Algazi, Alain and Mateus, Christine and Boasberg, Peter and Tumeh, Paul C and Chmielowski, Bartosz and Ebbinghaus, Scot W and Li, Xiaoyun Nicole and Kang, S Peter and Ribas, Antoni},
    number = {2},
    pages = {134--44},
    volume = {369},
    url = {http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4126516&tool=pmcentrez&rendertype=abstract},
    isbn = {1533-4406 (Electronic){\textbackslash}r0028-4793 (Linking)},
    doi = {10.1056/NEJMoa1305133},
    issn = {1533-4406},
    pmid = {23724846},
    keywords = {80 and over, Adult, Aged, Antibodies, Antineoplastic Agents, Antineoplastic Agents: administration {\&} dosage, Antineoplastic Agents: adverse effects, Antineoplastic Agents: pharmacokinetics, Brain Neoplasms, Brain Neoplasms: secondary, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Humans, Male, Melanoma, Melanoma: drug therapy, Melanoma: secondary, Middle Aged, Monoclonal, Monoclonal: administration {\&} dosage, Monoclonal: adverse effects, Monoclonal: pharmacokinetics, Programmed Cell Death 1 Receptor, Programmed Cell Death 1 Receptor: antagonists {\&} in, Skin Neoplasms, Skin Neoplasms: drug therapy, Skin Neoplasms: pathology}
}

@article{Ribas2015a,
    title = {{Supplementary - Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): A randomised, controlled, phase 2 trial}},
    year = {2015},
    author = {Ribas, Antoni and Puzanov, Igor and Dummer, Reinhard and Schadendorf, Dirk and Hamid, Omid and Robert, Caroline and Hodi, F. Stephen and Schachter, Jacob and Pavlick, Anna C. and Lewis, Karl D. and Cranmer, Lee D. and Blank, Christian U. and O'Day, Steven J. and Ascierto, Paolo A. and Salama, April K S and Margolin, Kim A. and Loquai, Carmen and Eigentler, Thomas K. and Gangadhar, Tara C. and Carlino, Matteo S. and Agarwala, Sanjiv S. and Moschos, Stergios J. and Sosman, Jeffrey A. and Goldinger, Simone M. and Shapira-Frommer, Ronnie and Gonzalez, Rene and Kirkwood, John M. and Wolchok, Jedd D. and Eggermont, Alexander and Li, Xiaoyun Nicole and Zhou, Wei and Zernhelt, Adriane M. and Lis, Joy and Ebbinghaus, Scot and Kang, S. Peter and Daud, Adil},
    number = {15},
    volume = {2045}
}

@article{Ribas2015b,
    title = {{P0116 Updated clinical efficacy of the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in 411 patients with melanoma}},
    year = {2015},
    journal = {European Journal of Cancer},
    author = {Ribas, A. and Wolchok, J.D. and Robert, C. and Kefford, R. and Hamid, O. and Daud, A. and Hwu, W-J. and Weber, J.S. and Joshua, A.M. and Gangadhar, T.C. and Patnaik, A. and Hersey, P. and Dronca, R. and Zarour, H. and Gergich, K. and Lindia, J.A. and Giannotti, M. and Li, X.N. and Ebbinghaus, S. and Kang, S.P. and Hodi, F.S.},
    pages = {e24},
    volume = {51},
    url = {http://linkinghub.elsevier.com/retrieve/pii/S0959804915005675},
    doi = {10.1016/j.ejca.2015.06.072},
    issn = {09598049}
}

@article{Robert2015a,
    title = {{Supplementary - Pembrolizumab versus Ipilimumab in Advanced Melanoma.}},
    year = {2015},
    journal = {The New England journal of medicine},
    author = {Robert, Caroline and Schachter, Jacob and Long, Georgina V and Arance, Ana and Grob, Jean Jacques and Mortier, Laurent and Daud, Adil and Carlino, Matteo S and McNeil, Catriona and Lotem, Michal and Larkin, James and Lorigan, Paul and Neyns, Bart and Blank, Christian U and Hamid, Omid and Mateus, Christine and Shapira-Frommer, Ronnie and Kosh, Michele and Zhou, Honghong and Ibrahim, Nageatte and Ebbinghaus, Scot and Ribas, Antoni and {KEYNOTE-006 investigators}},
    number = {26},
    pages = {2521--32},
    volume = {372},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/25891173},
    isbn = {1533-4406 (Electronic){\textbackslash}r0028-4793 (Linking)},
    doi = {10.1056/NEJMoa1503093},
    issn = {1533-4406},
    pmid = {25891173}
}

@article{Hemming2012,
    title = {{Pooling systematic reviews of systematic reviews: A Bayesian panoramic meta-analysis}},
    year = {2012},
    journal = {Statistics in Medicine},
    author = {Hemming, Karla and Bowater, Russell James and Lilford, Richard J.},
    number = {3},
    pages = {201--216},
    volume = {31},
    isbn = {1097-0258 (Electronic){\textbackslash}r0277-6715 (Linking)},
    doi = {10.1002/sim.4372},
    issn = {02776715},
    pmid = {21965138},
    keywords = {Meta-analysis, Panoramic meta-analysis, Random effects models, Systematic reviews}
}

@article{Hemming2013,
    title = {{A Systematic Review of Systematic Reviews and Panoramic Meta-Analysis: Staples versus Sutures for Surgical Procedures}},
    year = {2013},
    journal = {PLoS ONE},
    author = {Hemming, Karla and Pinkney, Thomas and Futaba, Kay and Pennant, Mary and Morton, Dion G. and Lilford, Richard J.},
    number = {10},
    volume = {8},
    isbn = {1932-6203 (Electronic){\textbackslash}r1932-6203 (Linking)},
    doi = {10.1371/journal.pone.0075132},
    issn = {19326203},
    pmid = {24116028}
}

@article{Tan2003,
    title = {{Strategy for randomised clinical trials in rare cancers}},
    year = {2003},
    journal = {BMJ : British Medical Journal},
    author = {Tan, Say-Beng and Dear, Keith B G and Bruzzi, Paolo and Machin, David},
    number = {7405},
    pages = {47--49},
    volume = {327},
    isbn = {0959-8138 LA  - ENG PT - JOURNAL ARTICLE},
    doi = {10.1136/bmj.327.7405.47},
    issn = {0959-8138},
    pmid = {12842959}
}

@article{Tartari2016,
    title = {{Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients: Recent insights and future challenges.}},
    year = {2016},
    journal = {Cancer treatment reviews},
    author = {Tartari, Francesca and Santoni, Matteo and Burattini, Luciano and Mazzanti, Paola and Onofri, Azzurra and Berardi, Rossana},
    pages = {20--24},
    volume = {48},
    publisher = {Elsevier Ltd},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/27310708},
    doi = {10.1016/j.ctrv.2016.06.002},
    issn = {1532-1967},
    pmid = {27310708},
    keywords = {Economic sustainability, Immunotherapy, Lung cancer, Melanoma, Per patient cost, Renal cell carcinoma}
}

@article{Burke2016,
    title = {{Clarification on Tartari et al: Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients}},
    year = {2016},
    journal = {Cancer Treatment Reviews},
    author = {Burke, Tom},
    url = {http://linkinghub.elsevier.com/retrieve/pii/S0305737216300871},
    doi = {10.1016/j.ctrv.2016.08.009},
    issn = {03057372}
}

@article{Gruenbaum2016,
    title = {{Pharmacologic Neuroprotection for Functional Outcomes After Traumatic Brain Injury: A Systematic Review of the Clinical Literature}},
    year = {2016},
    journal = {CNS Drugs},
    author = {Gruenbaum, Shaun E. and Zlotnik, Alexander and Gruenbaum, Benjamin F. and Hersey, Denise and Bilotta, Federico},
    number = {9},
    pages = {1--16},
    volume = {30},
    publisher = {Springer International Publishing},
    url = {http://link.springer.com/10.1007/s40263-016-0355-2},
    doi = {10.1007/s40263-016-0355-2},
    issn = {1172-7047},
    pmid = {27339615}
}

@article{Deerenberg2015,
    title = {{Small bites versus large bites for closure of abdominal midline incisions (STITCH): A double-blind, multicentre, randomised controlled trial}},
    year = {2015},
    journal = {The Lancet},
    author = {Deerenberg, Eva B. and Harlaar, Joris J. and Steyerberg, Ewout W. and Lont, Harold E. and Van Doorn, Helena C. and Heisterkamp, Joos and Wijnhoven, Bas P L and Schouten, Willem R. and Cense, Huib A. and Stockmann, Hein B A C and Berends, Frits J. and Dijkhuizen, F. Paul Hlj and Dwarkasing, Roy S. and Jairam, An P. and Van Ramshorst, Gabrielle H. and Kleinrensink, Gert Jan and Jeekel, Johannes and Lange, Johan F.},
    number = {10000},
    pages = {1254--1260},
    volume = {386},
    publisher = {Elsevier Ltd},
    isbn = {0140-6736},
    doi = {10.1016/S0140-6736(15)60459-7},
    issn = {1474547X},
    pmid = {26188742}
}

@article{Srinivasan2014,
    title = {{The steroids for corneal ulcers trial (SCUT): Secondary 12-month clinical outcomes of a randomized controlled trial}},
    year = {2014},
    journal = {American Journal of Ophthalmology},
    author = {Srinivasan, Muthiah and Mascarenhas, Jeena and Rajaraman, Revathi and Ravindran, Meenakshi and Lalitha, Prajna and O'Brien, Kieran S. and Glidden, David V. and Ray, Kathryn J. and Oldenburg, Catherine E. and Zegans, Michael E. and Whitcher, John P. and McLeod, Stephen D. and Porco, Travis C. and Lietman, Thomas M. and Acharya, Nisha R.},
    number = {2},
    pages = {327--333},
    volume = {157},
    publisher = {Elsevier Inc.},
    url = {http://dx.doi.org/10.1016/j.ajo.2013.09.025},
    isbn = {1879-1891 (Electronic){\textbackslash}r0002-9394 (Linking)},
    doi = {10.1016/j.ajo.2013.09.025},
    issn = {00029394},
    pmid = {24315294},
    arxivId = {NIHMS150003}
}

@article{Srinivasan2012a,
    title = {{The Steroids for Corneal Ulcers Trial: Study Design and Baseline Characteristics}},
    year = {2012},
    journal = {Archives of Ophthalmology},
    author = {Srinivasan, Muthiah and Mascarenhas, Jeena and Rajaraman, Revathi and Ravindran, Meenakshi and Lalitha, Prajna and Glidden, David V. and Ray, Kathryn J. and Hong, Kevin C. and Oldenburg, Catherine E. and Lee, Salena M. and Zegans, Michael E. and McLeod, Stephen D. and Lietman, Thomas M. and Acharya, Nisha R.},
    number = {2},
    pages = {151--7},
    volume = {130},
    isbn = {0000000000000},
    doi = {10.1001/archophthalmol.2011.303},
    issn = {1946-6242},
    pmid = {20371490},
    arxivId = {NIHMS150003},
    keywords = {33447, 44-207-794-0500 ext 35123 or, address correspondence to dr, centre for nephrology and, dengue, disease severity, e-mail, ethnic thais, genetic associations, henry stephens, hla, london nw3 2pf, lta, rowland hill street, royal free hospital campus, tel, the, the anthony nolan trust, tnf, uk, university college london}
}

@article{Chow2016,
    title = {{Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort}},
    year = {2016},
    journal = {Journal of Clinical Oncology},
    author = {Chow, L. Q. M. and Haddad, R. and Gupta, S. and Mahipal, A. and Mehra, R. and Tahara, M. and Berger, R. and Eder, J. P. and Burtness, B. and Lee, S.-H. and Keam, B. and Kang, H. and Muro, K. and Weiss, J. and Geva, R. and Lin, C.-C. and Chung, H. C. and Meister, A. and Dolled-Filhart, M. and Pathiraja, K. and Cheng, J. D. and Seiwert, T. Y.},
    url = {http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2016.68.1478},
    doi = {10.1200/JCO.2016.68.1478},
    issn = {0732-183X}
}

@article{Edwards2009,
    title = {{Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease. A Randomized Controlled Trial}},
    year = {2009},
    journal = {Journal of the American College of Cardiology},
    author = {Edwards, Nicola C. and Steeds, Richard P. and Stewart, Paul M. and Ferro, Charles J. and Townend, Jonathan N.},
    number = {6},
    pages = {505--512},
    volume = {54},
    publisher = {American College of Cardiology Foundation},
    isbn = {0735-1097},
    doi = {10.1016/j.jacc.2009.03.066},
    issn = {07351097},
    pmid = {19643310},
    keywords = {arterial stiffness, chronic kidney disease, left ventricular mass, renin-angiotensin-aldosterone system, spironolactone}
}

@article{Harman2015,
    title = {{Exploring the role and function of trial steering committees: results of an expert panel meeting.}},
    year = {2015},
    journal = {Trials},
    author = {Harman, Nicola L and Conroy, Elizabeth J and Lewis, Steff C and Murray, Gordon and Norrie, John and Sydes, Matt R and Lane, J Athene and Altman, Douglas G and Baigent, Colin and Bliss, Judith M and Campbell, Marion K and Elbourne, Diana and Evans, Stephen and Sandercock, Peter and Gamble, Carrol},
    pages = {597},
    volume = {16},
    publisher = {Trials},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/26715378\nhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4696246},
    doi = {10.1186/s13063-015-1125-z},
    issn = {1745-6215},
    pmid = {26715378},
    keywords = {Trials,oversight committee,trial steering committe, ac, clinical trial, committee, correspondence, data monitoring, executive committee, harman, liv, n, oversight committee, randomised controlled trial, terms of reference, trial steering committee, trials, uk}
}

@article{Salminen2015,
    title = {{Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis}},
    year = {2015},
    journal = {Jama},
    author = {Salminen, Paulina and Paajanen, Hannu and Rautio, Tero and Nordstr{\"{o}}m, Pia and Aarnio, Markku and Rantanen, Tuomo and Tuominen, Risto and Hurme, Saija and Virtanen, Johanna and Mecklin, Jukka-Pekka and Sand, Juhani and Jartti, Airi and Rinta-Kiikka, Irina and Gr{\"{o}}nroos, Juha M.},
    number = {23},
    pages = {2340},
    volume = {313},
    url = {http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.6154},
    isbn = {0098-7484},
    doi = {10.1001/jama.2015.6154},
    issn = {0098-7484},
    pmid = {26080338},
    keywords = {Appendectomy, Clinical Trials: methods, Clinical Trials: noninferiority}
}

@article{Vachhani2016,
    title = {{Spotlight on pembrolizumab in non-small cell lung cancer: the evidence to date}},
    journal = {OncoTargets and Therapy},
    author = {Vachhani, Pankit and Chen, Hongbin},
    doi = {10.2147/OTT.S97746},
    keywords = {KEYNOTE, non-small cell lung cancer, pembrolizumab}
}

@article{Reck2016,
    title = {{Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer}},
    year = {2016},
    journal = {New England Journal of Medicine},
    author = {Reck, Martin and Rodr{\'{i}}guez-Abreu, Delvys and Robinson, Andrew G. and Hui, Rina and Cs{\H{o}}szi, Tibor and F{\"{u}}l{\"{o}}p, Andrea and Gottfried, Maya and Peled, Nir and Tafreshi, Ali and Cuffe, Sinead and O’Brien, Mary and Rao, Suman and Hotta, Katsuyuki and Leiby, Melanie A. and Lubiniecki, Gregory M. and Shentu, Yue and Rangwala, Reshma and Brahmer, Julie R.},
    doi = {10.1056/NEJMoa1606774},
    issn = {0028-4793},
    pmid = {27718847}
}

@article{Thall2010,
    title = {{Bayesian Models and Decision Algorithms for Complex Early Phase Clinical Trials}},
    year = {2010},
    journal = {Statistical Science},
    author = {Thall, Peter F},
    number = {2},
    pages = {227--244},
    volume = {25},
    doi = {10.1214/09-STS315.Bayesian},
    keywords = {adaptive design, and phrases, bayesian design, clinical trial, dose-finding, ii trial, phase i, phase i trial}
}

@article{Boonstra2015,
    title = {{A statistical evaluation of dose expansion cohorts in phase I clinical trials.}},
    year = {2015},
    journal = {Journal of the National Cancer Institute},
    author = {Boonstra, Philip S and Shen, Jincheng and Taylor, Jeremy M G and Braun, Thomas M and Griffith, Kent a and Daignault, Stephanie and Kalemkerian, Gregory P and Lawrence, Theodore S and Schipper, Matthew J},
    number = {3},
    pages = {1--6},
    volume = {107},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/25710960},
    doi = {10.1093/jnci/dju429},
    issn = {1460-2105},
    pmid = {25710960},
    keywords = {Antineoplastic Agents, Antineoplastic Agents: administration {\&} dosage, Antineoplastic Agents: adverse effects, Clinical Trials, Phase I as Topic, Clinical Trials, Phase I as Topic: methods, Dose-Response Relationship, Drug, Humans, Maximum Tolerated Dose, Research Design}
}

@article{Tao2013,
    title = {{Dose-Finding Based on Bivariate Efficacy-Toxicity Outcome Using Archimedean Copula}},
    year = {2013},
    journal = {PLoS ONE},
    author = {Tao, Yuxi and Liu, Junlin and Li, Zhihui and Lin, Jinguan and Lu, Tao and Yan, Fangrong},
    number = {11},
    pages = {e78805},
    volume = {8},
    url = {http://dx.plos.org/10.1371/journal.pone.0078805},
    doi = {10.1371/journal.pone.0078805},
    issn = {1932-6203}
}

@article{He2015,
    title = {{Dimension of Model Parameter Space and Operating Characteristics in Adaptive Dose-Finding Studies}},
    year = {2016},
    journal = {Statistics in Medicine},
    author = {Iasonos, Alexia and Wages, Nolan A. and Conaway, Mark R. and Cheung, Ken and Yuan, Ying and O'Quigley, John},
    number = {21},
    pages = {3760--3775},
    volume = {35},
    isbn = {0000000000000},
    doi = {10.1038/nbt.3121.ChIP-nexus},
    issn = {1527-5418},
    pmid = {24655651},
    arxivId = {15334406}
}

@article{Dewan2012,
    title = {{CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial.}},
    year = {2012},
    journal = {Trials},
    author = {Dewan, Y},
    pages = {87},
    volume = {13},
    url = {http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/836/CN-00864836/frame.html},
    keywords = {antifibrinolytic, clinical trial, emergency care, intracranial bleeding, tranexamic acid, traumatic brain}
}

@article{Ivanova2005,
    title = {{Continuous toxicity monitoring in phase II trials in oncology}},
    year = {2005},
    journal = {Biometrics},
    author = {Ivanova, Anastasia and Qaqish, Bahjat F. and Schell, Michael J.},
    number = {2},
    pages = {540--545},
    volume = {61},
    isbn = {0006-341X (Print){\textbackslash}r0006-341X (Linking)},
    doi = {10.1111/j.1541-0420.2005.00311.x},
    issn = {0006341X},
    pmid = {16011702},
    keywords = {Phase II trial, Pocock boundary, Sequential monitoring, Unbiased estimate}
}

@article{Anderlini2015,
    title = {{Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1–2 dose de-escalation study}},
    year = {2015},
    journal = {Lancet Haematology},
    author = {Anderlini, Paolo and Wu, Juan and Gersten, Iris and Ewell, Marian and Tolar, Jakob and Antin, Joseph H. and Adams, Roberta and Arai, Sally and Eames, Gretchen and Horwitz, Mitchell E. and McCarty, John and Nakamura, Ryotaro and Pulsipher, Michael A. and Rowley, Scott and Leifer, Eric and Carter, Shelly L. and DiFronzo, Nancy L. and Horowitz, Mary M. and Confer, Dennis and Deeg, H. Joachim and Eapen, Mary},
    number = {9},
    pages = {367--375},
    volume = {2},
    isbn = {0000287431},
    doi = {10.1016/S2352-3026(15)00147-7},
    pmid = {25931448}
}

@article{Briasoulis2013,
    title = {{Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.}},
    year = {2013},
    journal = {BMC Cancer},
    author = {Briasoulis, Evangelos and Aravantinos, Gerasimos and Kouvatseas, George and Pappas, Periklis and Biziota, Eirini and Sainis, Ioannis and Makatsoris, Thomas and Varthalitis, Ioannis and Xanthakis, Ioannis and Vassias, Antonios and Klouvas, George and Boukovinas, Ioannis and Fountzilas, George and Syrigos, Kostantinos N and Kalofonos, Haralambos and Samantas, Epaminontas},
    number = {1},
    pages = {263},
    volume = {13},
    url = {http://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-13-263},
    isbn = {1471-2407},
    doi = {10.1186/1471-2407-13-263},
    issn = {1471-2407},
    pmid = {23718900},
    keywords = {Administration, Adolescent, Adult, Aged, Antineoplastic Agents, Biomarkers, Bone Neoplasms, Bone Neoplasms: drug therapy, Bone Neoplasms: secondary, Breast Neoplasms, Breast Neoplasms: drug therapy, Breast Neoplasms: mortality, Breast Neoplasms: pathology, Carcinoma, Dose-Response Relationship, Drug, Enzyme-Linked Immunosorbent Assay, Female, Follow-Up Studies, Humans, Liver Neoplasms, Liver Neoplasms: drug therapy, Liver Neoplasms: mortality, Liver Neoplasms: secondary, Lung Neoplasms, Lung Neoplasms: drug therapy, Lung Neoplasms: mortality, Lung Neoplasms: pathology, Male, Messenger, Messenger: genetics, Middle Aged, Neoplasm Staging, Non-Small-Cell Lung, Non-Small-Cell Lung: drug therapy, Non-Small-Cell Lung: mortality, Non-Small-Cell Lung: pathology, Oral, Phytogenic, Phytogenic: administration, Prognosis, Prostatic Neoplasms, Prostatic Neoplasms: drug therapy, Prostatic Neoplasms: mortality, Prostatic Neoplasms: pathology, RNA, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Survival Rate, Time-to-Treatment, Translational Medical Research, Tumor, Tumor: genetics, Tumor: metabolism, Vinblastine, Vinblastine: administration {\&} dosage, Vinblastine: analogs {\&} derivatives, Young Adult}
}

@article{Chen2013,
    title = {{Cyclosporine Modulation of Multidrug Resistance in Combination with Pravastatin, Mitoxantrone, and Etoposide for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML): A Phase 1/2 Study}},
    year = {2013},
    journal = {Leuk Lymphoma},
    author = {Chen, Tara L. and Estey, Elihu H. and Othus, Megan and Gardner, Kelda M. and Markle, Lauren J. and Walter, Roland B.},
    number = {11},
    pages = {2534--6},
    volume = {54},
    isbn = {8585348585},
    doi = {10.3109/10428194.2013.777836},
    issn = {15378276},
    pmid = {1000000221},
    arxivId = {NIHMS150003},
    keywords = {cyp6d1 transcription, hr96, musca domestica, phenobarbital induction, pyrethroid resistance}
}

@article{Shah2015,
    title = {{Phase I/II trial of lenalidomide and high dose melphalan with autologous stem cell transplantation for relapsed myeloma}},
    year = {2015},
    journal = {Leukemia},
    author = {Shah, Nina and Thall, Peter F. and Fox, Patricia S. and Bashir, Qaiser and Shah, Jatin J. and Parmar, Simrit and Lin, Pei and Kebriaei, Partow and Nieto, Yago and Popat, Uday R. and Hosing, Chitra M. and Cornelison, Amanda and Shpall, Elizabeth J. and Orlowski, Robert Z. and Champlin, Richard E. and Qazilbash, Muzaffar H.},
    number = {9},
    pages = {1945--48},
    volume = {29},
    isbn = {0000287431},
    doi = {10.1038/leu.2015.54},
    pmid = {25931448}
}

@article{Simon2016,
    title = {{Genomic alteration-driven clinical trial designs in oncology}},
    year = {2016},
    journal = {Annals of Internal Medicine},
    author = {Simon, Richard},
    number = {4},
    pages = {270--278},
    volume = {165},
    doi = {10.7326/M15-2413},
    issn = {15393704},
    pmid = {27214515}
}

@article{Yap2015,
    title = {{Dose transition pathways: a design, analysis and operational tool for dose-finding trials using model-based designs}},
    year = {2015},
    journal = {Trials},
    author = {Yap, Christina and Billingham, Lucinda and Craddock, Charles and O'Quigley, John},
    number = {S2},
    pages = {O13},
    volume = {16},
    publisher = {BioMed Central Ltd},
    url = {http://trialsjournal.biomedcentral.com/articles/10.1186/1745-6215-16-S2-O13},
    doi = {10.1186/1745-6215-16-S2-O13},
    issn = {1745-6215}
}

@article{Chen2016,
    title = {{Anti–programmed cell death (PD)-1 immunotherapy for malignant tumor: A systematic review and meta-analysis}},
    year = {2016},
    journal = {Translational Oncology},
    author = {Chen, Ran and Peng, Pei Chun and Wen, Bin and Li, Fu Ying and Xie, Sheng and Chen, Guozhong and Lu, Jiefu and Peng, Zhuoyu and Tang, Shao Bo and Liang, Yu Mei and Deng, Xin},
    number = {1},
    pages = {32--40},
    volume = {9},
    publisher = {The Authors},
    url = {http://dx.doi.org/10.1016/j.tranon.2015.11.010},
    isbn = {1412400422},
    doi = {10.1016/j.tranon.2015.11.010},
    issn = {19365233},
    pmid = {26947879}
}

@misc{clintrials-v0.1.4,
    title = {{clintrials v0.1.4}},
    year = {2016},
    author = {Brock, Kristian},
    publisher = {GitHub, Zenodo},
    url = {https://zenodo.org/record/164621 https://github.com/brockk/clintrials},
    doi = {10.5281/zenodo.164621},
    keywords = {Software}
}

@article{IOANNIDIS2016b,
    title = {{The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses}},
    year = {2016},
    journal = {The Milbank Quarterly},
    author = {IOANNIDIS, JOHN P.A.},
    number = {3},
    pages = {485--514},
    volume = {94},
    url = {http://doi.wiley.com/10.1111/1468-0009.12210},
    doi = {10.1111/1468-0009.12210},
    issn = {0887378X},
    pmid = {27620683}
}

@article{Parmar2016,
    title = {{How do you design randomised trials for smaller populations? A framework}},
    year = {2016},
    journal = {BMC Medicine},
    author = {Parmar, Mahesh K B and Sydes, Matthew R and Morris, Tim P},
    number = {183},
    volume = {14},
    doi = {10.1186/s12916-016-0722-3},
    keywords = {Randomised trials, Smaller populations, Trial design, Uncommon diseases}
}

@article{Carbognin2015,
    title = {{Differential activity of nivolumab, pembrolizumab and MPDL3280A according to the tumor expression of programmed death-ligand-1 (PD-L1): Sensitivity analysis of trials in melanoma, lung and genitourinary cancers}},
    year = {2015},
    journal = {PLoS ONE},
    author = {Carbognin, Luisa and Pilotto, Sara and Milella, Michele and Vaccaro, Vanja and Brunelli, Matteo and Cali{\`{o}}, Anna and Cuppone, Federica and Sperduti, Isabella and Giannarelli, Diana and Chilosi, Marco and Bronte, Vincenzo and Scarpa, Aldo and Bria, Emilio and Tortora, Giampaolo},
    number = {6},
    volume = {10},
    isbn = {1932-6203 (Electronic){\textbackslash}r1932-6203 (Linking)},
    doi = {10.1371/journal.pone.0130142},
    issn = {19326203},
    pmid = {26086854}
}

@article{Rupp2016,
    title = {{Quality of Life, Overall Survival, and Costs of Cancer Drugs Approved Based on Surrogate Endpoints}},
    year = {2016},
    journal = {JAMA Internal Medicine},
    author = {Rupp, Tracy and Zuckerman, Diana},
    pages = {4--6},
    url = {http://archinte.jamanetwork.com/article.aspx?doi=10.1001/jamainternmed.2016.7761},
    doi = {10.1001/jamainternmed.2016.7761},
    issn = {2168-6106},
    pmid = {27898978}
}

@article{Grigg2016,
    title = {{PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?}},
    year = {2016},
    journal = {Journal for immunotherapy of cancer},
    author = {Grigg, Claud and Rizvi, Naiyer A},
    pages = {48},
    volume = {4},
    publisher = {Journal for ImmunoTherapy of Cancer},
    url = {http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4986262&tool=pmcentrez&rendertype=abstract},
    doi = {10.1186/s40425-016-0153-x},
    issn = {2051-1426},
    pmid = {27532023},
    keywords = {Biomarker, Immune checkpoint inhibitor, Immunotherapy, Lung cancer, NSCLC, Nivolumab, PD-1, PD-L1, Pembrolizumab, biomarker, immune checkpoint inhibitor, immunotherapy, lung cancer, nivolumab, nsclc, pd-1, pd-l1, pembrolizumab}
}

@article{Reck2016a,
    title = {{Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer}},
    year = {2016},
    journal = {New England Journal of Medicine},
    author = {Reck, Martin and Rodr{\'{i}}guez-Abreu, Delvys and Robinson, Andrew G. and Hui, Rina and Cs{\H{o}}szi, Tibor and F{\"{u}}l{\"{o}}p, Andrea and Gottfried, Maya and Peled, Nir and Tafreshi, Ali and Cuffe, Sinead and O’Brien, Mary and Rao, Suman and Hotta, Katsuyuki and Leiby, Melanie A. and Lubiniecki, Gregory M. and Shentu, Yue and Rangwala, Reshma and Brahmer, Julie R.},
    pages = {NEJMoa1606774},
    url = {http://www.nejm.org/doi/10.1056/NEJMoa1606774},
    isbn = {0028-4793},
    doi = {10.1056/NEJMoa1606774},
    issn = {0028-4793},
    pmid = {27718847},
    keywords = {pembrolizumab}
}

@article{Main2015,
    title = {{The role of high-dose myeloablative chemotherapy with haematopoietic stem cell transplantation (HSCT) in children with central nervous system (CNS) tumours: protocol for a systematic review and meta-analysis.}},
    year = {2015},
    journal = {Systematic reviews},
    author = {Main, Caroline and Wilson, Jayne S and Stevens, Simon P and Houlton, Aimee E and English, Martin and Kearns, Pamela R and Phillips, Bob and Pizer, Barry and Wilne, Sophie and Wheatley, Keith},
    pages = {168},
    volume = {4},
    publisher = {Systematic Reviews},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/26589619\nhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4654793},
    doi = {10.1186/s13643-015-0155-7},
    issn = {2046-4053},
    pmid = {26589619},
    keywords = {Central nervous system tumours, Children, Haematopoietic stem cell transplantation, High-dose chemotherapy, Systematic review, ac, bham, c, central nervous system tumours, children, correspondence, haematopoietic stem cell, high-dose chemotherapy, main, systematic review, transplantation, uk}
}

@article{Cheung2005,
    title = {{Coherence Principles in Dose-Finding Studies}},
    year = {2005},
    journal = {Biometrika},
    author = {Cheung, Ying Kuen},
    number = {4},
    pages = {863--873},
    volume = {92}
}

@article{Azzouzi2016a,
    title = {{Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial}},
    year = {2016},
    journal = {The Lancet Oncology},
    author = {Azzouzi, Abdel-Rahmène and Vincendeau, Sébastien and Barret, Eric and Cicco, Antony and Kleinclauss, François and van der Poel, Henk G and Stief, Christian G and Rassweiler, Jens and Salomon, Georg and Solsona, Eduardo and Alcaraz, Antonio and Tammela, Teuvo T and Rosario, Derek J and Gomez-Veiga, Francisco and Ahlgren, Göran and Benzaghou, Fawzi and Gaillac, Bertrand and Amzal, Billy and Debruyne, Frans M J and Fromont, Gaëlle and Gratzke, Christian and Emberton, Mark},
    number = {16},
    pages = {1--11},
    volume = {2045},
    url = {http://linkinghub.elsevier.com/retrieve/pii/S1470204516306611},
    doi = {10.1016/S1470-2045(16)30661-1},
    issn = {14702045}
}

@article{Abdel-rahman2016,
    title = {{Evaluation of efficacy and safety of different pembrolizumab dose / schedules in treatment of non-small-cell lung cancer and melanoma : a systematic review}},
    year = {2016},
    author = {Abdel-rahman, Omar},
    number = {December},
    doi = {10.2217/imt-2016-0075},
    issn = {1750-743X},
    keywords = {dose, melanoma, nsclc, pembrolizumab}
}

@techreport{Wolfram1938,
    title = {{Diabetes mellitus and simple optic atrophy among siblings: report of four cases}},
    year = {1938},
    author = {Wolfram, DJ and Wagener, HP},
    institution = {MAYO CLINIC PROCEEDINGS}
}

@article{Barrett1997,
    title = {{Wolfram (DIDMOAD) syndrome}},
    year = {1997},
    journal = {Journal of Medical Genetics},
    author = {Barrett, T G and Bundey, S E},
    pages = {838--841},
    volume = {34}
}

@article{Barrett1995,
    title = {{Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome}},
    year = {1995},
    journal = {The Lancet},
    author = {Barrett, T. G. and Bundey, S. E. and Macleod, A. F.},
    number = {8988},
    pages = {1458--1463},
    volume = {346},
    isbn = {0140-6736 (Print){\textbackslash}r0140-6736 (Linking)},
    doi = {10.1016/S0140-6736(95)92473-6},
    issn = {01406736},
    pmid = {7490992}
}

@article{Nagy1998,
    title = {{The cell division cycle and the pathophysiology of Alzheimer's disease.}},
    year = {1998},
    journal = {Neuroscience},
    author = {Nagy, Z and Esiri, M M and Smith, A D},
    number = {4},
    pages = {731--9},
    volume = {87},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/9759963},
    isbn = {0306-4522 (Print){\textbackslash}r0306-4522 (Linking)},
    doi = {S0306452298002930 [pii]},
    issn = {0306-4522},
    pmid = {9759963},
    keywords = {alzheimer, apoptosis, cell cycle, cyclin, down, s disease, s syndrome, temporal lobe epilepsy}
}

@article{Shu2016,
    title = {{Into the Clinic With Nivolumab and Pembrolizumab.}},
    year = {2016},
    journal = {The oncologist},
    author = {Shu, Catherine A and Rizvi, Naiyer A},
    number = {5},
    pages = {527--8},
    volume = {21},
    url = {http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4861376&tool=pmcentrez&rendertype=abstract},
    doi = {10.1634/theoncologist.2016-0099},
    issn = {1549-490X},
    pmid = {27026678}
}

@misc{trialr,
    title = {{trialr - clinical trial designs in R {\&} Stan}},
    year = {2017},
    author = {Brock, Kristian},
    url = {https://github.com/brockk/trialr}
}

@misc{Cook2016,
    title = {{Immune Biomarkers Identify Sustained Quantitative and Functional Immune Reconstitution in the Setting of Adjunctive Lenalidomide Following T-Depleted RIC-Allo SCT for Multiple Myeloma}},
    year = {2016},
    author = {Cook, Gordon and Carter, Clive R and Brock, Kristian and McQuaker, Grant and Snowden, John A and Crawley, Charles and Hunter, Hannah and Cavenagh, Jamie D. and Lobb, Mark and Cullen, Katherine and Hodgkinson, Andrea and Sirovica, Mirjana and Cook, Mark},
    url = {https://ash.confex.com/ash/2016/webprogram/Paper94823.html}
}

@misc{Rawstron2016,
    title = {{Compartment Effect on the Prognostic Significance of MRD Detection in CLL: Impact of Treatment Type and Duration of Follow-up}},
    year = {2016},
    author = {Rawstron, Andy C and Howard, Dena and McParland, Lucy and de Tute, Ruth and Collett, Laura and Phillips, David and Chalmers, Anna and Varghese, Abraham Mullasseril and Munir, Talha and Gregory, Walter M and Bishop, Rebecca and Yates, Francesca J and Brock, Kristian and Mu{\~{n}}oz-Vicente, Samuel and Hillmen, Peter},
    url = {https://ash.confex.com/ash/2016/webprogram/Paper96818.html}
}

@misc{Rawstron,
    title = {{Addition of Obinutuzumab to Ibrutinib Enhances Depletion of CLL Cells in the Peripheral Blood and Bone Marrow after 1 Month of Combination Therapy: Initial Results from the Bloodwise TAP Iciclle Extension Study}},
    year = {2016},
    author = {Rawstron, Andy C and Munir, Talha and Mu{\~{n}}oz-Vicente, Samuel and Brock, Kristian and Yates, Francesca J and Bishop, Rebecca and Dalal, Surita and Tute, Ruth Mary de and Bloor, Adrian and Sheehy, Oonagh M and Pettitt, Andrew R. and Fox, Christopher P and Fegan, Christopher and Devereux, Stephen and Macdonald, Donald and Hillmen, Peter},
    url = {https://ash.confex.com/ash/2016/webprogram/Paper93314.html}
}

@misc{Rawstron2015,
    title = {{THE LLR TAP ICICLLE TRIAL ASSESSING BIOLOGICAL RESPONSE TO IBRUTINIB IN CLL: IMMEDIATE DISEASE REDISTRIBUTION PRECEDES CELL CYCLE ARREST BY 2 WEEKS WITH REDUCED BONE MARROW INFILTRATION BY 6 MONTHS}},
    year = {2015},
    author = {Rawstron, Andy and Munir, Talha and Dalal, Surita and Thompson, Jonny and Yap, Christina and Brock, Kristian and Yates, Francesca and Ogburn, Emma and Fox, Christopher and MacDonald, Donald and Fegan, Christopher and Bloor, Adrian and Hillmen, Peter},
    url = {http://learningcenter.ehaweb.org/eha/2015/20th/103132/andy.rawstron.the.llr.tap.iciclle.trial.assessing.biological.response.to.html?f=m3}
}

@misc{McNair2016,
    title = {{The NCRI Future of Surgery initiative: Defining a research agenda for outcomes of surgical randomized controlled trials}},
    year = {2016},
    booktitle = {NCRI Abstracts},
    author = {McNair, Angus and Brock, Kristian and Jones, Terry and Francis, Adele and Blazeby, Jane and Bach, Simon and Avery, Kerry and Fairhurst, Kathrine and Shaw, Richard},
    url = {http://abstracts.ncri.org.uk/abstract/the-ncri-future-of-surgery-initiative-defining-a-research-agenda-for-outcomes-of-surgical-randomized-controlled-trials/}
}

@misc{Rawstron2016a,
    title = {{The LLR TAP IcICLLe trial assessing biological response to ibrutinib in CLL: immediate disease redistribution precedes cell cycle arrest by 2 weeks with reduced bone marrow infiltration by 6 months}},
    year = {2016},
    booktitle = {NCRI Abstracts},
    author = {Rawstron, Andy and Munir, Talha and Dalal, Surita and Tute, Ruth de and Brock, Kristian and Yates, Francesca and Fox, Chris and MacDonald, Donald and Fox, Christopher and Bloor, Adrian and Hillmen, Peter},
    url = {http://abstracts.ncri.org.uk/abstract/the-llr-tap-iciclle-trial-assessing-biological-response-to-ibrutinib-in-cll-immediate-disease-redistribution-precedes-cell-cycle-arrest-by-2-weeks-with-reduced-bone-marrow-infiltration-by-6-months-2/}
}

@article{Brock2016,
    title = {{Relationships between paranoid thinking, self-esteem and the menstrual cycle}},
    year = {2016},
    journal = {Archives of Women's Mental Health},
    author = {Brock, Rosalind and Rowse, Georgina and Slade, Pauline},
    number = {2},
    pages = {271--279},
    volume = {19},
    isbn = {0073701505},
    doi = {10.1007/s00737-015-0558-4},
    issn = {14351102},
    pmid = {26260035},
    keywords = {Deservedness, Menstruation, Paranoia, Premenstrual, Self-esteem}
}

@article{Gonzalez-Cao2017,
    title = {{Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program}},
    year = {2017},
    journal = {Clinical and Translational Oncology},
    author = {Gonz{\'{a}}lez-Cao, M. and Arance, A. and Piulats, J. M. and Marquez-Rodas, I. and Manzano, J. L. and Berrocal, A. and Crespo, G. and Rodriguez, D. and Perez-Ruiz, E. and Berciano, M. and Soria, A. and Castano, A. G. and Espinosa, E. and Montagut, C. and Alonso, L. and Puertolas, T. and Aguado, C. and Royo, M. A. and Blanco, R. and Rodr{\'{i}}guez, J. F. and Mu{\~{n}}oz, E. and Mut, P. and Barron, F. and Martin-Algarra, S. and {Spanish Melanoma Group}},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/28054320 http://link.springer.com/10.1007/s12094-016-1602-1},
    doi = {10.1007/s12094-016-1602-1},
    issn = {1699-048X},
    pmid = {28054320},
    keywords = {CNS metastases, Expanded access program, Melanoma, Pembrolizumab, Survival}
}

@article{Druker2006,
    title = {{Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia}},
    year = {2006},
    journal = {New England Journal of Medicine},
    author = {Druker, Brian J. and Guilhot, François and O’Brien, Stephen G. and Gathmann, Insa and Kantarjian, Hagop and Gattermann, Norbert and Deininger, Michael W.N. and Silver, Richard T. and Goldman, John M. and Stone, Richard M. and Cervantes, Francisco and Hochhaus, Andreas and Powell, Bayard L. and Gabrilove, Janice L. and Rousselot, Philippe and Reiffers, Josy and Cornelissen, Jan J. and Hughes, Timothy and Agis, Hermine and Fischer, Thomas and Verhoef, Gregor and Shepherd, John and Saglio, Giuseppe and Gratwohl, Alois and Nielsen, Johan L. and Radich, Jerald P. and Simonsson, Bengt and Taylor, Kerry and Baccarani, Michele and So, Charlene and Letvak, Laurie and Larson, Richard A.},
    number = {23},
    pages = {2408--17},
    volume = {355}
}

@article{Jabbour2014,
    title = {{Early response with dasatinib or imatinib in chronic myeloid leukemia : 3-year follow-up from a randomized phase 3 trial ( DASISION )}},
    year = {2014},
    journal = {Blood},
    author = {Jabbour, Elias and Kantarjian, Hagop M. and Saglio, Giuseppe and Steegmann, Juan Luis and Shah, Neil P. and Boque, Concepcion and Chuah, Charles and Pavlovsky, Carolina and Mayer, Jir and Cortes, Jorge and Baccarani, Michele and Kim, Dong-Wook and Bradley-Garelik, M. Brigid and Mohamed, Hesham and Wildgust, Mark and Hochhaus, Andreas},
    number = {4},
    pages = {494--501},
    volume = {123},
    doi = {10.1182/blood-2013-06-511592.The}
}

@article{Larson2012,
    title = {{Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase : ENESTnd 3-year follow-up This article has been corrected since Advance Online Publication and a corrigendum is also printed}},
    year = {2012},
    journal = {Leukemia},
    author = {Larson, RA and Hochhaus, A and Hughes, TP and Clark, RE and Etienne, G and Kim, D-W and Flinn, IW and Kurokawa, M and Moiraghi, B and Yu, R and Blakesley, RE and Gallagher, NJ and Saglio, G and Kantarjian, HM},
    pages = {2197--2203},
    volume = {26},
    doi = {10.1038/leu.2012.134},
    keywords = {chronic myeloid leukemia, enestnd, imatinib, newly diagnosed, nilotinib, progression}
}

@article{Giles2012,
    title = {{Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase.}},
    year = {2012},
    journal = {Leukemia},
    author = {Giles, F J and Kantarjian, H M and le Coutre, P D and Baccarani, M and Mahon, F X and Blakesley, R E and Gallagher, N J and Gillis, K and Goldberg, S L and Larson, R A and Hochhaus, A and Ottmann, O G},
    number = {5},
    pages = {959--962},
    volume = {26},
    publisher = {Nature Publishing Group},
    url = {http://www.nature.com/doifinder/10.1038/leu.2011.355},
    isbn = {0887-6924},
    doi = {10.1038/leu.2011.355},
    issn = {1476-5551},
    pmid = {22157807},
    keywords = {bcr-abl, blastic phase, chronic myeloid leukemia, imatinib resistance, mutations, nilotinib}
}

@article{Palandri2008,
    title = {{Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: Outcome of the patients alive after a 6-year follow-up}},
    year = {2008},
    journal = {Haematologica},
    author = {Palandri, Francesca and Castagnetti, Fausto and Testoni, Nicoletta and Luatti, Simona and Marzocchi, Giulia and Bassi, Simona and Breccia, Massimo and Alimena, Giuliana and Pungolino, Ester and Rege-Cambrin, Giovanna and Varaldo, Riccardo and Miglino, Maurizio and Specchia, Giorgina and Zuffa, Eliana and Ferrara, Felicetto and Bocchia, Monica and Saglio, Giuseppe and Pane, Fabrizio and Alberti, Daniele and Martinelli, Giovanni and Baccarani, Michele and Rosti, Gianantonio},
    number = {12},
    pages = {1792--1796},
    volume = {93},
    isbn = {0390-6078},
    doi = {10.3324/haematol.13068},
    issn = {03906078},
    pmid = {18838477},
    keywords = {Blast crisis, Chronic myeloid leukemia, Imatinib, Long-term, Outcome}
}

@article{Hehlmann2012,
    title = {{How I treat CML blast crisis How I treat How I treat CML blast crisis}},
    year = {2012},
    journal = {Blood},
    author = {Hehlmann, Ruediger},
    number = {4},
    pages = {737--748},
    volume = {120},
    url = {http://bloodjournal.hematologylibrary.org/content/120/4/737.full.html},
    doi = {10.1182/blood-2012-03-380147}
}

@article{Druker2001,
    title = {{Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia chromosome}},
    year = {2001},
    journal = {New England Journal of Medicine},
    author = {Druker, Brian J. and Sawyers, Charles L. and Kantarjian, Hagop and Resta, Debra J. and Reese, Sofia Fernandes and Ford, John M. and Capdeville, Renaud and Talpaz, Moshe},
    number = {14},
    pages = {1038--1042},
    volume = {344}
}

@article{Saglio2010,
    title = {{Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study: Efficacy and tolerability of 140 milligrams once daily and 70 milligrams twice daily}},
    year = {2010},
    journal = {Cancer},
    author = {Saglio, Giuseppe and Hochhaus, Andreas and Goh, Yeow Tee and Masszi, Tamas and Pasquini, Ricardo and Maloisel, Frederic and Erben, Philipp and Cortes, Jorge and Paquette, Ronald and Bradley-Garelik, M. Brigid and Zhu, Chao and Dombret, Herve},
    number = {16},
    pages = {3852--3861},
    volume = {116},
    isbn = {0008-543X},
    doi = {10.1002/cncr.25123},
    issn = {0008543X},
    pmid = {20564086},
    keywords = {Blast crisis, Chronic myeloid leukemia, Dasatinib, Drug resistance, Imatinib}
}

@article{Jain2011,
    title = {{Chronic Myelogenous Leukemia: Role of Stem Cell Transplant in the Imatinib Era}},
    year = {2011},
    journal = {Hematology/Oncology Clinics of North America},
    author = {Jain, Nitin and Van Besien, Koen},
    number = {5},
    pages = {1025--1048},
    volume = {25},
    doi = {10.1016/j.hoc.2011.09.003},
    issn = {08898588},
    pmid = {22054733},
    keywords = {Allogeneic stem cell transplant, Chronic myelogenous leukemia, Imatinib, Tyrosine kinase inhibitors}
}

@article{Soverini2006,
    title = {{Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: By the GIMEMA working party on chronic myeloid leukemia}},
    year = {2006},
    journal = {Clinical Cancer Research},
    author = {Soverini, Simona and Colarossi, Sabrina and Gnani, Alessandra and Rosti, Gianantonio and Castagnetti, Fausto and Poerio, Angela and Iacobucci, Ilaria and Amabile, Marilina and Abruzzese, Elisabetta and Orlandi, Ester and Radaelli, Franca and Ciccone, Fabrizio and Tiribelli, Mario and Di Lorenzo, Roberto and Caracciolo, Clementina and Izzo, Barbara and Pane, Fabrizio and Saglio, Giuseppe and Baccarani, Michele and Martinelli, Giovanni},
    number = {24},
    pages = {7374--7379},
    volume = {12},
    isbn = {1078-0432 (Print){\textbackslash}r1078-0432 (Linking)},
    doi = {10.1158/1078-0432.CCR-06-1516},
    issn = {10780432},
    pmid = {17189410}
}

@article{Shashok2017,
    title = {{Can scientists and their institutions become their own open access publishers?}},
    year = {2017},
    author = {Shashok, Karen and Ruiz, Compositor},
    pages = {1--23},
    keywords = {academic publishing, diamond, editors, ethics, funders, gold, green, institutions, journals, open access, peer review, research center, research quality, researchers, stakeholders}
}

@article{Plimack2017,
    title = {{Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study}},
    year = {2017},
    journal = {The Lancet Oncology},
    author = {Plimack, Elizabeth R and Bellmunt, Joaquim and Gupta, Shilpa and Berger, Raanan and Chow, Laura Q M and Juco, Jonathan and Lunceford, Jared and Saraf, Sanatan and Perini, Rodolfo F and O'Donnell, Peter H},
    number = {17},
    pages = {1--8},
    volume = {2045},
    publisher = {Elsevier Ltd},
    url = {http://linkinghub.elsevier.com/retrieve/pii/S1470204517300074},
    doi = {10.1016/S1470-2045(17)30007-4},
    issn = {14702045}
}

@article{Guilhot2015,
    title = {{Analyzing molecular response in chronic myeloid leukemia clinical trials: Pitfalls and golden rules}},
    year = {2015},
    journal = {Cancer},
    author = {Guilhot, Joelle and Preudhomme, Claude and Mahon, Francois Xavier and Guilhot, Fran??ois},
    number = {4},
    pages = {490--497},
    volume = {121},
    doi = {10.1002/cncr.29053},
    issn = {10970142},
    keywords = {BCR-ABL1, Chronic myeloid leukemia, Molecular response, Statistical analyses}
}

@article{Oriana2013,
    title = {{Complete cytogenetic response and major molecular response as surrogate outcomes for overall survival in first-line treatment of chronic myelogenous leukemia: A case study for technology appraisal on the basis of surrogate outcomes evidence}},
    year = {2013},
    journal = {Value in Health},
    author = {Oriana, Ciani and Martin, Hoyle and Toby, Pavey and Chris, Cooper and Ruth, Garside and Claudius, Rudin and Rod, Taylor},
    number = {6},
    pages = {1081--1090},
    volume = {16},
    publisher = {Elsevier},
    url = {http://dx.doi.org/10.1016/j.jval.2013.07.004},
    doi = {10.1016/j.jval.2013.07.004},
    issn = {10983015},
    pmid = {24041359},
    keywords = {chronic myeloid leukemia complete cytogenetic resp}
}

@article{Hutchinson2007,
    title = {{Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra.}},
    year = {2007},
    journal = {Journal of neurotrauma},
    author = {Hutchinson, Peter J and O'Connell, Mark T and Rothwell, Nancy J and Hopkins, Stephen J and Nortje, Jürgens and Carpenter, Keri L H and Timofeev, Ivan and Al-Rawi, Pippa G and Menon, David K and Pickard, John D},
    number = {10},
    pages = {1545--1557},
    volume = {24},
    isbn = {0897-7151 (Print){\textbackslash}n0897-7151 (Linking)},
    doi = {10.1089/neu.2007.0295},
    issn = {0897-7151},
    pmid = {17970618},
    keywords = {head trauma, inflammation, microdialysis}
}

@article{Helmy2011,
    title = {{Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury}},
    year = {2011},
    journal = {Progress in Neurobiology},
    author = {Helmy, Adel and De Simoni, Maria Grazia and Guilfoyle, Mathew R. and Carpenter, Keri L H and Hutchinson, Peter J.},
    number = {3},
    pages = {352--372},
    volume = {95},
    publisher = {Elsevier Ltd},
    url = {http://dx.doi.org/10.1016/j.pneurobio.2011.09.003},
    isbn = {1873-5118 (Electronic){\textbackslash}r0301-0082 (Linking)},
    doi = {10.1016/j.pneurobio.2011.09.003},
    issn = {03010082},
    pmid = {21939729},
    arxivId = {0808.1443},
    keywords = {Blood brain barrier, Cerebrospinal fluid, Cytokines, Inflammation, Microdialysis, Traumatic brain injury}
}

@article{Morganti-Kossman1997,
    title = {{Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue.}},
    year = {1997},
    journal = {Molecular psychiatry},
    author = {Morganti-Kossman, M C and Lenzlinger, P M and Hans, V and Stahel, P and Csuka, E and Ammann, E and Stocker, R and Trentz, O and Kossmann, T},
    pages = {133--136},
    volume = {2},
    isbn = {1359-4184 (Print){\textbackslash}r1359-4184 (Linking)},
    doi = {10.1038/sj.mp.4000227},
    issn = {1359-4184},
    pmid = {9106236},
    keywords = {a profound inflammatory response, acute-phase-response, alpha, astrocytes, blood, brain barrier, brain injury, interleukins, is initiated immedi-, nerve growth factor, transforming growth factor-beta, tumor necrosis factor-}
}

@article{Helmy2012,
    title = {{Principal component analysis of the Cytokine and Chemokine response to human traumatic brain injury}},
    year = {2012},
    journal = {PLoS ONE},
    author = {Helmy, Adel and Antoniades, Chrystalina A. and Guilfoyle, Mathew R. and Carpenter, Keri L H and Hutchinson, Peter J.},
    number = {6},
    pages = {1--14},
    volume = {7},
    doi = {10.1371/journal.pone.0039677},
    issn = {19326203},
    pmid = {22745809}
}

@article{Wages2014a,
    title = {{pocrm: An R-package for Phase I trials of combinations of agents}},
    year = {2014},
    journal = {Comput Methods Programs Biomed},
    author = {Wages, Nolan A. and Varhegyir, Nikole},
    number = {1},
    pages = {211--8},
    volume = {112},
    isbn = {1243576810911},
    doi = {10.1016/j.cmpb.2013.05.020.pocrm},
    keywords = {continual reassessment method, dose finding, drug combination, partial ordering, phase i trials}
}

@article{Armstrong2016,
    title = {{Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): A multicentre, double-blind, randomised, placebo-controlled phase 2 study}},
    year = {2016},
    journal = {The Lancet},
    author = {Armstrong, Matthew James and Gaunt, Piers and Aithal, Guruprasad P. and Barton, Darren and Hull, Diana and Parker, Richard and Hazlehurst, Jonathan M. and Guo, Kathy and Abouda, George and Aldersley, Mark A. and Stocken, Deborah and Gough, Stephen C. and Tomlinson, Jeremy W. and Brown, Rachel M. and H{\"{u}}bscher, Stefan G. and Newsome, Philip N.},
    number = {10019},
    pages = {679--690},
    volume = {387},
    isbn = {0140-6736},
    doi = {10.1016/S0140-6736(15)00803-X},
    issn = {1474547X},
    pmid = {26608256}
}

@article{Stock2012,
    title = {{Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate}},
    year = {2012},
    journal = {Journal of Rheumatology},
    author = {Stock, Thomas C. and Bloom, Bradley J. and Wei, Nathan and Ishaq, Saliha and Park, Won and Wang, Xin and Gupta, Pankaj and Mebus, Charles A.},
    number = {4},
    pages = {720--727},
    volume = {39},
    isbn = {0315-162X},
    doi = {10.3899/jrheum.110874},
    issn = {0315162X},
    pmid = {22382341},
    keywords = {Interleukin 1, Interleukin 18, Purinergic P2X7 receptor, Rheumatoid arthritis}
}

@article{Herbst2015,
    title = {{Lung Master Protocol (Lung-MAP) - A biomarker-driven protocol for accelerating development of therapies for squamous cell lung cancer: SWOG S1400}},
    year = {2015},
    journal = {Clinical Cancer Research},
    author = {Herbst, Roy S and Gandara, David R and Hirsch, Fred R and Redman, Mary W and LeBlanc, Michael and Mack, Philip C and Schwartz, Lawrence H and Vokes, Everett and Ramalingam, Suresh S and Bradley, Jeffrey D and Sparks, Dana and Zhou, Yang and Miwa, Crystal and Miller, Vincent A and Yelensky, Roman and Li, Yali and Allen, Jeff D and Sigal, Ellen V and Wholley, David and Sigman, Caroline C. and Blumenthal, Gideon M. and Malik, Shakun and Kelloff, Gary J. and Abrams, Jeffrey S. and Blanke, Charles D. and Papadimitrakopoulou, Vassiliki A.},
    number = {7},
    pages = {1514--1524},
    volume = {21},
    doi = {10.1158/1078-0432.CCR-13-3473},
    issn = {15573265},
    pmid = {25680375}
}

@article{Lunn2000,
    title = {{WinBUGS – A Bayesian modelling framework: Concepts, structure, and extensibility}},
    year = {2000},
    journal = {Statistics and Computing},
    author = {Lunn, David J. and Thomas, Andrew and Best, Nicky and Spiegelhalter, David},
    pages = {325--337},
    volume = {10},
    isbn = {0960-3174},
    doi = {10.1023/A:1008929526011},
    issn = {09603174},
    pmid = {2601},
    arxivId = {arXiv:1011.1669v3},
    keywords = {bugs, directed acyclic graphs, markov chain monte carlo, object-, orientation, run-time linking, type extension, winbugs}
}

@article{Shien2016a,
    title = {{Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non-small cell lung cancer}},
    year = {2016},
    journal = {Lung Cancer},
    author = {Shien, Kazuhiko and Papadimitrakopoulou, Vassiliki A. and Wistuba, Ignacio I.},
    pages = {79--87},
    volume = {99},
    publisher = {Elsevier Ireland Ltd},
    url = {http://dx.doi.org/10.1016/j.lungcan.2016.06.016},
    doi = {10.1016/j.lungcan.2016.06.016},
    issn = {18728332},
    pmid = {27565919},
    keywords = {Biomarker, Immune checkpoint inhibition, NSCLC, PD-1, PD-L1}
}

@article{Chan2017,
    title = {{Low-dose pembrolizumab for relapsed/refractory Hodgkin lymphoma: high efficacy with minimal toxicity}},
    year = {2017},
    journal = {Annals of Hematology},
    author = {Chan, Thomas S. Y. and Luk, Tsan-Hei and Lau, June S. M. and Khong, Pek-Lan and Kwong, Yok-Lam},
    publisher = {Annals of Hematology},
    url = {http://link.springer.com/10.1007/s00277-017-2931-z},
    doi = {10.1007/s00277-017-2931-z},
    issn = {0939-5555},
    keywords = {{\&} Kwong, Hodgkin lymphoma, J. S. M., Khong, Lau, Luk, P.-L., Pembrolizumab, Refractory, Relapse, T. S. Y., T.-H., Y.-L. (2017). Low-dose pembrolizumab for relapsed/, hodgkin lymphoma, pembrolizumab, relapseChan}
}

@article{Tighiouart2010,
    title = {{Dose Finding with Escalation with Overdose Control (EWOC) in Cancer Clinical Trials}},
    year = {2010},
    journal = {Statistical Science},
    author = {Tighiouart, Mourad and Rogatko, André},
    number = {2},
    pages = {217--226},
    volume = {25},
    doi = {10.1214/10-STS333},
    issn = {0883-4237},
    pmid = {24825779},
    arxivId = {arXiv:1011.6479v1},
    keywords = {and phrases, cancer phase i trials, dose-limiting toxicity, escalation with overdose control, optimal bayesian fea-, tolerated dose}
}

@article{Manuscript2011,
    title = {{Continual Reassessment and Related Dose-Finding Designs}},
    year = {2011},
    journal = {Statistical Science},
    author = {O'Quigley, John and Conaway, Mark},
    number = {2},
    pages = {202--216},
    volume = {25},
    doi = {10.1214/10-STS332.Continual},
    keywords = {and phrases, bayesian methods, clinical trial, continual reassessment method, dose escalation, dose-finding, efficacy, maximum likelihood, maximum tolerated dose, most successful dose, phase 1, phase 2 trials, studies, toxicity, trials}
}

@article{Hui2017,
    title = {{Pembrolizumab as first-line therapy for patients with PD-L1–positive advanced non–small cell lung cancer: a phase 1 trial}},
    year = {2017},
    journal = {Annals of Oncology},
    author = {Hui, R. and Garon, E. B. and Goldman, J. W. and Leighl, N. B. and Hellmann, M. D. and Patnaik, A. and Gandhi, L. and Eder, J. P. and Ahn, M.-J. and Horn, L. and Felip, E. and Carcereny, E. and Rangwala, R. and Lubiniecki, G. M. and Zhang, J. and Emancipator, K. and Roach, C. and Rizvi, N. A.},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/28168303},
    doi = {10.1093/annonc/mdx008},
    pmid = {28168303}
}

@article{Brock2017,
    title = {{165: PePS2: Pembrolizumab in Performance Status 2 non-small-cell lung cancer}},
    year = {2017},
    journal = {Lung Cancer},
    author = {Brock, K. and Billingham, C. and Llewellyn, L. and Smith, H. and McNab, G. and Middleton, G.},
    pages = {S76},
    volume = {103},
    publisher = {Elsevier Ireland Ltd},
    url = {http://linkinghub.elsevier.com/retrieve/pii/S0169500217302155},
    doi = {10.1016/S0169-5002(17)30215-5},
    issn = {01695002}
}

@article{Haines2003,
    title = {{Bayesian Optimal Designs for Phase I Clinical Trials}},
    year = {2015},
    journal = {Applied Statistics Series C},
    author = {Liu, Suyu and Yuan, Ying},
    pages = {507--523},
    volume = {64},
    keywords = {constrained optimal design, maximum tolerated dose, sequential design}
}

@article{Julious2004,
    title = {{Tutorial in biostatistics: Sample sizes for clinical trials with Normal data}},
    year = {2004},
    journal = {Statistics in Medicine},
    author = {Julious, Steven A.},
    number = {12},
    pages = {1921--1986},
    volume = {23},
    isbn = {0277-6715 (Print){\textbackslash}r0277-6715 (Linking)},
    doi = {10.1002/sim.1783},
    issn = {02776715},
    pmid = {15195324},
    keywords = {Baselines, Bioequivalence, Cross-over trials, Equivalence trials, Non-inferiority trials, Parallel group trials, Power, Precision, Sample size, Superiority trials, Type I error, Type II error}
}

@misc{Pinheiro2016,
    title = {{nlme: Linear and Nonlinear Mixed Effects Models}},
    year = {2016},
    author = {Pinheiro, Jose and Bates, Douglas and DebRoy, Saikat and Sarkar, Deepayan and {R Development Core Team}},
    url = {http://cran.r-project.org/package=nlme}
}

@book{Machin2008,
    title = {{Sample Size Tables for Clinical Studies}},
    year = {2008},
    author = {Machin, David and Campbell, Michael J. and Tan, Say Beng and Ta, Sze Huey},
    edition = {3rd},
    publisher = {Wiley},
    isbn = {9781405146500}
}

@article{Hirsch2016,
    title = {{PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the “Blueprint PD-L1 IHC Assay Comparison Project”}},
    year = {2016},
    journal = {Journal of Thoracic Oncology},
    author = {Hirsch, Fred R. and McElhinny, Abigail and Stanforth, Dave and Ranger-Moore, James and Jansson, Malinka and Kulangara, Karina and Richardson, William and Towne, Penny and Hanks, Debra and Vennapusa, Bharathi and Mistry, Amita and Kalamegham, Rasika and Averbuch, Steve and Novotny, James and Rubin, Eric and Emancipator, Kenneth and McCaffery, Ian and Williams, J. Andrew and Walker, Jill and Longshore, John and Tsao, Ming S. and Kerr, Keith M.},
    number = {2},
    pages = {208--222},
    volume = {12},
    publisher = {Elsevier Inc},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/27913228\nhttp://linkinghub.elsevier.com/retrieve/pii/S1556086416335365},
    doi = {10.1016/j.jtho.2016.11.2228},
    issn = {15560864},
    pmid = {27913228},
    keywords = {Immunohistochemistry, Immunotherapy, PD-L1 assays, lung cancer}
}

@article{Arlt1999,
    title = {{Biotransformation of oral dehydroepiandrosterone in elderly men: Significant increase in circulating estrogens}},
    year = {1999},
    journal = {Journal of Clinical Endocrinology and Metabolism},
    author = {Arlt, Wiebke and Haas, Joachim and Callies, Frank and Reincke, Martin and H{\"{u}}bler, Doris and Oettel, Michael and Ernst, Michael and Schulte, Heinrich Maria and Allolio, Bruno},
    number = {6},
    pages = {2170--2176},
    volume = {84},
    isbn = {0021-972X},
    doi = {10.1210/jc.84.6.2170},
    issn = {0021972X},
    pmid = {10372727}
}

@article{Hinson1999,
    title = {{DHEA deficiency syndrome: A new term for old age?}},
    year = {1999},
    journal = {Journal of Endocrinology},
    author = {Hinson, J. P. and Raven, P. W.},
    number = {1},
    pages = {1--5},
    volume = {163},
    isbn = {0022-0795 (Print){\textbackslash}r0022-0795 (Linking)},
    doi = {10.1677/joe.0.1630001},
    issn = {00220795},
    pmid = {10495400}
}

@article{Arlt1998,
    title = {{Oral Dehydroepiandrosterone for Adrenal Androgen Replacement : Pharmacokinetics and Peripheral Conversion to Androgens and Estrogens in Young}},
    year = {1998},
    journal = {Journal of Clinical Endocrinology and Metabolism},
    author = {Arlt, Wiebke and Justl, Hans-georg and Callies, Frank and Reincke, Martin and Oettel, Michael and Ernst, Michael and Hu, Doris and Schulte, Heinrich Maria and Allolio, Bruno and Wuerzburg, Clinic},
    number = {6},
    pages = {1928--1934},
    volume = {83}
}

@article{James2016,
    title = {{Continual reassessment method for dose escalation clinical trials in oncology: a comparison of prior skeleton approaches using AZD3514 data}},
    year = {2016},
    journal = {BMC Cancer},
    author = {James, Gareth D. and Symeonides, Stefan N. and Marshall, Jayne and Young, Julia and Clack, Glen},
    number = {1},
    pages = {703},
    volume = {16},
    publisher = {BMC Cancer},
    url = {http://bmccancer.biomedcentral.com/articles/10.1186/s12885-016-2702-6},
    doi = {10.1186/s12885-016-2702-6},
    issn = {1471-2407},
    keywords = {Clinical trial, Continual reassessment meth, Phase 1, bayesian, clinical trial, continual reassessment method, oncology, phase 1, skeleton}
}

@article{Ji2013a,
    title = {{Modified toxicity probability interval design: a safer and more reliable method than the 3 + 3 design for practical phase I trials.}},
    year = {2013},
    journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
    author = {Ji, Yuan and Wang, Sue Jane},
    number = {14},
    pages = {1785--1791},
    volume = {31},
    isbn = {1527-7755 (Electronic){\textbackslash}r0732-183X (Linking)},
    doi = {10.1200/JCO.2012.45.7903},
    issn = {15277755},
    pmid = {23569307}
}

@article{Srinivasan2012,
    title = {{Corticosteroids for Bacterial Keratitis: The Steroids for Corneal Ulcers Trial (SCUT)}},
    year = {2012},
    journal = {Archives of Ophthalmology},
    author = {Srinivasan, Muthiah and Mascarenhas, Jeena and Rajaraman, Revathi and Ravindran, Meenakshi and Lalitha, Prajna and Glidden, David V and Ray, Kathryn J and Hong, Kevin C and Oldenburg, Catherine E and Lee, Salena M and Zegans, Michael E and Mcleod, Stephen D and Lietman, Thomas M and Acharya, Nisha R.},
    number = {2},
    pages = {143--150},
    volume = {130},
    doi = {10.1001/archophthalmol.2011.315},
    issn = {0003-9950}
}

@article{Reinstein2009,
    title = {{Stromal Thickness in the Normal Cornea: Three-dimensional Display With Artemis Very High-frequency Digital Ultrasound}},
    year = {2009},
    journal = {J Refract Surg},
    author = {Reinstein, Dan Z. and Archer, Timothy J. and Gobbe, Marine and Silverman, Ronald H. and Coleman, D. Jackson},
    number = {9},
    pages = {776--86},
    volume = {25},
    isbn = {3300000106},
    doi = {10.1097/OPX.0b013e3182540562.The},
    issn = {09652140},
    pmid = {20402989},
    arxivId = {NIHMS150003}
}

@article{Wheeler2017,
    title = {{How to design a dose-finding study using the Continual Reassessment Method}},
    year = {2017},
    author = {Wheeler, Graham M and Mander, Adrian P and Jaki, Thomas and Bedding, Alun and Yap, Christina and Brock, Kristian and Bond, Simon J},
    keywords = {Bayesian adaptive designs, Continual Reassessment Method, Maximum Tolerated Dose, dose escalation, phase I trials}
}

@article{Bauer2010a,
    title = {{Selection and bias-two hostile brothers}},
    year = {2010},
    journal = {Statistics in Medicine},
    author = {Bauer, Peter and Koenig, Franz and Brannatha, Werner and Poscha, Martin},
    number = {1},
    pages = {1--13},
    volume = {29},
    doi = {10.1002/sim.3716},
    issn = {02776715},
    pmid = {19844944},
    keywords = {Admission bias, Many one comparison, Mean bias, Mean square error, Sample size reassessment, Treatment selection}
}

@article{Badala2008,
    title = {{Sample size formulae for the Bayesian continual reassessment method}},
    year = {2013},
    journal = {Clinical Trials},
    author = {Cheung, Ying Kuen},
    number = {6},
    volume = {10},
    isbn = {6176321972},
    doi = {10.1177/1740774513497294},
    issn = {15378276},
    pmid = {1000000221},
    arxivId = {NIHMS150003}
}

@article{Ribas2016,
    title = {{Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.}},
    year = {2016},
    journal = {Jama},
    author = {Ribas, Antoni and Hamid, Omid and Daud, Adil and Hodi, F Stephen and Wolchok, Jedd D and Kefford, Richard and Joshua, Anthony M and Patnaik, Amita and Hwu, Wen-Jen and Weber, Jeffrey S and Gangadhar, Tara C and Hersey, Peter and Dronca, Roxana and Joseph, Richard W and Zarour, Hassane and Chmielowski, Bartosz and Lawrence, Donald P and Algazi, Alain and Rizvi, Naiyer A and Hoffner, Brianna and Mateus, Christine and Gergich, Kevin and Lindia, Jill A and Giannotti, Maxine and Li, Xiaoyun Nicole and Ebbinghaus, Scot and Kang, S Peter and Robert, Caroline},
    number = {15},
    pages = {1600--9},
    volume = {315},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/27092830},
    doi = {10.1001/jama.2016.4059},
    issn = {1538-3598},
    pmid = {27092830}
}

@article{Fearon2015,
    title = {{In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn’s disease}},
    year = {2014},
    journal = {Nature medicine},
    author = {Atreya, Raja and Neumann, Helmut and Neufert, Clemens and Waldner, Maximilian J and Willma, Marcus and App, Christine and Maas, Stefanie and Gebhardt, Bernd and Heimke-brinck, Ralph and Reuter, Eva and Rau, Tilman T and Uter, Wolfgang and Wang, Thomas D and Kiesslich, Ralf and Vieth, Michael and Hannappel, Ewald and Neurath, Markus F and Arbor, Ann and Bayreuth, Klinikum},
    number = {3},
    pages = {313--318},
    volume = {20},
    doi = {10.1038/nm.3462.In}
}

@article{Cedarbaum1999,
    title = {{The ALSFRS-R : a revised ALS functional rating scale that incorporates assessments of respiratory function}},
    year = {1999},
    author = {Cedarbaum, Jesse M and Stambler, Nancy and Fuller, Cynthia and Hilt, Dana and Thurmond, Barbara and Nakanishi, Arline and Als, Bdnf and Group, Study and Iii, Phase},
    pages = {13--21},
    volume = {169},
    keywords = {amyotrophic lateral sclerosis, pulmonary function, rating scales}
}

@article{Royston2013,
    title = {{Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome.}},
    year = {2013},
    journal = {BMC medical research methodology},
    author = {Royston, Patrick and Parmar, Mahesh Kb},
    number = {1},
    pages = {152},
    volume = {13},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/24314264},
    isbn = {1471-2288},
    doi = {10.1186/1471-2288-13-152},
    issn = {1471-2288},
    pmid = {24314264},
    keywords = {hazard ratio, logrank test, non-proportional hazards, piecewise exponential distribution, randomized controlled trials, restricted mean survival time, time-to-event data}
}

@article{Teare2014,
    title = {{Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study.}},
    year = {2014},
    journal = {Trials},
    author = {Teare, M Dawn and Dimairo, Munyaradzi and Shephard, Neil and Hayman, Alex and Whitehead, Amy and Walters, Stephen J},
    pages = {264},
    volume = {15},
    url = {http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4227298&tool=pmcentrez&rendertype=abstract},
    isbn = {1745-6215 (Electronic){\textbackslash}r1745-6215 (Linking)},
    doi = {10.1186/1745-6215-15-264},
    issn = {1745-6215},
    pmid = {24993581},
    keywords = {Computer Simulation, Data Interpretation, Feasibility Studies, Humans, Models, Pilot Projects, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic: methods, Randomized Controlled Trials as Topic: statistics, Sample Size, Statistical}
}

@article{Tierney2007,
    title = {{Practical methods for incorporating summary time-to-event data into meta-analysis.}},
    year = {2007},
    journal = {Trials},
    author = {Tierney, Jayne F and Stewart, Lesley A and Ghersi, Davina and Burdett, Sarah and Sydes, Matthew R},
    number = {1},
    pages = {16},
    volume = {8},
    url = {http://trialsjournal.biomedcentral.com/articles/10.1186/1745-6215-8-16},
    isbn = {10.1186/1745-6215-8-16},
    doi = {10.1186/1745-6215-8-16},
    issn = {1745-6215},
    pmid = {17555582},
    keywords = {Biomedicine general, Health Sciences, Medicine, Medicine/Public Health, Statistics for Life Sciences, general}
}

@article{Thabane2010,
    title = {{A tutorial on pilot studies: the what, why and how}},
    year = {2010},
    journal = {BMC Med Res Methodol},
    author = {Thabane, L and Ma, J and Chu, R and Cheng, J and Ismaila, A and Rios, L P and Robson, R and Thabane, M and Giangregorio, L and Goldsmith, C H},
    number = {August 2016},
    pages = {1},
    volume = {10},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/20053272},
    isbn = {1471-2288 (Electronic){\textbackslash}r1471-2288 (Linking)},
    doi = {10.1186/1471-2288-10-1},
    issn = {1471-2288},
    pmid = {20053272},
    keywords = {*Pilot Projects, *Research Design/standards, Clinical Trials, Phase III as Topic/methods, Humans, Randomized Controlled Trials as Topic}
}

@article{Statistical,
    title = {{Meta-Analysis of Hazard Ratios}},
    journal = {NCSS Statistical Software},
    author = {Statistical, Ncss and Ncss, Software and Reserved, All Rights},
    number = {1995},
    pages = {1--13},
    volume = {chapter 45}
}

@article{Colquhoun2011,
    title = {{In praise of randomisation: the importance of causality in medicine and its subversion by philosophers of science}},
    year = {2011},
    journal = {Evidence, Inference and Enquiry},
    author = {Colquhoun, David},
    pages = {323--343},
    isbn = {9780191754050},
    doi = {10.5871/bacad/9780197264843.003.0012}
}

@article{VanRavenzwaaij2017,
    title = {{A simulation study of the strength of evidence in the recommendation of medications based on two trials with statistically significant results}},
    year = {2017},
    journal = {Plos One},
    author = {van Ravenzwaaij, Don and Ioannidis, John P. A. and Tiwari, RC and Liu, G and Natanegara, F and Railkar, R and Schmidli, H and Song, G},
    number = {3},
    pages = {e0173184},
    volume = {12},
    url = {http://dx.plos.org/10.1371/journal.pone.0173184},
    isbn = {1111111111},
    doi = {10.1371/journal.pone.0173184},
    issn = {1932-6203},
    pmid = {28273140}
}

@article{Lambertus2016,
    title = {{Progression of Late-Onset Stargardt Disease}},
    year = {2016},
    journal = {Investigative Opthalmology {\&} Visual Science},
    author = {Lambertus, Stanley and Lindner, Moritz and Bax, Nathalie M. and Mauschitz, Matthias M. and Nadal, Jennifer and Schmid, Matthias and Schmitz-Valckenberg, Steffen and den Hollander, Anneke I. and Weber, Bernhard H. F. and Holz, Frank G. and van der Wilt, Gert Jan and Fleckenstein, Monika and Hoyng, Carel B. and {Foveal sparing Atrophy Study Team (FAST)}},
    number = {13},
    pages = {5186},
    volume = {57},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/27699414%5Cnhttp://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.16-19833},
    doi = {10.1167/iovs.16-19833},
    issn = {1552-5783},
    pmid = {27699414},
    keywords = {8000, and affects 1, autosomal recessive retinal dystrophy, biomarker, caused by mutations in, disease progression, fundus autofluorescence, late-onset stargardt, retinal pigment epithelium atrophy, targardt disease is an, the abca4 gene}
}

@article{Mcmaster2010,
    title = {{Conservative Sample Size Determination for Repeated Measures Analysis of Covariance}},
    year = {2010},
    journal = {Ann Biom Biostat},
    author = {Morgan, Timothy M. and Case, L. Douglas},
    number = {1},
    volume = {1},
    isbn = {8015815967},
    doi = {10.3816/CLM.2009.n.003.Novel},
    issn = {1878-5832},
    pmid = {21959306},
    arxivId = {NIHMS150003},
    keywords = {genetic susceptibility, hypergammaglobulinemia, igm, mgus, monoclonal gammopathy of undetermined, polyclonal gammopathy, precursor disease, significance, waldenstrom macroglobulinemia}
}

@article{Simon2016a,
    title = {{The Bayesian basket design for genomic variant-driven phase II trials}},
    year = {2016},
    journal = {Seminars in Oncology},
    author = {Simon, Richard and Geyer, Susan and Subramanian, Jyothi and Roychowdhury, Sameek},
    number = {1},
    pages = {13--18},
    volume = {43},
    publisher = {Elsevier},
    url = {http://dx.doi.org/10.1053/j.seminoncol.2016.01.002},
    doi = {10.1053/j.seminoncol.2016.01.002},
    issn = {15328708},
    pmid = {26970120},
    keywords = {Actionable mutations, Basket clinical trials, Genomic clinical trials}
}

@article{Rogatko2007,
    title = {{Translation of innovative designs into phase I trials}},
    year = {2007},
    journal = {Journal of Clinical Oncology},
    author = {Rogatko, André and Schoeneck, David and Jonas, William and Tighiouart, Mourad and Khuri, Fadlo R. and Porter, Alan},
    number = {31},
    pages = {4982--4986},
    volume = {25},
    isbn = {1527-7755 (Electronic) 0732-183X (Linking)},
    doi = {10.1200/JCO.2007.12.1012},
    issn = {0732183X},
    pmid = {17971597}
}

@article{Fraise2013,
    title = {{The antibacterial activity and stability of acetic acid}},
    year = {2013},
    journal = {Journal of Hospital Infection},
    author = {Fraise, A. P. and Wilkinson, M. A C and Bradley, C. R. and Oppenheim, B. and Moiemen, N.},
    number = {4},
    pages = {329--331},
    volume = {84},
    publisher = {Elsevier Ltd},
    url = {http://dx.doi.org/10.1016/j.jhin.2013.05.001},
    doi = {10.1016/j.jhin.2013.05.001},
    issn = {01956701},
    pmid = {23747099},
    keywords = {Acetic acid, Activity, Antibacterial, Burns}
}

@article{Zor2010,
    title = {{Pain relief during dressing changes of major adult burns: Ideal analgesic combination with ketamine}},
    year = {2010},
    journal = {Burns},
    author = {Zor, Fatih and Ozturk, Serdar and Bilgin, Ferruh and Isik, Selcuk and Cosar, Ahmet},
    number = {4},
    pages = {501--505},
    volume = {36},
    publisher = {Elsevier Ltd and International Society of Burns Injuries},
    url = {http://dx.doi.org/10.1016/j.burns.2009.08.007},
    isbn = {1879-1409 (Electronic){\textbackslash}r0305-4179 (Linking)},
    doi = {10.1016/j.burns.2009.08.007},
    issn = {03054179},
    pmid = {19819634},
    keywords = {Burn dressing change, Dexmedetomidine, Ketamine, Midazolam, Pain management}
}

@article{Halstead2015,
    title = {{Antimicrobial dressings: Comparison of the ability of a panel of dressings to prevent biofilm formation by key burn wound pathogens}},
    year = {2015},
    journal = {Burns},
    author = {Halstead, Fenella D. and Rauf, Maryam and Bamford, Amy and Wearn, Christopher M. and Bishop, Jonathan R B and Burt, Rebecca and Fraise, Adam P. and Moiemen, Naiem S. and Oppenheim, Beryl A. and Webber, Mark A.},
    number = {8},
    pages = {1683--1694},
    volume = {41},
    publisher = {Elsevier Ltd and International Society of Burns Injuries},
    url = {http://dx.doi.org/10.1016/j.burns.2015.06.005},
    doi = {10.1016/j.burns.2015.06.005},
    issn = {18791409},
    pmid = {26188884},
    keywords = {Antimicrobial, Biofilms, Burns, Dressings, Wounds}
}

@article{Halstead2015a,
    title = {{The antibacterial activity of acetic acid against biofilm-producing pathogens of relevance to burns patients}},
    year = {2015},
    journal = {PLoS ONE},
    author = {Halstead, Fenella D. and Rauf, Maryam and Moiemen, Naiem S. and Bamford, Amy and Wearn, Christopher M. and Fraise, Adam P. and Lund, Peter A. and Oppenheim, Beryl A. and Webber, Mark A.},
    number = {9},
    pages = {1--15},
    volume = {10},
    url = {http://dx.doi.org/10.1371/journal.pone.0136190},
    doi = {10.1371/journal.pone.0136190},
    issn = {19326203},
    pmid = {26352256}
}

@article{Seymour2017,
    title = {{iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics}},
    year = {2017},
    journal = {The Lancet Oncology},
    author = {Seymour, Lesley and Bogaerts, Jan and Perrone, Andrea and Ford, Robert and Schwartz, Lawrence H and Mandrekar, Sumithra and Lin, Nancy U and Liti{\`{e}}re, Saskia and Dancey, Janet and Chen, Alice and Hodi, F Stephen and Therasse, Patrick and Hoekstra, Otto S and Shankar, Lalitha K and Wolchok, Jedd D and Ballinger, Marcus and Caramella, Caroline and de Vries, Elisabeth G E},
    number = {3},
    pages = {e143-e152},
    volume = {18},
    publisher = {Elsevier Ltd},
    url = {http://linkinghub.elsevier.com/retrieve/pii/S1470204517300748},
    doi = {10.1016/S1470-2045(17)30074-8},
    issn = {14702045},
    pmid = {28271869}
}

@article{Hajian-Tilaki2014,
    title = {{Sample size estimation in diagnostic test studies of biomedical informatics}},
    year = {2014},
    journal = {Journal of Biomedical Informatics},
    author = {Hajian-Tilaki, Karimollah},
    pages = {193--204},
    volume = {48},
    publisher = {Elsevier Inc.},
    url = {http://dx.doi.org/10.1016/j.jbi.2014.02.013},
    isbn = {1532-0464},
    doi = {10.1016/j.jbi.2014.02.013},
    issn = {15320464},
    pmid = {24582925},
    keywords = {Area under the curve, Diagnostic studies, ROC analysis, Sample size, Sensitivity, Specificity}
}

@article{Beishuizen2002,
    title = {{Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve?}},
    year = {2002},
    journal = {Critical care (London, England)},
    author = {Beishuizen, Albertus and Thijs, Lambertus G and Vermes, István},
    number = {5},
    pages = {434--438},
    volume = {6},
    isbn = {1364-8535},
    doi = {10.1186/cc1530},
    issn = {1364-8535},
    pmid = {12398784},
    keywords = {adrenal axis, adrenal insufficiency, dehydroepiandrosterone sulphate, hypothalamic, multiple trauma, pituitary, sepsis}
}

@article{Jones2003,
    title = {{An introduction to power and sample size estimation}},
    year = {2003},
    journal = {Emerg. Med. J.},
    author = {Jones, S R},
    number = {5},
    pages = {453--458},
    volume = {20},
    url = {http://emj.bmj.com/content/20/5/453.full?sid=ed74053f-4bdc-40bb-a477-e98a4d5171f1},
    isbn = {1472-0213 (Electronic){\textbackslash}n1472-0205 (Linking)},
    doi = {10.1136/emj.20.5.453},
    issn = {1472-0205},
    pmid = {12954688}
}

@article{Lijmer1999,
    title = {{Empirical evidence of bias}},
    year = {1999},
    journal = {JAMA: the journal of the American Medical Association},
    author = {Lijmer, Jeroen G. and Mol, Ben Willem and Heisterkamp, Siem and Bonsel, Gouke J. and Prins, Martin H. and Meulen, Jan H. P. van der and Bossuyt, Patrick M. M.},
    number = {11},
    pages = {1061-},
    volume = {282},
    url = {http://dx.doi.org/10.1001/jama.1995.03520290060030},
    isbn = {0098-7484},
    doi = {10.1001/jama.1995.03520290060030},
    issn = {0098-7484},
    pmid = {1083},
    keywords = {704-C, Randomisation-compulsory}
}

@article{Bossuyt2003,
    title = {{Towards complete and,accurate reporting of studies of diagnostic accuracy: The STARD initiative}},
    year = {2003},
    journal = {British Medical Journal},
    author = {Bossuyt, Patrick M and Reitsma, Johannes B and Bruns, David E and Gatsonis, Constantine A and Glasziou, Paul P and Irwig, Les M and Lijmer, Jeroen G and Moher, David and Rennie, Drummond and de Vet, H. C. W. and {STARD steering group}},
    number = {7379},
    pages = {41--44},
    volume = {326},
    url = {<Go to ISI>://WOS:000180302000028\nhttp://www.bmj.com//content/326/7379/41.1},
    isbn = {0959-535X},
    doi = {10.1136/bmj.326.7379.41}
}

@article{Wiley2016,
    title = {{A crossover design for comparative efficacy: A 36-week randomized trial of bevacizumab and ranibizumab for diabetic macular edema}},
    year = {2016},
    journal = {Ophthalmology},
    author = {Wiley, Henry E. and Thompson, Darby J S and Bailey, Clare and Chew, Emily Y. and Cukras, Catherine A. and Jaffe, Glenn J. and Lee, Richard W J and Loken, Erin K. and Meyerle, Catherine B. and Wong, Wai and Ferris, Frederick L.},
    number = {4},
    pages = {841--849},
    volume = {123},
    doi = {10.1016/j.ophtha.2015.11.021},
    issn = {15494713},
    pmid = {26875003}
}

@article{Lam2014,
    title = {{Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy : preparation for gene therapy clinical trial.}},
    year = {2014},
    journal = {JAMA ophthalmology},
    author = {Lam, Byron L and Feuer, William J and Schiffman, Joyce C and Porciatti, Vittorio and Vandenbroucke, Ruth and Rosa, Potyra R and Gregori, Giovanni and Guy, John},
    number = {4},
    pages = {428--36},
    volume = {132},
    url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-84898603855&partnerID=tZOtx3y1},
    isbn = {2168-6165},
    doi = {10.1001/jamaophthalmol.2013.7971},
    issn = {2168-6173},
    pmid = {24525545},
    arxivId = {NIHMS150003},
    keywords = {Adolescent, Adult, Child, Clinical Trials as Topic, DNA Mutational Analysis, DNA, Mitochondrial, DNA, Mitochondrial: genetics, Dependovirus, Dependovirus: genetics, Electroretinography, Endpoint Determination, Female, Genetic Therapy, Genetic Vectors, Humans, Intravitreal Injections, Male, Middle Aged, NADH Dehydrogenase, NADH Dehydrogenase: genetics, Nerve Fibers, Nerve Fibers: pathology, Optic Atrophy, Hereditary, Leber, Optic Atrophy, Hereditary, Leber: diagnosis, Optic Atrophy, Hereditary, Leber: genetics, Optic Atrophy, Hereditary, Leber: therapy, Prospective Studies, Retinal Ganglion Cells, Retinal Ganglion Cells: metabolism, Retinal Ganglion Cells: pathology, Tomography, Optical Coherence, Visual Acuity, Visual Acuity: physiology, Visual Field Tests, Visual Fields, Visual Fields: physiology, Young Adult}
}

@article{Yeh2012,
    title = {{One year study on the integrative intervention of acupressure and interactive multimedia for visual health in school children}},
    year = {2012},
    journal = {Complementary Therapies in Medicine},
    author = {Yeh, Mei Ling and Chen, Hsing Hsia and Chung, Yu Chu},
    number = {6},
    pages = {385--392},
    volume = {20},
    publisher = {Elsevier Ltd},
    url = {http://dx.doi.org/10.1016/j.ctim.2012.09.001},
    isbn = {0965-2299},
    doi = {10.1016/j.ctim.2012.09.001},
    issn = {09652299},
    pmid = {23131368},
    keywords = {Auricular acupressure, Controlled trial, Interactive multimedia, Knowledge, Myopia, Refractive error, School children, Visual acuity}
}

@article{Shepheard2017,
    title = {{A prognostic , disease progression , and pharmacodynamic}},
    year = {2017},
    author = {Shepheard, Stephanie R and Wuu, Joanne and Cardoso, Michell and Wiklendt, Luke and Dinning, Phil G and Chataway, Tim and Schultz, David and Benatar, Michael},
    pages = {1--8},
    volume = {0},
    isbn = {0000000000}
}

@article{Morris2014,
    title = {{A web-based tool for eliciting probability distributions from experts}},
    year = {2014},
    journal = {Environmental Modelling and Software},
    author = {Morris, David E. and Oakley, Jeremy E. and Crowe, John A.},
    pages = {1--4},
    volume = {52},
    publisher = {Elsevier Ltd},
    url = {http://dx.doi.org/10.1016/j.envsoft.2013.10.010},
    isbn = {1364-8152},
    doi = {10.1016/j.envsoft.2013.10.010},
    issn = {13648152},
    keywords = {Bayesian prior distribution, Expert judgement, Subjective probability, Web-based elicitation}
}

@article{Kersten2014,
    title = {{Is the pain visual analogue scale linear and responsive to change? An exploration using rasch analysis}},
    year = {2014},
    journal = {PLoS ONE},
    author = {Kersten, Paula and White, Peter J. and Tennant, Alan},
    number = {6},
    volume = {9},
    isbn = {1932-6203 (Electronic){\textbackslash}r1932-6203 (Linking)},
    doi = {10.1371/journal.pone.0099485},
    issn = {19326203},
    pmid = {24921952}
}

@article{Sharon2017,
    title = {{Can an immune checkpoint inhibitor (sometimes) make things worse?}},
    year = {2017},
    journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
    author = {Sharon, Elad},
    pages = {10--13},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/28258060},
    isbn = {2402766565},
    doi = {10.1158/1078-0432.CCR-16-2926},
    issn = {1078-0432},
    pmid = {28258060}
}

@article{Champiat2016,
    title = {{Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by}},
    year = {2016},
    author = {Dercle, Laurent and Ammari, Samy and Massard, Christophe and Soria, Jean-charles and Fert, Charles},
    pages = {1--10},
    doi = {10.1158/1078-0432.CCR-16-1741}
}

@article{Kato2017,
    title = {{Hyper-progressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate}},
    year = {2017},
    journal = {Clinical Cancer Research},
    author = {Kato, Shumei and Goodman, Aaron Michael and Walavalkar, Vighnesh and Barkauskas, Donald A. and Sharabi, Andrew and Kurzrock, Razelle},
    pages = {clincanres.3133.2016},
    url = {http://clincancerres.aacrjournals.org/lookup/doi/10.1158/1078-0432.CCR-16-3133},
    doi = {10.1158/1078-0432.CCR-16-3133},
    issn = {1078-0432},
    pmid = {28351930}
}

@article{Mills2009,
    title = {{Design, analysis, and presentation of crossover trials.}},
    year = {2009},
    journal = {Trials},
    author = {Mills, Edward J and Chan, An-Wen and Wu, Ping and Vail, Andy and Guyatt, Gordon H and Altman, Douglas G},
    pages = {27},
    volume = {10},
    isbn = {1745-6215 (Electronic){\textbackslash}r1745-6215 (Linking)},
    doi = {10.1186/1745-6215-10-27},
    issn = {1745-6215},
    pmid = {19405975}
}

@article{Camus2016,
    title = {{Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome}},
    year = {2016},
    journal = {Veterinary Pathology},
    author = {Camus, M. S. and Priest, H. L. and Koehler, J. W. and Driskell, E. A. and Rakich, P. M. and Ilha, M. R. and Krimer, P. M.},
    number = {6},
    pages = {1--7},
    volume = {53},
    url = {http://vet.sagepub.com/lookup/doi/10.1177/0300985816638721},
    doi = {10.1177/0300985816638721},
    issn = {0300-9858},
    pmid = {27034386},
    keywords = {13, 21, accounting for up to, are common cutaneous neoplasms, cytology, dog, dogs, grading, histology, in, mast cell tumor, mast cell tumors, mcts, neoplasia, of all canine skin, skin, tumors}
}

@article{Scarpa2016,
    title = {{Cytological grading of canine cutaneous mast cell tumours}},
    year = {2016},
    journal = {Veterinary and Comparative Oncology},
    author = {Scarpa, Filippo and Sabattini, Silvia and Bettini, Giuliano},
    number = {3},
    pages = {245--251},
    volume = {14},
    doi = {10.1111/vco.12090},
    issn = {14765829},
    pmid = {24717019},
    keywords = {canine, cytology, grading, mast cell tumour}
}

@article{Hergt2016,
    title = {{Use of a 2-tier histologic grading system for canine cutaneous mast cell tumors on cytology specimens}},
    year = {2016},
    journal = {Veterinary Clinical Pathology},
    author = {Hergt, Franziska and von Bomhard, Wolf and Kent, Michael S. and Hirschberger, Johannes},
    number = {3},
    pages = {477--483},
    volume = {45},
    doi = {10.1111/vcp.12387},
    issn = {1939165X},
    pmid = {27483044},
    keywords = {Cytomorphologic criteria, dog, fine-needle aspirates, nuclear abnormalities}
}

@article{Gelman,
    title = {{The garden of forking paths}},
    year = {2013},
    author = {Gelman, Andrew and Loken, Eric}
}

@book{Yuan2016,
    title = {{Bayesian Designs for Phase I–II Clinical Trials}},
    year = {2016},
    author = {Yuan, Ying and Nguyen, Hoang Q. and Thall, Peter F.},
    edition = {1st},
    publisher = {CRC Press},
    address = {C},
    isbn = {9781498709552}
}

@article{Jin2014,
    title = {{Using Data Augmentation to Facilitate Conduct of Phase I-II Clinical Trials with Delayed Outcomes.}},
    year = {2014},
    journal = {Journal of the American Statistical Association},
    author = {Jin, Ick Hoon and Liu, Suyu and Thall, Peter F and Yuan, Ying},
    number = {506},
    pages = {525--536},
    volume = {109},
    url = {http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4217535&tool=pmcentrez&rendertype=abstract},
    doi = {10.1080/01621459.2014.881740},
    issn = {0162-1459},
    pmid = {25382884},
    keywords = {bayesian adaptive clinical design, data augmentation algorithm, design, dose-finding, missing data, phase i-ii clinical trial, piecewise exponential model}
}

@article{Thall2017,
    title = {{Parametric dose standardization for optimizing two-agent combinations in a phase I-II trial with ordinal outcomes}},
    year = {2017},
    journal = {Journal of the Royal Statistical Society. Series C: Applied Statistics},
    author = {Thall, Peter F. and Nguyen, Hoang Q. and Zinner, Ralph G.},
    number = {1},
    pages = {201--224},
    volume = {66},
    doi = {10.1111/rssc.12162},
    issn = {14679876},
    keywords = {Adaptive design, Bayesian design, Combination trial, Ordinal variables, Phase I-II clinical trial, Utility}
}

@article{White2011,
    title = {{Strategy for intention to treat analysis in randomised trials with missing outcome Data Strategy for intention to treat analysis in randomised}},
    year = {2011},
    journal = {British Medical Journal},
    author = {White, Ian and Horton, Nicholas and Carpenter, James and Pocock, Stuart},
    number = {d40},
    volume = {342},
    doi = {10.1136/bmj.d40}
}

@misc{JacqminGadda,
    title = {{Introduction to mixed model and missing data issues in longitudinal studies}},
    author = {Jacqmin-Gadda, Helene},
    publisher = {INSERM Workshop U897},
    address = {Bordeaux}
}

@article{White2011a,
    title = {{Strategies for handling missing data in randomised trials}},
    year = {2011},
    journal = {Trials},
    author = {White, Ian},
    number = {October},
    pages = {A59},
    volume = {12},
    url = {http://www.trialsjournal.com/content/12/S1/A59},
    issn = {1745-6215}
}

@article{Groenewegen2014,
    title = {{Measures for improving treatment outcomes for patients with epilepsy - Results from a large multinational patient-physician survey}},
    year = {2014},
    journal = {Epilepsy and Behavior},
    author = {Groenewegen, Andr?? and Tofighy, Azita and Ryvlin, Philippe and Steinhoff, Bernhard J. and Dedeken, Peter},
    pages = {58--67},
    volume = {34},
    isbn = {1525-5050{\textbackslash}r1525-5069},
    doi = {10.1016/j.yebeh.2014.02.033},
    issn = {15255069},
    pmid = {2014230559},
    keywords = {Diagnosis, Epilepsy, Follow-up, Patient-physician, Survey, Treatment}
}

@article{Loring2011,
    title = {{Common data elements in epilepsy research: Development and implementation of the NINDS epilepsy CDE project}},
    year = {2011},
    journal = {Epilepsia},
    author = {Loring, David W. and Lowenstein, Daniel H. and Barbaro, Nicholas M. and Fureman, Brandy E. and Odenkirchen, Joanne and Jacobs, Margaret P. and Austin, Joan K. and Dlugos, Dennis J. and French, Jacqueline A. and Gaillard, William Davis and Hermann, Bruce P. and Hesdorffer, Dale C. and Roper, Steven N. and Van Cott, Anne C. and Grinnon, Stacie and Stout, Alexandra},
    number = {6},
    pages = {1186--1191},
    volume = {52},
    isbn = {1528-1167 (Electronic) 0013-9580 (Linking)},
    doi = {10.1111/j.1528-1167.2011.03018.x},
    issn = {00139580},
    pmid = {21426327},
    keywords = {Epilepsy, National Institute of Neurological Disorders and S, Research}
}

@article{Thurman2011,
    title = {{Standards for epidemiologic studies and surveillance of epilepsy}},
    year = {2011},
    journal = {Epilepsia},
    author = {Thurman, David J. and Beghi, Ettore and Begley, Charles E. and Berg, Anne T. and Buchhalter, Jeffrey R. and Ding, Ding and Hesdorffer, Dale C. and Hauser, W. Allen and Kazis, Lewis and Kobau, Rosemarie and Kroner, Barbara and Labiner, David and Liow, Kore and Logroscino, Giancarlo and Medina, Marco T. and Newton, Charles R. and Parko, Karen and Paschal, Angelia and Preux, Pierre Marie and Sander, Josemir W. and Selassie, Anbesaw and Theodore, William and Tomson, Torbjörn and Wiebe, Samuel},
    number = {SUPPL. 7},
    pages = {2--26},
    volume = {52},
    isbn = {1528-1167 (Electronic){\textbackslash}r0013-9580 (Linking)},
    doi = {10.1111/j.1528-1167.2011.03121.x},
    issn = {00139580},
    pmid = {21899536},
    arxivId = {arXiv:1011.1669v3},
    keywords = {Epidemiology, Epilepsy, Surveillance}
}

@article{Devlin2010,
    title = {{PATIENT-REPORTED OUTCOME MEASURES IN THE NHS: NEW METHODS FOR ANALYSING AND REPORTING EQ-5D DATA}},
    year = {2010},
    journal = {Health Economics},
    author = {Devlin, Nancy J. and Parkin, David and Browne, John},
    number = {June},
    pages = {886--905},
    volume = {19},
    isbn = {1099-1050; 1057-9230},
    doi = {10.1002/hec},
    issn = {1099-1050},
    pmid = {19816948},
    arxivId = {10.1002/hec.3108},
    keywords = {EQ-5D, PROMs, health outcomes, performance indicators}
}

@article{Fisher2012,
    title = {{Seizure diaries for clinical research and practice: limitations and future prospects.}},
    year = {2012},
    journal = {Epilepsy {\&} behavior : E{\&}B},
    author = {Fisher, Robert S. and Blum, David E. and DiVentura, Bree and Vannest, Jennifer and Hixson, John D. and Moss, Robert and Herman, Susan T. and Fureman, Brandy E. and French, Jacqueline A.},
    number = {3},
    pages = {304--310},
    volume = {24},
    publisher = {Elsevier Inc.},
    url = {http://dx.doi.org/10.1016/j.yebeh.2012.04.128},
    isbn = {1525-5069},
    doi = {10.1016/j.yebeh.2012.04.128},
    issn = {15255069},
    pmid = {22652423},
    keywords = {Clinical trials, Diaries, Epilepsy, Internet, Patient-reported outcomes, Seizure}
}

@techreport{Devlin2009,
    title = {{Using the EQ-5D as a performance measurement tool in the NHS}},
    year = {2009},
    author = {Devlin, Nancy J. and Parkin, David and Browne, John},
    institution = {City University London},
    address = {London}
}

@article{Hung2015,
    title = {{Validation of the EQ-5D in Patients with Traumatic Limb Injury}},
    year = {2015},
    journal = {Journal of Occupational Rehabilitation},
    author = {Hung, Mei Chuan and Lu, Wen Shian and Chen, Sheng Shiung and Hou, Wen Hsuan and Hsieh, Ching Lin and Wang, Jung Der},
    number = {2},
    pages = {387--393},
    volume = {25},
    publisher = {Springer US},
    url = {http://dx.doi.org/10.1007/s10926-014-9547-0},
    isbn = {1573-3688 (Electronic){\textbackslash}n1053-0487 (Linking)},
    doi = {10.1007/s10926-014-9547-0},
    issn = {10530487},
    pmid = {25261389},
    keywords = {Construct validity, EQ-5D, Predictive validity, Responsiveness, Traumatic limb injury}
}

@article{Ware1996,
    title = {{A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.}},
    year = {1996},
    journal = {Medical Care},
    author = {Ware, John Jr and Kosinski, Mark MA and Keller, SD Susan D},
    number = {3},
    pages = {220--233},
    volume = {34},
    isbn = {0025-7079 (Print){\textbackslash}r0025-7079 (Linking)},
    doi = {10.2307/3766749},
    issn = {0025-7079},
    pmid = {8628042},
    arxivId = {0025-7079}
}

@article{Jenkinson1997,
    title = {{A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies?}},
    year = {1997},
    journal = {Journal of Public Health},
    author = {Jenkinson, C. and Layte, R. and Jenkinson, D. and Lawrence, K. and Petersen, S. and Paice, C. and Stradling, J.},
    number = {2},
    pages = {179--186},
    volume = {19},
    url = {https://academic.oup.com/jpubhealth/article-lookup/doi/10.1093/oxfordjournals.pubmed.a024606},
    isbn = {0957-4832 (Print){\textbackslash}r0957-4832},
    doi = {10.1093/oxfordjournals.pubmed.a024606},
    issn = {1741-3842},
    pmid = {9243433}
}

@article{Ware1998,
    title = {{How to score the SF-12 physical and mental health summary scales}},
    year = {1998},
    journal = {Lincoln, RI: Quality Metric.},
    author = {Ware, J. E. and Kosinski, M. and Keller, S. D.},
    number = {April},
    isbn = {1891810022 9781891810022}
}

@article{MentalHealthCommissionofCanada2009,
    title = {{SF-12 Health Survey Patient name : Date : PCS : MCS :}},
    year = {2009},
    journal = {Mental Health Commission of Canada},
    author = {{Mental Health Commission of Canada}},
    pages = {24},
    url = {http://www.mentalhealthcommission.ca/English/system/files/private/FNIM_Toward_Recovery_and_Well_Being_ENG_0.pdf%5Cnhttp://www.cpa.ca/docs/File/Practice/strategy-text-en.pdf},
    isbn = {9780981379524},
    doi = {10.7870/cjcmh-2013-001},
    issn = {0713-3936}
}

@article{Salen1994,
    title = {{The disability rating index: An instrument for the assessment of disability in clinical settings}},
    year = {1994},
    journal = {Journal of Clinical Epidemiology},
    author = {Salen, Bo A. and Erik, Erik V. and Nordemar, Rolf},
    number = {12},
    pages = {1423--1435},
    volume = {47},
    isbn = {0895-4356},
    doi = {10.1016/0895-4356(94)90086-8},
    issn = {08954356},
    pmid = {7730851},
    keywords = {Disability evaluation, Evaluation study, Outcome assessment, Physical disability}
}

@article{Wall2014a,
    title = {{Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss}},
    year = {2014},
    journal = {Jama},
    author = {Wall, Michael and McDermott, Michael P. and Kieburtz, Karl D. and Corbett, James J. and Feldon, Steven E. and Friedman, Deborah I. and Katz, David M. and Keltner, John L. and Schron, Eleanor B. and Kupersmith, Mark J.},
    number = {16},
    pages = {1641},
    volume = {311},
    url = {http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2014.3312},
    doi = {10.1001/jama.2014.3312},
    issn = {0098-7484},
    pmid = {24756514}
}

@article{Wall2014b,
    title = {{The Idiopathic Intracranial Hypertension Treatment Trial}},
    year = {2014},
    journal = {JAMA Neurology},
    author = {Wall, Michael and Kupersmith, Mark J. and Kieburtz, Karl D. and Corbett, James J. and Feldon, Steven E. and Friedman, Deborah I. and Katz, David M. and Keltner, John L. and Schron, Eleanor B. and McDermott, Michael P.},
    number = {6},
    pages = {693},
    volume = {71},
    url = {http://archneur.jamanetwork.com/article.aspx?doi=10.1001/jamaneurol.2014.133},
    isbn = {0000000000000},
    doi = {10.1001/jamaneurol.2014.133},
    issn = {2168-6149}
}

@article{Friedman2014,
    title = {{The Idiopathic Intracranial Hypertension Treatment Trial: Design Considerations and Methods}},
    year = {2014},
    journal = {Journal of Neuro-Ophthalmology},
    author = {Friedman, Deborah I. and McDermott, Michael P. and Kieburtz, Karl and Kupersmith, Mark and Stoutenburg, Ann and Keltner, John L. and Feldon, Steven E. and Schron, Eleanor and Corbett, James J. and Wall, Michael},
    number = {2},
    pages = {107--117},
    volume = {34},
    url = {http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00041327-201406000-00002},
    isbn = {0000000000000},
    doi = {10.1097/WNO.0000000000000114},
    issn = {1070-8022}
}

@article{Molenberghs2004,
    title = {{Analyzing incomplete longitudinal clinical trial data}},
    year = {2004},
    journal = {Biostatistics},
    author = {Molenberghs, G. and Thijs, Herbert and Jansen, Ivy and Beunckens, Caroline},
    number = {3},
    pages = {445--464},
    volume = {5},
    url = {http://biostatistics.oupjournals.org/cgi/doi/10.1093/biostatistics/5.3.445},
    doi = {10.1093/biostatistics/5.3.445},
    issn = {1465-4644}
}

@article{Kakkis2015,
    title = {{Recommendations for the development of rare disease drugs using the accelerated approval pathway and for qualifying biomarkers as primary endpoints}},
    year = {2015},
    journal = {Orphanet Journal of Rare Diseases},
    author = {Kakkis, Emil D and O’Donovan, Mary and Cox, Gerald and Hayes, Mark and Goodsaid, Federico and Tandon, PK and Furlong, Pat and Boynton, Susan and Bozic, Mladen and Orfali, May and Thornton, Mark},
    number = {1},
    pages = {16},
    volume = {10},
    url = {http://www.ojrd.com/content/10/1/16},
    isbn = {1750-1172},
    doi = {10.1186/s13023-014-0195-4},
    issn = {1750-1172},
    pmid = {25757705}
}

@article{Silberstein2007,
    title = {{Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial}},
    year = {2007},
    journal = {Headache},
    author = {Silberstein, Stephen D. and Lipton, Richard B. and Dodick, David W. and Freitag, Frederick G. and Ramadan, Nabih and Mathew, Ninan and Brandes, Jan L. and Bigal, Marcelo and Saper, Joel and Ascher, Steven and Jordan, Donna M. and Greenberg, Steven J. and Hulihan, Joseph},
    number = {2},
    pages = {170--180},
    volume = {47},
    isbn = {0017-8748},
    doi = {10.1111/j.1526-4610.2006.00684.x},
    issn = {00178748},
    pmid = {17300356},
    keywords = {Chronic daily headache, Clinical trial, Migraine, Preventive treatment, Topiramate, Transformed migraine}
}

@article{Tfelt-Hansen2012,
    title = {{Guidelines for controlled trials of drugs in migraine: Second edition}},
    year = {2012},
    journal = {Cephalalgia},
    author = {Tfelt-Hansen, P. and Block, G. and Dahl{\"{o}}f, C. and Diener, H. C. and Ferrari, Md and Goadsby, Pj and Guidetti, V. and Jones, B. and Lipton, Rb and Massiou, H. and Meinert, C. and Sandrini, G. and Steiner, T. and Winter, Pbo},
    number = {1},
    volume = {32},
    isbn = {1468-2982 (Electronic){\textbackslash}r0333-1024 (Linking)},
    doi = {10.1046/j.1468-2982.2000.00117.x},
    issn = {03331024},
    pmid = {11167908}
}

@article{Bigal2015,
    title = {{Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: A multicentre, randomised, double-blind, placebo-controlled, phase 2b study}},
    year = {2015},
    journal = {The Lancet Neurology},
    author = {Bigal, Marcelo E. and Edvinsson, Lars and Rapoport, Alan M. and Lipton, Richard B. and Spierings, Egilius L H and Diener, Hans Christoph and Burstein, Rami and Loupe, Pippa S. and Ma, Yuju and Yang, Ronghua and Silberstein, Stephen D.},
    number = {11},
    pages = {1091--1100},
    volume = {14},
    publisher = {Elsevier Ltd},
    isbn = {1474-4465 (Electronic){\textbackslash}r1474-4422 (Linking)},
    doi = {10.1016/S1474-4422(15)00245-8},
    issn = {14744465},
    pmid = {26432181}
}

@article{Tepper2017,
    title = {{Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial}},
    year = {2017},
    journal = {The Lancet Neurology},
    author = {Tepper, Stewart and Ashina, Messoud and Reuter, Uwe and Brandes, Jan L and Dole{\v{z}}il, David and Silberstein, Stephen and Winner, Paul and Leonardi, Dean and Mikol, Daniel and Lenz, Robert},
    pages = {425--34},
    volume = {16},
    isbn = {1474-4422},
    doi = {10.1016/S1474-4422(17)30083-2},
    issn = {14744422},
    pmid = {28460892}
}

@article{Dodick2010,
    title = {{OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program}},
    year = {2010},
    journal = {Headache},
    author = {Dodick, David W. and Turkel, Catherine C. and Degryse, Ronald E. and Aurora, Sheena K. and Silberstein, Stephen D. and Lipton, Richard B. and Diener, Hans Christoph and Brin, Mitchell F.},
    number = {6},
    pages = {921--936},
    volume = {50},
    isbn = {1526-4610},
    doi = {10.1111/j.1526-4610.2010.01678.x},
    issn = {15264610},
    pmid = {20487038},
    keywords = {Botulinum toxin A, Chronic migraine, Prophylaxis}
}

@article{Tepper2017a,
    title = {{Appendix to Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial}},
    year = {2017},
    journal = {The Lancet Neurology},
    author = {Tepper, Stewart and Ashina, Messoud and Reuter, Uwe and Brandes, Jan L and Dole{\v{z}}il, David and Silberstein, Stephen and Winner, Paul and Leonardi, Dean and Mikol, Daniel and Lenz, Robert},
    isbn = {0000030449},
    doi = {10.1056/NEJMoa1506699},
    issn = {1533-4406},
    pmid = {22316447}
}

@article{Liu2005,
    title = {{The Analysis of ordered categorical data: an overview and a survey of recent developments}},
    year = {2005},
    journal = {Sociedad de Estadıstica e Investigacion Operativa Test},
    author = {Liu, Ivy and Agresti, Alan},
    number = {1},
    pages = {1--73},
    volume = {14},
    isbn = {1133-0686},
    doi = {10.1007/BF02595397},
    issn = {1133-0686}
}

@article{Coeytaux2006,
    title = {{Four methods of estimating the minimal important difference score were compared to establish a clinically significant change in Headache Impact Test}},
    year = {2006},
    journal = {Journal of Clinical Epidemiology},
    author = {Coeytaux, Remy R. and Kaufman, Jay S. and Chao, Ryon and Mann, J. Douglas and DeVellis, Robert F.},
    number = {4},
    pages = {374--380},
    volume = {59},
    isbn = {0895-4356 (Print){\textbackslash}r0895-4356 (Linking)},
    doi = {10.1016/j.jclinepi.2005.05.010},
    issn = {08954356},
    pmid = {16549259},
    keywords = {Chronic daily headache, Clinical change, Headache Impact Test, Health-related quality of life, Measurement, Minimal important difference}
}

@article{Biton2014,
    title = {{Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial}},
    year = {2014},
    journal = {Epilepsia,},
    author = {Biton, Victor and Berkovic, Samuel F and Abou-khalil, Bassel and Sperling, Michael R and Johnson, Martin E and Lu, Sarah},
    number = {1},
    pages = {57--66},
    volume = {55},
    doi = {10.1111/epi.12433},
    keywords = {2010, being investigated for the, bialer, brivaracetam, brv, currently, efficacy, et al, high-affinity synaptic vesicle pro-, is a pyrrolidine derivative, it is a novel, partial epilepsy, phase iii, safety, tolerability, treatment of epilepsy}
}

@article{French2012,
    title = {{Adjunctive perampanel for refractory partial-onset seizures}},
    year = {2012},
    journal = {Neurology},
    author = {French, Jacqueline A and Krauss, Gregory L and Biton, Victor and Squillacote, David and Yang, Haichen and Laurenza, Antonio and Kumar, Dinesh and Rogawski, Michael A.},
    pages = {589--596},
    volume = {79}
}

@article{Kupersmith2015,
    title = {{Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.}},
    year = {2015},
    journal = {Ophthalmology},
    author = {Kupersmith, Mark J.},
    number = {9},
    pages = {1939--45},
    volume = {122},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/26198807%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4549202},
    doi = {10.1016/j.ophtha.2015.06.003},
    issn = {1549-4713},
    pmid = {26198807}
}

@article{Garway-Heath2013,
    title = {{The United Kingdom glaucoma treatment study: A multicenter, randomized, placebo-controlled clinical trial: Design and methodology}},
    year = {2013},
    journal = {Ophthalmology},
    author = {Garway-Heath, David F. and Lascaratos, Gerassimos and Bunce, Catey and Crabb, David P. and Russell, Richard A. and Shah, Ameet},
    number = {1},
    pages = {68--76},
    volume = {120},
    publisher = {Elsevier Inc.},
    url = {http://dx.doi.org/10.1016/j.ophtha.2012.07.028},
    isbn = {1549-4713},
    doi = {10.1016/j.ophtha.2012.07.028},
    issn = {01616420},
    pmid = {22986112}
}

@article{Leske1999,
    title = {{Early manifest glaucoma trial}},
    year = {1999},
    journal = {Ophthalmology},
    author = {Leske, M.Cristina and Heijl, Anders and Hyman, Leslie and Bengtsson, Bo},
    number = {11},
    pages = {2144--2153},
    volume = {106},
    url = {http://www.sciencedirect.com/science/article/pii/S0161642099904979},
    isbn = {0161-6420},
    doi = {10.1016/S0161-6420(99)90497-9},
    issn = {01616420},
    pmid = {10571351}
}

@article{Mitsikostas2015,
    title = {{New players in the preventive treatment of migraine}},
    year = {2015},
    journal = {BMC Medicine},
    author = {Mitsikostas, Dimos D. and Rapoport, Alan M.},
    number = {1},
    pages = {279},
    volume = {13},
    publisher = {BMC Medicine},
    url = {http://www.biomedcentral.com/1741-7015/13/279},
    isbn = {1741-7015 (Electronic){\textbackslash}r1741-7015 (Linking)},
    doi = {10.1186/s12916-015-0522-1},
    issn = {1741-7015},
    pmid = {26555040},
    keywords = {Migraine,Cluster headache,Prevention,CGRP,Monoclon, cgrp, cluster headache, migraine, monoclonal antibodies, neuromodulation, neurostimulation, prevention, stimulation, supraorbital and supratrochlear nerve, vagus nerve stimulation}
}

@article{Silberstein2008,
    title = {{Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults}},
    year = {2008},
    journal = {Cephalalgia},
    author = {Silberstein, S. and Tfelt-Hansen, P. and Dodick, D. W. and Limmroth, V. and Lipton, R. B. and Pascual, J. and Wang, S. J.},
    number = {5},
    pages = {484--495},
    volume = {28},
    isbn = {1468-2982},
    doi = {10.1111/j.1468-2982.2008.01555.x},
    issn = {03331024},
    pmid = {18294250},
    keywords = {Chronic migraine, Clinical trials, Headache, Medication-overuse headache, Prophylactic treatment}
}

@article{CIGTS1999,
    title = {{The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients.}},
    year = {1999},
    journal = {Ophthalmology},
    author = {{CIGTS}},
    number = {4},
    pages = {653--62},
    volume = {106},
    url = {http://www.sciencedirect.com/science/article/pii/S0161642099901471\nhttp://www.ncbi.nlm.nih.gov/pubmed/10201583},
    isbn = {0161-6420},
    doi = {10.1016/S0161-6420(99)90147-1},
    issn = {0161-6420},
    pmid = {10201583}
}

@article{Dushay2012,
    title = {{Short-Term Exenatide Treatment Leads to Signi fi cant Weight Loss in a Subset of Obese Women Without Diabetes}},
    year = {2012},
    journal = {Diabetes Care},
    author = {DUSHAY, JODY and GAO, CHUANYUN and GOPALAKRISHNAN, GOSALA S. and CRAWLEY, MEGHAN and MITTEN, EMILIE K. and WILKER, ELISSA and MULLINGTON, JANET and MARATOS-FLIER, ELEFTHERIA and {OBJECTIVEdTo}},
    pages = {4--11},
    volume = {35},
    doi = {10.2337/dc11-0931.}
}

@article{Grieve1998,
    title = {{Estimating treatment effects in clinical crossover trials.}},
    year = {1998},
    journal = {Journal of biopharmaceutical statistics},
    author = {Grieve, A and Senn, S},
    number = {February 2015},
    pages = {191--233},
    volume = {8},
    doi = {10.1080/10543409808835235},
    issn = {1054-3406},
    pmid = {9598420}
}

@article{Senn2013,
    title = {{Seven myths of randomisation in clinical trials}},
    year = {2013},
    journal = {Statistics in Medicine},
    author = {Senn, Stephen},
    number = {9},
    pages = {1439--1450},
    volume = {32},
    isbn = {1097-0258; 0277-6715},
    doi = {10.1002/sim.5713},
    issn = {02776715},
    pmid = {23255195},
    keywords = {Blinding, Conditioning, Covariates, Randomisation}
}

@article{Senn2004,
    title = {{Controversies concerning randomization and additivity in clinical trials}},
    year = {2004},
    journal = {Statistics in Medicine},
    author = {Senn, Stephen},
    number = {24},
    pages = {3729--3753},
    volume = {23},
    isbn = {0277-6715},
    doi = {10.1002/sim.2074},
    issn = {02776715},
    pmid = {15580598},
    keywords = {Additivity, Clinical trails, History of statistics, Randomisation, Unit-treatment interaction}
}

@article{Gelman2017,
    title = {{Beyond subjective and objective in statistics}},
    year = {2017},
    journal = {Journal of the Royal Statistical Society},
    author = {Gelman, Andrew and Hennig, Christian},
    number = {4},
    pages = {1--31},
    volume = {180},
    arxivId = {arXiv:1508.05453v1}
}

@article{Altman1983,
    title = {{Statistical guidelines for contributors to medical journals.}},
    year = {1983},
    journal = {British medical journal (Clinical research ed.)},
    author = {Altman, D G and Gore, S M and Gardner, M J and Pocock, S J},
    number = {6376},
    pages = {1489--1493},
    volume = {286},
    isbn = {0267-0623 (Print){\textbackslash}n0267-0623 (Linking)},
    doi = {10.1136/bmj.286.6376.1489},
    issn = {0267-0623},
    pmid = {6405856}
}

@article{James2015AdditionTrial,
    title = {{Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial}},
    year = {2015},
    author = {James, Nicholas D and Sydes, Matthew R and Clarke, Noel W and Mason, Malcolm D and Dearnaley, David P and Spears, Melissa R and Ritchie, Alastair W S and Parker, Christopher C and Russell, J Martin and Attard, Gerhardt and De Bono, Johann and Cross, William and Jones, Rob J and Thalmann, George and Amos, Claire and Matheson, David and Millman, Robin and Alzouebi, Mymoona and Beesley, Sharon and Birtle, Alison J and Brock, Susannah and Cathomas, Richard and Chakraborti, Prabir and Chowdhury, Simon and Cook, Audrey and Elliott, Tony and Gale, Joanna and Gibbs, Stephanie and Graham, John D and Hetherington, John and Hughes, Robert and Laing, Robert and Mckinna, Fiona and Mclaren, Duncan B and O 'sullivan, Joe M and Parikh, Omi and Peedell, Clive and Protheroe, Andrew and Robinson, Angus J and Srihari, Narayanan and Srinivasan, Rajaguru and Staff, John and Sundar, Santhanam and Tolan, Shaun and Tsang, David and Wagstaff, John and Parmar, Mahesh K B},
    doi = {10.1016/S0140-6736(15)01037-5}
}

@article{Thall1995SINGLE-ARMOUTCOMES,
    title = {{SINGLE-ARM CLINICAL TRIALS WITH MULTIPLE OUTCOMES}},
    year = {1995},
    author = {Thall, Peter F and Simon, Richard M and Estey, Elihu H},
    number = {October 1993},
    pages = {357--379},
    volume = {14}
}

@article{Mander2015ATrials,
    title = {{A product of independent beta probabilities dose escalation design for dual-agent phase I trials}},
    year = {2015},
    journal = {Statistics in Medicine},
    author = {Mander, Adrian P. and Sweeting, Michael J.},
    isbn = {0277-6715},
    doi = {10.1002/sim.6434},
    issn = {10970258},
    pmid = {25630638},
    keywords = {Adaptive design, Dose escalation, Dual-agent trial, Nonparametric, Phase I clinical trial}
}

@article{EichlerTrials,
    title = {{" Threshold-crossing " : A Useful Way to Establish the Counterfactual in Clinical Trials?}},
    author = {Eichler, H-G and Bloechl-Daum, B and Bauer, P and Bretz, F and Brown, J and Hampson, Lv and Honig, P and Krams, M and Leufkens, H and Lim, R},
    doi = {10.1002/cpt.515}
}

@article{Saglio2016HHSAccess,
    title = {{HHS Public Access}},
    year = {2016},
    author = {Saglio, Giuseppe and Hochhaus, Andreas and Goh, Yeow Tee and Masszi, Tamas and Pasquini, Ricardo and Maloisel, Frederic and Erben, Philipp and Cortes, Jorge and Paquette, Ronald and Bradley-garelik, M Brigid and Zhu, Chao and Sciences, Biological and Jena, Universitaetsklinikum and Curitiba, De Clinicas De and Clinic, Medical and Angeles, Los},
    number = {16},
    pages = {3852--3861},
    volume = {116},
    doi = {10.1002/cncr.25123.Dasatinib}
}

@article{Philipson1997ExperimentsSampling,
    title = {{Experiments and subject sampling}},
    year = {1997},
    author = {Philipson, B Y Tomas},
    pages = {619--630}
}

@article{CytokineMeans,
    title = {{Cytokine means}}
}

@article{Hirsch2017SeminarTreatments,
    title = {{Seminar Lung cancer: current therapies and new targeted treatments}},
    year = {2017},
    journal = {www.thelancet.com},
    author = {Hirsch, Fred R and Scagliotti, Giorgio V and Mulshine, James L and Kwon, Regina and Curran, Walter J and Wu, Yi-Long and Paz-Ares, Luis},
    number = {21},
    volume = {389},
    doi = {10.1016/S0140-6736(16)30958-8}
}

@article{Levy2017NonparametricAmerica,
    title = {{Nonparametric Applications of Shaffer ' s Extension of Dunnett ' s Procedure Author ( s ): Kenneth J . Levy Source : The American Statistician , Vol . 34 , No . 2 ( May , 1980 ), pp . 99-102 Published by : Taylor {\&} Francis , Ltd . on behalf of the America}},
    year = {2017},
    author = {Levy, Kenneth J},
    number = {2},
    pages = {99--102},
    volume = {34},
    keywords = {1n, dunnett, let s2 be the, means t, multiple comparisons, nonparametric procedures, s procedure, then, u and variances -2, unbiased estimate of -2, usual}
}

@article{FosterSTEROIDS,
    title = {{STEROIDS ! AND ! IMMUNITY ! FROM ! INJURY ! THROUGH ! TO ! REHABILITATION ! ( SIR ! Study )! By ! Mark ! Anthony ! Foster !}},
    author = {Foster, Mark}
}